@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_77  a   gn:DS_77_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_77" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biotic_relationship>
                "parasite" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "<i>Opisthorchis viverrini</i> metacercariae obtained from cyprinoid fish was infected to hamster." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#geo_loc_name>
                "Thailand:Khon Kaen province, fresh water reservoir" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#host>
                "cyprinoid fish" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#host_taxid>
                "30727" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host>
                "hamsters" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_taxid>
                "10026" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_tissue_sampled>
                "livers, gallbladders, extrahepatic bile ducts" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-77" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "Opisthorchis viverrini" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The metacercariae were obtained from cyprinoid fish captured from a fresh water reservoir in the endemic area (Khon Kaen province, Thailand) which naturally infected.  After digestion the fish by pepsin–HCl and washings with normal saline, the metacercariae were collected and identified by a dissecting microscope. Viable metacercariae were infected to the hamsters and adult <i>O. viverrini</i> worms were obtained from the livers, gallbladders and extrahepatic bile ducts of hamsters after 2–3 months." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The samples were released with glycoamidase A, labeled with 2-PA. The sample was separated by the ODS and amide–silica columns. The sample analyzed by MALDITOF-MS and HPLC mapping method. The identification of <i>N</i>-glycan structures was mapping in the GALAXY database (DOI: 10.4052/tigg.15.235). " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Glycans of adult <i>Opisthorchis viverrini</i> worms obtained from infected hamster livers, gallbladders and extrahepatic bile ducts." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "6198" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_228  a  gn:DS_228_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:3910" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_228" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "48" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample tissue was obtained from the patients with lung adenocarcinoma and pathologist-verified to be 100% normal lung tissues." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "lung adenocarcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#growth_stage>
                "adult" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-228" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The tissue was washed with cold phosphate-buffered saline and homogenized in the same buffer. The sample was centrifuged for 10 min at 4  degree Celsius. The membrane fraction pellet was then resuspended in PBS and recentrifuged. The sample was washed twice and lyophilized. The sample was incubated with acetone for 1 h at -80  degree Celsius for delipidation. The sample was centrifugated for 20 min at 4  degree Celsius and the pellet was resuspended in acetone and recentrifuged. The sample was then lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was treated with anhydrous hydrazine for 10 h at 100  degree Celsius. The sample was azeotropic distillated with toluene, the released <i>N</i>-glycans were incubated with saturated sodium bicarbonate/acetic anhydride solution at 4  degree Celsius for 20 min and for another 30 min at room temperature. The sample was subjected to cation-exchange column chromatography and evaporated. The sample was labeled with the fluorescent reagent 2-aminopyridine (PA) and separated by diethylaminoethanol (DEAE) column. The sample was further separated by an octadecyl silica (ODS) column. Each peak was identified by comparisons its elution time with the reference PA-glycans, co-injection with the reference PA-glycan, digestion with several glycosidases and determination the changes in elution times in comparison with the elution times of the reference PA-glycans, or determination the molecular mass by using matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS). Some peaks containing more than one glycan were further separated by an amide column and then identified as described above. One of the peaks was treated with β-galactosidase." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycan mixtures from proteins obtained from human lung specimens containing 85-90% alveoli, 5% bronchioles and 5-10% fibrovascular of the patient with lung adenocarcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "lung; 85-90% alveoli, 5% bronchioles and 5-10% fibrovascular" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_28  a   gn:DS_28_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-23" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "26 - 38" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Eiji Miyoshi lab, Osaka University" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The samples obtained from healthy sera and stored -80 degree Celsius were filtered and then diluted with buffer A (sodium phosphate buffer, NaCl, NaN<sub>3</sub>). The diluted sample was subjected to an anti-haptoglobin affinity column, which was coupled with anti-human haptoglobin, at room temperature. After washing the column with buffer A, the sample was eluted with elution buffer (Glycine, NaCl) from the column. The sample was immediately neutralized with Tris-HCl. The sample was passed through a PD-10 column equilibrated with water and evaporated. The residue was dissolved in water (sample solution A). The sample was subjected to SDS-PAGE under reduced conditions and stained with CBB." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was treated with iodoacetamide (sample solution B) and incubated with acetic acid at 80 degree Celsius for 2 hr to remove sialic acids. After evaporating, the residue was digested with PNGase F (in NH<sub>4</sub>HCO<sub>3</sub>). The released <i>N</i>-glycans were applied to a GlycoTAG apparatus. Then, a portion of the sample was digested with α1-3/4 fucosidase followed by digestion with β1-4 galactosidase. The samples were subjected to NP-HPLC analysis. The amount of detected <i>N</i>-glycans was calculated based on the peak areas of standard <i>N</i>-glycan samples." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-80 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of three fifths healthy (NVs); NV3, NV4 and NV5." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_29  a   gn:DS_29_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1793" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-24" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "mean 65" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka University-related Hospitals" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "pancreatic cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The samples obtained from pancreatic cancers sera and stored -80 degree Celsius were filtered and then diluted with buffer A (sodium phosphate buffer, NaCl, NaN<sub>3</sub>). The diluted sample was subjected to an anti-haptoglobin affinity column, which was coupled with anti-human haptoglobin, at room temperature. After washing the column with buffer A, the sample was eluted with elution buffer (Glycine, NaCl) from the column. The sample was immediately neutralized with Tris-HCl. The sample was passed through a PD-10 column equilibrated with water and evaporated. The residue was dissolved in water (sample solution A). The sample was subjected to SDS-PAGE under reduced conditions and stained with CBB." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was treated with iodoacetamide (sample solution B) and incubated with acetic acid at 80 degree Celsius for 2 hr to remove sialic acids. After evaporating, the residue was digested with PNGase F (in NH<sub>4</sub>HCO<sub>3</sub>). The released <i>N</i>-glycans were applied to a GlycoTAG apparatus. Then, a portion of the sample was digested with α1-3/4 fucosidase followed by digestion with β1-4 galactosidase. The samples were subjected to NP-HPLC analysis. The amount of detected <i>N</i>-glycans was calculated based on the peak areas of standard <i>N</i>-glycan samples." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-80 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of three fifths pancreatic cancers (PCs); PC1, PC2 and PC4." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_30  a   gn:DS_30_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-24" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_30" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D050500" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "mean 66" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka University-related Hospitals" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "chronic pancreatitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-30" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The samples obtained from chronic pancreatitis sera and stored -80 degree Celsius were filtered and then diluted with buffer A (sodium phosphate buffer, NaCl, NaN<sub>3</sub>). The diluted sample was subjected to an anti-haptoglobin affinity column, which was coupled with anti-human haptoglobin, at room temperature. After washing the column with buffer A, the sample was eluted with elution buffer (Glycine, NaCl) from the column. The sample was immediately neutralized with Tris-HCl. The sample was passed through a PD-10 column equilibrated with water and evaporated. The residue was dissolved in water (sample solution A). The sample was subjected to SDS-PAGE under reduced conditions and stained with CBB." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was treated with iodoacetamide (sample solution B) and incubated with acetic acid at 80 degree Celsius for 2 hr to remove sialic acids. After evaporating, the residue was digested with PNGase F (in NH<sub>4</sub>HCO<sub>3</sub>). The released <i>N</i>-glycans were applied to a GlycoTAG apparatus. Then, a portion of the sample was digested with α1-3/4 fucosidase followed by digestion with β1-4 galactosidase. The samples were subjected to NP-HPLC analysis. The amount of detected <i>N</i>-glycans was calculated based on the peak areas of standard <i>N</i>-glycan samples." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-80 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of three fifths chronic pancreatitis (CPs); CP1, CP2 and CP3." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_31  a   gn:DS_31_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-24" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_31" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "26 - 38, n=5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Eiji Miyoshi lab, Osaka University" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-31" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The samples obtained from young healthy sera and stored -80 degree Celsius were filtered and then diluted with buffer A (sodium phosphate buffer, NaCl, NaN<sub>3</sub>). The diluted sample was subjected to an anti-haptoglobin affinity column, which was coupled with anti-human haptoglobin, at room temperature. After washing the column with buffer A, the sample was eluted with elution buffer (Glycine, NaCl) from the column. The sample was immediately neutralized with Tris-HCl. The sample was passed through a PD-10 column equilibrated with water and evaporated. The residue was dissolved in water (sample solution A). The sample was subjected to SDS-PAGE under reduced conditions and stained with CBB." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "For the analysis at Asn184 and Asn241, the sample was added a reducing solution containing Tris-HCl, guanidine hydrochloride, EDTA and dithiothreitol. The sample was incubated at 50 degree Celsius for 1 hr. Then the sample was added iodoacetamide and allowed for 30 min at room temperature in the dark. The sample was passed through a Nap-5 column equilibrated with HCl and the eluate was immediately neutralized with Tris-HCl. The sample was mixed with Tris-HCl containing lysylendopeptidase and trypsin, and then incubated for 16 hr at 37 degree Celsius. After boiling, the sample was evaporated. The residue was dissolved in water (sample solution B). The sample solution B was separated using an ODS column. The proteins were identified using the NCBInr database with the MASCOT database-searching algorithm.<br>For the analysis at Asn207 and Asn211, the tryptic digests (sample solution B) was added water and mixed with 1-butanol/ethanol. The sample was subjected to Sepharose CL4B chromatography equilibrated with 1-butanol/ethanol/H<sub>2</sub>O. After gentle shaking for 30 min, the gel was washed three times with the same organic solvent. The gel was then incubated with ethanol/H<sub>2</sub>O, for 10 min, and the liquid-phase was evaporated. The residue was dissolved in acetic acid and incubated for 2 hr at 80 degree Celsius to remove sialic acids. The sample was evaporated and dissolved in water, and a portion was mixed with endoprotease Glu-C (in NH<sub>4</sub>HCO<sub>3</sub>), then incubated for 16 hr at 37 degree Celsius and boiled (sample solution C). The sample solution C was subjected to LC-ESI MS analysis, using an ODS column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-80 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of young healthy." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_32  a   gn:DS_32_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-24" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_32" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "63 - 75, n=3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Eiji Miyoshi lab, Osaka University" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-32" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The samples were filtered and then diluted with buffer A (sodium phosphate buffer, NaCl, NaN<sub>3</sub>). The diluted sample was circulated 5 times on an anti-haptoglobin affinity column, which was coupled with anti-human haptoglobin, at room temperature. After washing the column with buffer A, the sample was eluted with elution buffer (Glycine, NaCl) from the column. The sample was immediately neutralized with Tris-HCl. The sample was passed through a PD-10 column equilibrated with water. The sample was evaporated to dryness. The residue was dissolved in water (sample solution A). The sample was subjected to SDS-PAGE under reduced conditions and stained with CBB." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "For the analysis at Asn184 and Asn241, the sample was added a reducing solution containing Tris-HCl, guanidine hydrochloride, EDTA and dithiothreitol. The sample was incubated at 50 degree Celsius for 1 hr. Then the sample was added iodoacetamide and allowed for 30 min at room temperature in the dark. The sample was passed through a Nap-5 column equilibrated with HCl and the eluate was immediately neutralized with Tris-HCl. The sample was mixed with Tris-HCl containing lysylendopeptidase and trypsin, and then incubated for 16 hr at 37 degree Celsius. After boiling, the sample was evaporated. The residue was dissolved in water (sample solution B). The sample solution B was separated using an ODS column. The proteins were identified using the NCBInr database with the MASCOT database-searching algorithm.<br>For the analysis at Asn207 and Asn211, the tryptic digests (sample solution B) was added water and mixed with 1-butanol/ethanol. The sample was subjected to Sepharose CL4B chromatography equilibrated with 1-butanol/ethanol/H<sub>2</sub>O. After gentle shaking for 30 min, the gel was washed three times with the same organic solvent. The gel was then incubated with ethanol/H<sub>2</sub>O, for 10 min, and the liquid-phase was evaporated. The residue was dissolved in acetic acid and incubated for 2 hr at 80 degree Celsius to remove sialic acids. The sample was evaporated and dissolved in water, and a portion was mixed with endoprotease Glu-C (in NH<sub>4</sub>HCO<sub>3</sub>), then incubated for 16 hr at 37 degree Celsius and boiled (sample solution C). The sample solution C was subjected to LC-ESI MS analysis, using an ODS column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-80 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of old healthy." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_33  a   gn:DS_33_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1793" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-24" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_33" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "mean 65" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka University-related Hospitals" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "pancreatic cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-33" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The samples were filtered and then diluted with buffer A (sodium phosphate buffer, NaCl, NaN<sub>3</sub>). The diluted sample was circulated 5 times on an anti-haptoglobin affinity column, which was coupled with anti-human haptoglobin, at room temperature. After washing the column with buffer A, the sample was eluted with elution buffer (Glycine, NaCl) from the column. The sample was immediately neutralized with Tris-HCl. The sample was passed through a PD-10 column equilibrated with water. The sample was evaporated to dryness. The residue was dissolved in water (sample solution A). The sample was subjected to SDS-PAGE under reduced conditions and stained with CBB." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "For the analysis at Asn184 and Asn241, the sample was added a reducing solution containing Tris-HCl, guanidine hydrochloride, EDTA and dithiothreitol. The sample was incubated at 50 degree Celsius for 1 hr. Then the sample was added iodoacetamide and allowed for 30 min at room temperature in the dark. The sample was passed through a Nap-5 column equilibrated with HCl and the eluate was immediately neutralized with Tris-HCl. The sample was mixed with Tris-HCl containing lysylendopeptidase and trypsin, and then incubated for 16 hr at 37 degree Celsius. After boiling, the sample was evaporated. The residue was dissolved in water (sample solution B). The sample solution B was separated using an ODS column. The proteins were identified using the NCBInr database with the MASCOT database-searching algorithm.<br>For the analysis at Asn207 and Asn211, the tryptic digests (sample solution B) was added water and mixed with 1-butanol/ethanol. The sample was subjected to Sepharose CL4B chromatography equilibrated with 1-butanol/ethanol/H<sub>2</sub>O. After gentle shaking for 30 min, the gel was washed three times with the same organic solvent. The gel was then incubated with ethanol/H<sub>2</sub>O, for 10 min, and the liquid-phase was evaporated. The residue was dissolved in acetic acid and incubated for 2 hr at 80 degree Celsius to remove sialic acids. The sample was evaporated and dissolved in water, and a portion was mixed with endoprotease Glu-C (in NH<sub>4</sub>HCO<sub>3</sub>), then incubated for 16 hr at 37 degree Celsius and boiled (sample solution C). The sample solution C was subjected to LC-ESI MS analysis, using an ODS column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-80 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of pancreatic cancer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male n=2, female n=3" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_34  a   gn:DS_34_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-24" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_34" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D050500" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "mean 66" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka University-related Hospitals" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "chronic pancreatitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-34" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The samples were filtered and then diluted with buffer A (sodium phosphate buffer, NaCl, NaN<sub>3</sub>). The diluted sample was circulated 5 times on an anti-haptoglobin affinity column, which was coupled with anti-human haptoglobin, at room temperature. After washing the column with buffer A, the sample was eluted with elution buffer (Glycine, NaCl) from the column. The sample was immediately neutralized with Tris-HCl. The sample was passed through a PD-10 column equilibrated with water. The sample was evaporated to dryness. The residue was dissolved in water (sample solution A). The sample was subjected to SDS-PAGE under reduced conditions and stained with CBB." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "For the analysis at Asn184 and Asn241, the sample was added a reducing solution containing Tris-HCl, guanidine hydrochloride, EDTA and dithiothreitol. The sample was incubated at 50 degree Celsius for 1 hr. Then the sample was added iodoacetamide and allowed for 30 min at room temperature in the dark. The sample was passed through a Nap-5 column equilibrated with HCl and the eluate was immediately neutralized with Tris-HCl. The sample was mixed with Tris-HCl containing lysylendopeptidase and trypsin, and then incubated for 16 hr at 37 degree Celsius. After boiling, the sample was evaporated. The residue was dissolved in water (sample solution B). The sample solution B was separated using an ODS column. The proteins were identified using the NCBInr database with the MASCOT database-searching algorithm.<br>For the analysis at Asn207 and Asn211, the tryptic digests (sample solution B) was added water and mixed with 1-butanol/ethanol. The sample was subjected to Sepharose CL4B chromatography equilibrated with 1-butanol/ethanol/H<sub>2</sub>O. After gentle shaking for 30 min, the gel was washed three times with the same organic solvent. The gel was then incubated with ethanol/H<sub>2</sub>O, for 10 min, and the liquid-phase was evaporated. The residue was dissolved in acetic acid and incubated for 2 hr at 80 degree Celsius to remove sialic acids. The sample was evaporated and dissolved in water, and a portion was mixed with endoprotease Glu-C (in NH<sub>4</sub>HCO<sub>3</sub>), then incubated for 16 hr at 37 degree Celsius and boiled (sample solution C). The sample solution C was subjected to LC-ESI MS analysis, using an ODS column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-80 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of chronic pancreatitis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male n=3, female n=2" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_164  a  gn:DS_164_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_164" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was called normal 1." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-164" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed desialylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was obtained from the urine of the healthy pregnant woman." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_165  a  gn:DS_165_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_165" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was called normal 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-165" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed desialylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was obtained from the urine of the healthy pregnant woman." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_166  a  gn:DS_166_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3590" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_166" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was called hydatidiform mole 1." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hydatidiform mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-166" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed desialylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was obtained from the urine of the patient with hydatidiform mole." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_167  a  gn:DS_167_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3590" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_167" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was called hydatidiform mole 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hydatidiform mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-167" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed desialylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was obtained from the urine of the patient with hydatidiform mole." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_168  a  gn:DS_168_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3590" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_168" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was called hydatidiform mole 3." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hydatidiform mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-168" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed desialylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was obtained from the urine of the patient with hydatidiform mole." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_169  a  gn:DS_169_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_169" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D002820" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was called invasive mole 1." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "invasive mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-169" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed desialylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was obtained from the urine of the patient with invasive mole." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_170  a  gn:DS_170_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_170" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D002820" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was called invasive mole 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "invasive mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-170" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed desialylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was obtained from the urine of the patient with invasive mole." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_18  a   gn:DS_18_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3594" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was called choriocarcinoma 1." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "choriocarcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_171" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed desialylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was obtained from the urine of the patient with choriocarcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_19  a   gn:DS_19_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3594" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was called choriocarcinoma 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "choriocarcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_172" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed desialylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was obtained from the urine of the patient with choriocarcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_20  a   gn:DS_20_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3594" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was called choriocarcinoma 3." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "choriocarcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_173" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed desialylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was obtained from the urine of the patient with choriocarcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_21  a   gn:DS_21_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3594" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was called choriocarcinoma 4." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "choriocarcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_174" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed desialylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was obtained from the urine of the patient with choriocarcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_175  a  gn:DS_175_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_175" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Membrane glycoproteins" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "baby hamster kidney (BHK) cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_175" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "N-linked sugar chains of the membrane glycoproteins of baby hamster kidney cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_176  a  gn:DS_176_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_176" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Membrane glycoproteins" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "baby hamster kidney (BHK) cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_176" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "N-linked sugar chains of the membrane glycoproteins of baby hamster kidney cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_98  a   gn:DS_98_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_98" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded NUD and analyzed at Laboratory 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-98" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was stored in guanidine/HCl, Tris-HCl and dithiothreitol solution and delivered with dry ice to Laboratory 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in guanidium hydrocholoride in Tris-HCl and incubated with DTT at 50  degree Celsius for 3 h. The sample mixture was added sodium iodoacetate and  incubated in the dark at room temperature for 30 min. The sample was applied to NAP 5 and dried up by Speed Vac. Then the sample was treated with PNGase F in phosphate buffer at 37  degree Celsius for 18 h. The sample was added H<sub>2</sub>O and applied to NAP 5. After drying, the sample was incubated with anhydrous hydrazine at 65  degree Celsius for 6 h. The sample was evaporated and incubated with acetic anhydride in sodium bicarbonate-saturated solution at 4  degree Celsius for 30 min. The sample was subjected to Dowex 50W-X8(H<sup>+</sup>) and added cold ethanol, then the supernatant was dried. The sample was incubated with phenylhydrazine solution at room temperature for 30 min. The sample profiles obtained from on-line LC-ESI-MS of solution digests and by in-gel digestion followed by LC-ESI-MS. The sample was subjected to MS on FT ICR-MS." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_99  a   gn:DS_99_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_99" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded VDS and analyzed at Laboratory 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "v99" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was lyophilized and delivered with dry ice to Laboratory 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was incubated with 2-mercaptethanol in guanidium hydrocholoride and EDTA in Tris-HCl at room temperature for 2 h. The sample was added sodium iodoacetate and incubated in the dark at room temperature for 2 h. The sample was applied to NAP 5 and dried up by Speed Vac. Then the sample was treated with PNGase F in phosphate buffer at 37  degree Celsius for 18 h. The sample was added H<sub>2</sub>O and applied to NAP 5. After drying, the sample was incubated with anhydrous hydrazine at 65  degree Celsius for 6 h. The sample was evaporated and incubated with acetic anhydride in sodium bicarbonate-saturated solution at 4  degree Celsius for 30 min. The sample was subjected to Dowex 50W-X8(H<sup>+</sup>) and added cold ethanol, then the supernatant was dried. The sample was incubated with phenylhydrazine solution at room temperature for 30 min. The sample profiles obtained from on-line LC-ESI-MS of solution digests and by in-gel digestion followed by LC-ESI-MS. The sample was subjected to MS on FT ICR-MS." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_100  a  gn:DS_100_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_100" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded Sap-II and analyzed at Laboratory 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-100" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was stored in Tris-HCl, NaCl and NaN<sub>3</sub> solution and delivered with dry ice to Laboratory 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was incubated with 2-mercaptethanol in guanidium hydrocholoride and EDTA in Tris-HCl at room temperature for 2 h. The sample was added sodium iodoacetate and incubated in the dark at room temperature for 2 h. The sample was applied to NAP 5 and dried up by Speed Vac. Then the sample was treated with PNGase F in phosphate buffer at 37  degree Celsius for 18 h. The sample was added H<sub>2</sub>O and applied to NAP 5. After drying, the sample was incubated with anhydrous hydrazine at 65  degree Celsius for 6 h. The sample was evaporated and incubated with acetic anhydride in sodium bicarbonate-saturated solution at 4  degree Celsius for 30 min. The sample was subjected to Dowex 50W-X8(H<sup>+</sup>) and added cold ethanol, then the supernatant was dried. The sample was incubated with phenylhydrazine solution at room temperature for 30 min. The sample profiles obtained from on-line LC-ESI-MS of solution digests and by in-gel digestion followed by LC-ESI-MS. The sample was subjected to MS on FT ICR-MS." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_101  a  gn:DS_101_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_101" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded NUD and analyzed at Laboratory 7." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-101" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was stored in guanidine/HCl, Tris-HCl and dithiothreitol solution and delivered with dry ice to Laboratory 7." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The lyophilized sample was dissolved in distilled anhydrazine with water. The sample was hydrazinolysis at 60  degree Celsius for 6 h and saturated with NaHCO<sub>3</sub> and acetic anhydride. Then the sample was passed through a Dowex column, and dried. The released glycans were captured by a nanoparticle possessing 2-(2-aminobenzoylamino)-2-hydrazinocarbonyl-ethanethiol (ABHE), and subsequently released by dithiothreitol. The sample was loaded onto a TSKgel Amide-80 column and eluted with solvent B (triethylamine/acetic acid). The samples were identified based on their retention time in comparison with those of reference glycans. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_102  a  gn:DS_102_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_102" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded VDS and analyzed at Laboratory 7." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-102" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was lyophilized and delivered with dry ice to Laboratory 7." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The lyophilized sample was dissolved in distilled anhydrazine with water. The sample was hydrazinolysis at 60  degree Celsius for 6 h and saturated with NaHCO<sub>3</sub> and acetic anhydride. Then the sample was passed through a Dowex column, and dried. The released glycans were captured by a nanoparticle possessing 2-(2-aminobenzoylamino)-2-hydrazinocarbonyl-ethanethiol (ABHE), and subsequently released by dithiothreitol. The sample was loaded onto a TSKgel Amide-80 column and eluted with solvent B (triethylamine/acetic acid). The samples were identified based on their retention time in comparison with those of reference glycans. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_103  a  gn:DS_103_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_103" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded Sap-II and analyzed at Laboratory 7." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-103" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was stored in Tris-HCl, NaCl and NaN<sub>3</sub> solution and delivered with dry ice to Laboratory 7." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The lyophilized sample was dissolved in distilled anhydrazine with water. The sample was hydrazinolysis at 60  degree Celsius for 6 h and saturated with NaHCO<sub>3</sub> and acetic anhydride. Then the sample was passed through a Dowex column, and dried. The released glycans were captured by a nanoparticle possessing 2-(2-aminobenzoylamino)-2-hydrazinocarbonyl-ethanethiol (ABHE), and subsequently released by dithiothreitol. The sample was loaded onto a TSKgel Amide-80 column and eluted with solvent B (triethylamine/acetic acid). The samples were identified based on their retention time in comparison with those of reference glycans. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_104  a  gn:DS_104_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_104" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded NUD and analyzed at Laboratory 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-104" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was stored in guanidine/HCl, Tris-HCl and dithiothreitol solution and delivered with dry ice to Laboratory 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in Tris-HCl containing guanidium hydrochloride and reduced with dithiothreitol. The sample was added iodoacetamide and incubated, and then passed through an ultrafiltration membrane filter. The sample was collected with water and lyophilized. The sample was dissolved in ammonium hydrogen carbonate, and digested with trypsin. The sample was boiled and lyophilized. The sample was dissolved with water. The sample was injected into the AutoGlycoCutter. The released <i>O</i>-glycans was dried and labeled with 2-aminobenzoic acid (2-AA) and sodium cyanoborohydride in methanol containing sodium acetate and boric acid. After heating and then cooling, the sample was applied to a column of Sephadex LH-20. Then the sample was dissolved in water and analyzed by NP-HPLC with a polymer-based Asahi Shodex NH2P-50 4E column. The sample was analyzed by MALDI-TOF MS. The sample was analyzed by ESI-IT-TOF MS (LC-MS) loaded onto a TSK-Gel Super Amide column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_105  a  gn:DS_105_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_105" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded VDS and analyzed at Laboratory 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-105" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was lyophilized and delivered with dry ice to Laboratory 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in Tris-HCl containing guanidium hydrochloride and reduced with dithiothreitol. The sample was added iodoacetamide and incubated, and then passed through an ultrafiltration membrane filter. The sample was collected with water and lyophilized. The sample was dissolved in ammonium hydrogen carbonate, and digested with trypsin. The sample was boiled and lyophilized. The sample was dissolved with water. The sample was injected into the AutoGlycoCutter. The released <i>O</i>-glycans was dried and labeled with 2-aminobenzoic acid (2-AA) and sodium cyanoborohydride in methanol containing sodium acetate and boric acid. After heating and then cooling, the sample was applied to a column of Sephadex LH-20. Then the sample was dissolved in water and analyzed by NP-HPLC with a polymer-based Asahi Shodex NH2P-50 4E column. The sample was analyzed by MALDI-TOF MS. The sample was analyzed by ESI-IT-TOF MS (LC-MS) loaded onto a TSK-Gel Super Amide column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_106  a  gn:DS_106_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_106" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded Sap-II and analyzed at Laboratory 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-106" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was stored in Tris-HCl, NaCl and NaN<sub>3</sub> solution and delivered with dry ice to Laboratory 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in Tris-HCl containing guanidium hydrochloride and reduced with dithiothreitol. The sample was added iodoacetamide and incubated, and then passed through an ultrafiltration membrane filter. The sample was collected with water and lyophilized. The sample was dissolved in ammonium hydrogen carbonate, and digested with trypsin. The sample was boiled and lyophilized. The sample was dissolved with water. The sample was injected into the AutoGlycoCutter. The released <i>O</i>-glycans was dried and labeled with 2-aminobenzoic acid (2-AA) and sodium cyanoborohydride in methanol containing sodium acetate and boric acid. After heating and then cooling, the sample was applied to a column of Sephadex LH-20. Then the sample was dissolved in water and analyzed by NP-HPLC with a polymer-based Asahi Shodex NH2P-50 4E column. The sample was analyzed by MALDI-TOF MS. The sample was analyzed by ESI-IT-TOF MS (LC-MS) loaded onto a TSK-Gel Super Amide column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_107  a  gn:DS_107_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-23" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_107" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded NUD and analyzed at Laboratory 9." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-107" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was stored in guanidine/HCl, Tris-HCl and dithiothreitol solution and delivered with dry ice to Laboratory 9." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample buffer was changed by dialysis against ammonium bicarbonate. Then the sample was lyophilized. The sample was dissolved in PBS, then added DW and denature buffer (SDS in Tris-HCl/2-mercaptoethanol) and heated. The sample was subsequently added PNGase F and incubated. The sample was loaded on a reversed-phased column Oasis HLB and directly subjected to reduced β-elimination on it. The sample was applied NaBD<sub>4</sub> in NaOH and incubated. The sample was passed through Oasis HLB column and added aqueous acetic acid. The sample was desalted by a cation-exchange column Oasis MCX. The sample was eluted with distilled water and dried. The sample was added acetic acid in methanol and dried. The sample was permethylated by solid NaOH technique and the NaOH small beads were mixed with DMSO. The dried sample was added the slurry followed by iodomethane and agitated. The samples were applied to a reversed-phased column Oasis HLB after the reaction stopped with HCl on the ice, followed by elution of permethylated alditols with aqueous acetonitrile and dried. The samples were analyzed by MALDI-TOF MS." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_108  a  gn:DS_108_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-23" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_108" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded VDS and analyzed at Laboratory 9." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-108" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was lyophilized and delivered with dry ice to Laboratory 9." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in PBS, then added DW and denature buffer (SDS in Tris-HCl/2-mercaptoethanol) and heated. The sample was subsequently added PNGase F and incubated. The sample was loaded on a reversed-phased column Oasis HLB and directly subjected to reduced β-elimination on it. The sample was applied NaBD<sub>4</sub> in NaOH and incubated. The sample was passed through Oasis HLB column and added aqueous acetic acid. The sample was desalted by a cation-exchange column Oasis MCX. The sample was eluted with distilled water and dried. The sample was added acetic acid in methanol and dried. The sample was permethylated by solid NaOH technique and the NaOH small beads were mixed with DMSO. The dried sample was added the slurry followed by iodomethane and agitated. The samples were applied to a reversed-phased column Oasis HLB after the reaction stopped with HCl on the ice, followed by elution of permethylated alditols with aqueous acetonitrile and dried. The samples were analyzed by MALDI-TOF MS." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_109  a  gn:DS_109_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-23" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_109" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded Sap-II and analyzed at Laboratory 9." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-109" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was stored in Tris-HCl, NaCl and NaN<sub>3</sub> solution and delivered with dry ice to Laboratory 9." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in PBS, then added DW and denature buffer (SDS in Tris-HCl/2-mercaptoethanol) and heated. The sample was subsequently added PNGase F and incubated. The sample was loaded on a reversed-phased column Oasis HLB and directly subjected to reduced β-elimination on it. The sample was applied NaBD<sub>4</sub> in NaOH and incubated. The sample was passed through Oasis HLB column and added aqueous acetic acid. The sample was desalted by a cation-exchange column Oasis MCX. The sample was eluted with distilled water and dried. The sample was added acetic acid in methanol and dried. The sample was permethylated by solid NaOH technique and the NaOH small beads were mixed with DMSO. The dried sample was added the slurry followed by iodomethane and agitated. The samples were applied to a reversed-phased column Oasis HLB after the reaction stopped with HCl on the ice, followed by elution of permethylated alditols with aqueous acetonitrile and dried. The samples were analyzed by MALDI-TOF MS." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_110  a  gn:DS_110_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-23" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_110" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded NUD and analyzed at Laboratory 13." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-110" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was stored in guanidine/HCl, Tris-HCl and dithiothreitol solution and delivered with dry ice to Laboratory 13." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed with SDS-PAGE in reducing conditions. The sample was blotted on Immobilon PSQ membrane and stained with Imperial. The stained bands were excised and reduced β-elimination. The samples were loaded onto a graphitized carbon column packed in-house with Hypercarb particles. The samples were eluted with NH<sub>4</sub>HCO<sub>3</sub>/acetonitrile gradient into a Thermo LTQ linear ion trap mass spectrometer run in negative ion mode. Their sequences were identified by MS/MS. The ratio between the areas obtained from equal amounts of the standard oligosaccharides was used to estimate the relative amounts of oligosaccharides on IgA for glycans." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_111  a  gn:DS_111_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-23" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_111" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded VDS and analyzed at Laboratory 13." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-111" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was lyophilized and delivered with dry ice to Laboratory 13." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed with SDS-PAGE in reducing conditions. The sample was blotted on Immobilon PSQ membrane and stained with Imperial. The stained bands were excised and reduced β-elimination. The samples were loaded onto a graphitized carbon column packed in-house with Hypercarb particles. The samples were eluted with NH<sub>4</sub>HCO<sub>3</sub>/acetonitrile gradient into a Thermo LTQ linear ion trap mass spectrometer run in negative ion mode. Their sequences were identified by MS/MS. The ratio between the areas obtained from equal amounts of the standard oligosaccharides was used to estimate the relative amounts of oligosaccharides on IgA for glycans." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_112  a  gn:DS_112_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-23" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=2 ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDAS GDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSP SCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLC GCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRV AAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_112" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "IgA1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01876&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "one of the authors (K. K.)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was coded Sap-II and analyzed at Laboratory 13." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "multiple myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-112" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was isolated from a serum from a patient with multiple myeloma by precipitation with 50% saturated ammonium sulfate followed by Sepharose 6B and by DEAE-cellulose. The sample was stored in Tris-HCl, NaCl and NaN<sub>3</sub> solution and delivered with dry ice to Laboratory 13." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed with SDS-PAGE in reducing conditions. The sample was blotted on Immobilon PSQ membrane and stained with Imperial. The stained bands were excised and reduced β-elimination. The samples were loaded onto a graphitized carbon column packed in-house with Hypercarb particles. The samples were eluted with NH<sub>4</sub>HCO<sub>3</sub>/acetonitrile gradient into a Thermo LTQ linear ion trap mass spectrometer run in negative ion mode. Their sequences were identified by MS/MS. The ratio between the areas obtained from equal amounts of the standard oligosaccharides was used to estimate the relative amounts of oligosaccharides on IgA for glycans." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgA1 purified from the patient with multiple myeloma." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_84  a   gn:DS_84_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_84" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biological_product>
                "nest" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#env_feature>
                "house" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#geo_loc_name>
                "Indonesia" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-84" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "Collocalia fuciphaga" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Edible bird’s nest (EBN) was dried and grounded. After through a mesh, the sample was kept in distilled water and then heated.  The sample was treated with Pancreatin F and the heated. The sample was filtrated with a filter paper and then freeze-dried. The sample was treated with neuraminidase from <i>C. perfringens</i> and then heated." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was proteolyzed with chymotrypsin and trypsin mixture. The sample was digested with glycoamidase A and released <i>N</i>-glycans were derivatized with 2-aminopyridine. The mixture of PA-derivatives of the <i>N</i>-glycans was separated by HPLC on a TSKgel DEAE-5PW column and then on a Shim-pack HRC-ODS column and on a TSK-gel Amide-80 column. <i>N</i>-glycan structures was identified using three kinds of HPLC columns in comparison with PA-glycans in the GALAXY database. PA-glycans, which were unknown in GALAXY, were trimmed by exoglycosidase treatment and were analyzed by MALDI-TOF-MS." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans obtained from a house nest  which is made from saliva of a male <i>Collocalia fuciphaga</i> in Indonesia." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "46478" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_113  a  gn:DS_113_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-23" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P08637|FCG3A_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-A OS=Homo sapiens OX=9606 GN=FCGR3A PE=1 SV=2 MWQLLLPTALLLLVSAGMRTEDLPKAVVFLEPQWYRVLEKDSVTLKCQGAYSPEDNSTQW FHNESLISSQASSYFIDAATVDDSGEYRCQTNLSTLSDPVQLEVHIGWLLLQAPRWVFKE EDPIHLRCHSWKNTALHKVTYLQNGKGRKYFHHNSDFYIPKATLKDSGSYFCRGLFGSKN VSSETVNITITQGLAVSTISSFFPPGYQVSFCLVMVLLFAVDTGLYFSVKTNIRSSTRDW KDHKFKWRKDPQDK" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_113" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG) and Fcgamma receptor IIIa (FcgammaRIIIa)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&#m_P08637" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Dr Lawrence Chasin (Columbia University, NY)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "Fut8<sup>- ⁄ -</sup> cell line Ms704, CHO⁄ DG44 cell line" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was a complex of Fc portion of IgG and N38Q, N74Q and  N169Q mutated sFcgammaRIIIa (Only N45 and N162 are <i>N</i>-glycosylation sites). (38->56, 74->92, 169->180aa at UniProtIDSeq.) " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-113" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Nonfucosylated IgG1 expressed in Fut8<sup>- ⁄ -</sup> cell line Ms704 was digested with papain. The sample was loaded onto an Affi-gel protein A column. cDNA encoding FcgammaRIIIa was isolated by reverse transcription-PCR of oligo(dT)-primed RNA from human leukocyte 5'-stretch plus cDNA library. To mutate N of the FcgammaRIII <i>N</i>-glycosylation sites into Q, a site-directed PCR mutagenesis kit was employed. N38Q, N74Q and N169Q mutated sFcgammaRIIIa modified with sialylated biantennary <i>N</i>-glycans was expressed in CHO⁄DG44 cell line." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "sFcgammaRIIIa sample was dissolved in sodium acetate buffer and treated with α-sialidase (<i>Arthrobacter ureafaciens</i>) at 37  degree Celsius for 12 h. The sample was dissolved in sodium acetate buffer and treated with β-galactosidase (<i>Streptococcus pneumoniae</i>) at 37 degree Celsius for 12 h. The sample was dissolved in sodium acetate buffer and treated with <i>N</i>-acetylhexosaminidase (<i>S. pneumoniae</i>) at 37  degree Celsius for 12 h. The sample was dissolved in sodium acetate buffer and treated with Endo D (<i>Diplococcus pneumoniae</i>) at 37  degree Celsius for 12 h. The sample was neutralized and then subjected to Ni-NTA chromatography. <i>N</i>-glycosylation profiling was performed the HPLC mapping method on the basis of elution profiles of pyridyl amino derivatives of their <i>N</i>-linked oligosaccharides on Shim-pack HRC-octadecyl silica columns. The nonfucosylated Fc fragment and desialylated sFcgammaRIIIa mutant were mixed at a molar ratio of 1 : 1 and then loaded to a gel filtration column, Superose 12. The sample was crystalized and diffraction data were collected on a beamline BL44XU (SPring-8). Determined the crystal structure by a molecular replacement technique." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Complex formed between nonfucosylated IgG1-Fc portion and a soluble form of FcgammaRIIIa (sFcgammaRIIIa) with two <i>N</i>-glycosylation sites in which other three <i>N</i>-glycosylation sites were mutated." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_188  a  gn:DS_188_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:684" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-07" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_188" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "62" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The patient, HT,  was diagnosed as hepatocellular carcinoma with liver cirrhosis by ultrasonography and angiography and later confirmed by histological examination at autopsy. Macroscopic feature of carcinoma; massive. The value of AFP (ng/ml) was 32,600 and CEA (ng/ml) was 3.3." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hepatocellular carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "Edmondson grade III" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-188" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200.  The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed by comparing the fraction patterns of the radioactive oligosaccharides released by hydrazinolysis by paper electrophoresis and serial chromatography on columns of AAL-Sepharose, ConA-Sepharose, DSA-Sepharose, E-PHA-agarose, and Allo A-II agarose, followed by Bio-Gel P-4 column chromatography. The sample was further confirmed by sequential exoglycosidase digestion." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of patients with hepatocellular carcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_189  a  gn:DS_189_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:684" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-07" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_189" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "68" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The patient, NA,  was diagnosed as hepatocellular carcinoma with liver cirrhosis by ultrasonography and angiography and later confirmed by histological examination at autopsy. Macroscopic feature of carcinoma; solitary. The value of AFP (ng/ml) was 9,800 and CEA (ng/ml) was 6.0." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hepatocellular carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "Edmondson grade III" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-189" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200.  The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed by comparing the fraction patterns of the radioactive oligosaccharides released by hydrazinolysis by paper electrophoresis and serial chromatography on columns of AAL-Sepharose, ConA-Sepharose, DSA-Sepharose, E-PHA-agarose, and Allo A-II agarose, followed by Bio-Gel P-4 column chromatography. The sample was further confirmed by sequential exoglycosidase digestion." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of patients with hepatocellular carcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_190  a  gn:DS_190_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:684" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-07" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_190" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "65" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The patient, OY,  was diagnosed as hepatocellular carcinoma with liver cirrhosis by ultrasonography and angiography and later confirmed by histological examination at autopsy. Macroscopic feature of carcinoma; massive. The value of AFP (ng/ml) was 1,800 and CEA (ng/ml) was 7.3." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hepatocellular carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "Edmondson grade II" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-190" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200.  The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to paper electrophoresis. The acidic fractions were digested with exhaustive <i>Archrobacter</i> sialidase and partial desialylation (data not shown). The neutral and pooled converted neutral fractions from acidic were digested with a mixture of diplococcal β-galactosidase, almond α-fucosidase I, and jack bean β-<i>N</i>-acetylhexosaminidase. Then the sample was analyzed by Bio-Gel P-4 column chromatography. The mixture of the samples was separated by a ConA-Sepharose column chromatography into the passed-through fraction, ConA(-) and the bound fraction, ConA(+), which eluted with α- methyl mannnopyranoside. ConA(+) was separated by affinity chromatography on an AAL-Sepharose column into the passed-through fraction, fractions I, and the bound fraction, fractions II which eluted with buffer containing <sub>L</sub>-fucose. ConA(-) was separated by an AAL-Sepharose column into the passed-through fraction, AAL(-), retarded, AAL(R) and the bound fraction, AAL(+) which eluted with buffer containing <sub>L</sub>-fucose. AAL(-) was further separated by DSA-Sepharose column chromatography into retarded, DSA(R) and the bound fraction, fraction III which eluted with buffer containing <i>N</i>-acetylglucosamine oligomers mixture. DSA(R) was subjected to E-PHA-agarose column and named fraction VI. AAL(R) was subjected to DSA-Sepharose column and named fraction IV. AAL(+) was separated by DSA-Sepharose column chromatography into passed through fraction, DSA(-), retarded, DSA(R), and bound fraction, fraction V which eluted with <i>N</i>-acetylglucosamine oligomers solution. DSA(-) was further separated by E-PHA-agarose column chromatography into passed through, fractions VII and retarded fractions VIII. DSA(R) was subjected to E-PHA-agarose column and named fraction IX. The samples were subjected to Bio-Gel P-4 column chromatography. Aliquots of  the radioactive fractions were subjected to affinity chromatography with use of an Allo A-II-agarose column and the bound was eluted with the buffer containing lactose." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of patients with hepatocellular carcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_191  a  gn:DS_191_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:684" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-07" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_191" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "53" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The patient, HH,  was diagnosed as hepatocellular carcinoma with liver cirrhosis by ultrasonography and angiography and later confirmed by histological examination at autopsy. Macroscopic feature of carcinoma; solitary. The value of AFP (ng/ml) was 200,000 and CEA (ng/ml) was 3.4." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hepatocellular carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "Edmondson grade II" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-191" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200.  The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed by comparing the fraction patterns of the radioactive oligosaccharides released by hydrazinolysis by paper electrophoresis and serial chromatography on columns of AAL-Sepharose, ConA-Sepharose, DSA-Sepharose, E-PHA-agarose, and Allo A-II agarose, followed by Bio-Gel P-4 column chromatography. The sample was further confirmed by sequential exoglycosidase digestion." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of patients with hepatocellular carcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_192  a  gn:DS_192_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_192" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "ET" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-192" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200.  The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed by comparing the fraction patterns of the radioactive oligosaccharides released by hydrazinolysis by paper electrophoresis and serial chromatography on columns of AAL-Sepharose, ConA-Sepharose, DSA-Sepharose, E-PHA-agarose, and Allo A-II agarose, followed by Bio-Gel P-4 column chromatography. The sample was further confirmed by sequential exoglycosidase digestion." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_193  a  gn:DS_193_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_193" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "KA" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-193" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200.  The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed by comparing the fraction patterns of the radioactive oligosaccharides released by hydrazinolysis by paper electrophoresis and serial chromatography on columns of AAL-Sepharose, ConA-Sepharose, DSA-Sepharose, E-PHA-agarose, and Allo A-II agarose, followed by Bio-Gel P-4 column chromatography. The sample was further confirmed by sequential exoglycosidase digestion." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of healthy sample." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_194  a  gn:DS_194_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_194" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Purchased from Sigma Chemical Co., St. Louis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-194" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200.  The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed by comparing the fraction patterns of the radioactive oligosaccharides released by hydrazinolysis by paper electrophoresis and serial chromatography on columns of AAL-Sepharose, ConA-Sepharose, DSA-Sepharose, E-PHA-agarose, and Allo A-II agarose, followed by Bio-Gel P-4 column chromatography. The sample was further confirmed by sequential exoglycosidase digestion." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of healthy and commercial sample." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_123  a  gn:DS_123_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#>
                "Lewis b+" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_123" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#_The_sample_was_purified_by_affinity_chromaography_and_further_by_concanavalin_A-Sepharose_column_chromatography_and_gel_filtration._>
                "PURIFICATION OF CEA, NCA-2 AND NFA-2 SAMPLES" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "feces" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named NFA-2KM." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healty" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-123" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was purified from feces of healthy individual." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to hydrazinolysis. Then the sample were labeled by NaB<sub>3</sub>H<sub>4</sub> reduction after N-acetylation. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides from normal human feces." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_124  a  gn:DS_124_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#>
                "Lewis b+" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_124" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#_The_sample_was_purified_by_affinity_chromaography_and_further_by_concanavalin_A-Sepharose_column_chromatography_and_gel_filtration._>
                "PURIFICATION OF CEA, NCA-2 AND NFA-2 SAMPLES" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "feces" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named NFA-2AM." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healty" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-124" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was purified from feces of healthy individual." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to hydrazinolysis. Then the sample were labeled by NaB<sub>3</sub>H<sub>4</sub> reduction after N-acetylation. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides from normal human feces." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_125  a  gn:DS_125_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#>
                "Lewis b+" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_125" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#_The_sample_was_purified_by_affinity_chromaography_and_further_by_concanavalin_A-Sepharose_column_chromatography_and_gel_filtration._>
                "PURIFICATION OF CEA, NCA-2 AND NFA-2 SAMPLES" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "feces" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named NFA-2KT." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healty" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-125" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was purified from feces of healthy individual." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to hydrazinolysis. Then the sample were labeled by NaB<sub>3</sub>H<sub>4</sub> reduction after N-acetylation. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides from normal human feces." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_126  a  gn:DS_126_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#>
                "Lewis b+" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_126" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#_The_sample_was_purified_by_affinity_chromaography_and_further_by_concanavalin_A-Sepharose_column_chromatography_and_gel_filtration._>
                "PURIFICATION OF CEA, NCA-2 AND NFA-2 SAMPLES" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "feces" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named NFA-2YK." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healty" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-126" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was purified from feces of healthy individual." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to hydrazinolysis. Then the sample were labeled by NaB<sub>3</sub>H<sub>4</sub> reduction after N-acetylation. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides from normal human feces." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_127  a  gn:DS_127_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1520" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_127" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_type>
                "A" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named CEA-TY." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "colon carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "metastasis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-127" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was purified by Sepharose 4B gel filtration. Then the sample was furter purified on Sepharose 6B and Sephadex G-200.  ここから下は、サンプルTAとあるのだが、TYのことだろうか？取り寄せ中のPMID: 53193も見てから、総合的に判断すること。 The sample was then subjected to affinity chrornatography on a column of concanavalin A-Sepharose 4B. The sample was eluted with methyl α-D-rnannopyranoside." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to hydrazinolysis. Then the sample were labeled by NaB<sub>3</sub>H<sub>4</sub> reduction after N-acetylation. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides from liver metastasis of colon carcinoma patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "liver" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_128  a  gn:DS_128_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1520" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_128" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_type>
                "A" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named CEA-MY." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "colon carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "metastasis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-128" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to hydrazinolysis. Then the sample were labeled by NaB<sub>3</sub>H<sub>4</sub> reduction after N-acetylation. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides from liver metastasis of colon carcinoma patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "liver" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_129  a  gn:DS_129_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1520" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_129" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_type>
                "A" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named CEA-TT." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "colon carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "metastasis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-129" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to hydrazinolysis. Then the sample were labeled by NaB<sub>3</sub>H<sub>4</sub> reduction after N-acetylation. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides from liver metastasis of colon carcinoma patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "liver" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_130  a  gn:DS_130_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_130" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "meconium" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_type>
                "various types" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named NCA-2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-130" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was purified from a pooled meconium collected from more than 20 neonates of various blood types. The sample was treated with perchloric acid, the antigens with carcinoembryonic antigen activity were adsorbed to goat anti-CEA adsorbent.  The eluted sample was further purified by serial chromatography on a Sepharose 6B and a Sephadex G-200 column. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to hydrazinolysis. Then the sample were labeled by NaB<sub>3</sub>H<sub>4</sub> reduction after N-acetylation. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides from a pooled meconium collected from more than 20 neonates of various blood types." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_138  a  gn:DS_138_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-09-07" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q14118|DAG1_HUMAN Dystroglycan OS=Homo sapiens OX=9606 GN=DAG1 PE=1 SV=2 MRMSVGLSLLLPLSGRTFLLLLSVVMAQSHWPSEPSEAVRDWENQLEASMHSVLSDLHEA VPTVVGIPDGTAVVGRSFRVTIPTDLIASSGDIIKVSAAGKEALPSWLHWDSQSHTLEGL PLDTDKGVHYISVSATRLGANGSHIPQTSSVFSIEVYPEDHSELQSVRTASPDPGEVVSS ACAADEPVTVLTVILDADLTKMTPKQRIDLLHRMRSFSEVELHNMKLVPVVNNRLFDMSA FMAGPGNAKKVVENGALLSWKLGCSLNQNSVPDIHGVEAPAREGAMSAQLGYPVVGWHIA NKKPPLPKRVRRQIHATPTPVTAIGPPTTAIQEPPSRIVPTPTSPAIAPPTETMAPPVRD PVPGKPTVTIRTRGAIIQTPTLGPIQPTRVSEAGTTVPGQIRPTMTIPGYVEPTAVATPP TTTTKKPRVSTPKPATPSTDSTTTTTRRPTKKPRTPRPVPRVTTKVSITRLETASPPTRI RTTTSGVPRGGEPNQRPELKNHIDRVDAWVGTYFEVKIPSDTFYDHEDTTTDKLKLTLKL REQQLVGEKSWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDKGGLSAVDAFEIHVHRRPQ GDRAPARFKAKFVGDPALVLNDIHKKIALVKKLAFAFGDRNCSTITLQNITRGSIVVEWT NNTLPLEPCPKEQIAGLSRRIAEDDGKPRPAFSNALEPDFKATSITVTGSGSCRHLQFIP VVPPRRVPSEAPPTEVPDRDPEKSSEDDVYLHTVIPAVVVAAILLIAGIIAMICYRKKRK GKLTLEDQATFIKKGVPIIFADELDDSKPPPSSSMPLILQEEKAPLPPPEYPNQSVPETT PLNQDTMGEYTPLRDEDPNAPPYQPPPPFTAPMEGKGSRPKNMTPYRSPPPYVPP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "DAG1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_138" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "α-dystroglycan" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#dmf_Q14118" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_cell_line>
                "HEK293T cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-138" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "α-Dystroglycan (αDG) lost upon endogenous processing via furin-like cleavage was introduced T322R mutation, truncated and fused with Fc at R373 by standard PCR and genetic engineering techniques using the expression plasmids. HEK293T cells were grown overnight and transfected using Polyethylenimine Max. The protein was expressed in Dulbecco’s modified Eagle’s medium supplemented with fetal bovine serum. The sample was purified using a Protein G affinity column. The sample was separated by SDS-PAGE and subjected to in-gel tryptic digestion and recovery of peptides/glycopeptides from the gel." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to reduction with dithiothreitol, alkylation with iodoacetamide in ammonium bicarbonate buffer, destaining with acetonitrile in ammonium bicarbonate buffer and then digestion overnight with trypsin. The sample was sequentially extracted with distilled water, formic acid, and acetonitrile/formic acid, dried down, and then redissolved in formic acid for further cleaned up by ZipTip C18. The sample was analyzed by nanospray LC-MS/MS. The sample was loaded onto an Acclaim PepMap RSLC column and separated. HCD and CID MS<sup>2</sup> data sets were filtered for candidate glycopeptide spectra based on the presence of MS<sup>2</sup> ions corresponding to the expected tryptic peptide core containing the target <i>O</i>-glycosylation sites and/or peptide fragment ions. The data was interpreted and assigned manually. And some MS<sup>2</sup> ions were further analyzed by CID MS<sup>3</sup>." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Fc-fused α-dystroglycan (αDG) recombinant proteins, amino acid substitutions and deletion mutants of αDG (αDG373(T322R)) were made by standard PCR and genetic engineering techniques using the expression plasmids in wild type HEK293T cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_139  a  gn:DS_139_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-09-10" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q14118|DAG1_HUMAN Dystroglycan OS=Homo sapiens OX=9606 GN=DAG1 PE=1 SV=2 MRMSVGLSLLLPLSGRTFLLLLSVVMAQSHWPSEPSEAVRDWENQLEASMHSVLSDLHEA VPTVVGIPDGTAVVGRSFRVTIPTDLIASSGDIIKVSAAGKEALPSWLHWDSQSHTLEGL PLDTDKGVHYISVSATRLGANGSHIPQTSSVFSIEVYPEDHSELQSVRTASPDPGEVVSS ACAADEPVTVLTVILDADLTKMTPKQRIDLLHRMRSFSEVELHNMKLVPVVNNRLFDMSA FMAGPGNAKKVVENGALLSWKLGCSLNQNSVPDIHGVEAPAREGAMSAQLGYPVVGWHIA NKKPPLPKRVRRQIHATPTPVTAIGPPTTAIQEPPSRIVPTPTSPAIAPPTETMAPPVRD PVPGKPTVTIRTRGAIIQTPTLGPIQPTRVSEAGTTVPGQIRPTMTIPGYVEPTAVATPP TTTTKKPRVSTPKPATPSTDSTTTTTRRPTKKPRTPRPVPRVTTKVSITRLETASPPTRI RTTTSGVPRGGEPNQRPELKNHIDRVDAWVGTYFEVKIPSDTFYDHEDTTTDKLKLTLKL REQQLVGEKSWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDKGGLSAVDAFEIHVHRRPQ GDRAPARFKAKFVGDPALVLNDIHKKIALVKKLAFAFGDRNCSTITLQNITRGSIVVEWT NNTLPLEPCPKEQIAGLSRRIAEDDGKPRPAFSNALEPDFKATSITVTGSGSCRHLQFIP VVPPRRVPSEAPPTEVPDRDPEKSSEDDVYLHTVIPAVVVAAILLIAGIIAMICYRKKRK GKLTLEDQATFIKKGVPIIFADELDDSKPPPSSSMPLILQEEKAPLPPPEYPNQSVPETT PLNQDTMGEYTPLRDEDPNAPPYQPPPPFTAPMEGKGSRPKNMTPYRSPPPYVPP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "DAG1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_139" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "α-dystroglycan" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#dmf_Q14118" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#host>
                "HCT116 cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-139" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "α-Dystroglycan (αDG) lost upon endogenous processing via furin-like cleavage was introduced T322R mutation, truncated and fused with Fc at R373 by standard PCR and genetic engineering techniques using the expression plasmids. HCT116 cells were grown overnight and transfected using Polyethylenimine Max. The protein was expressed in Dulbecco’s modified Eagle’s medium supplemented with fetal bovine serum. The sample was purified using a Protein G affinity column. The sample was separated by SDS-PAGE and subjected to in-gel tryptic digestion and recovery of peptides/glycopeptides from the gel." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to reduction with dithiothreitol, alkylation with iodoacetamide in ammonium bicarbonate buffer, destaining with acetonitrile in ammonium bicarbonate buffer and then digestion overnight with trypsin. The sample was sequentially extracted with distilled water, formic acid, and acetonitrile/formic acid, dried down, and then redissolved in formic acid for further cleaned up by ZipTip C18. The sample was analyzed by nanospray LC-MS/MS. The sample was loaded onto an Acclaim PepMap RSLC column and separated. HCD and CID MS<sup>2</sup> data sets were filtered for candidate glycopeptide spectra based on the presence of MS<sup>2</sup> ions corresponding to the expected tryptic peptide core containing the target <i>O</i>-glycosylation sites and/or peptide fragment ions. The data was interpreted and assigned manually. And some MS<sup>2</sup> ions were further analyzed by CID MS<sup>3</sup>." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Fc-fused α-dystroglycan (αDG) recombinant proteins, amino acid substitutions and deletion mutants of αDG (αDG373(T322R)) were made by standard PCR and genetic engineering techniques using the expression plasmids in wild type HCT116 cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_140  a  gn:DS_140_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-09-10" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q14118|DAG1_HUMAN Dystroglycan OS=Homo sapiens OX=9606 GN=DAG1 PE=1 SV=2 MRMSVGLSLLLPLSGRTFLLLLSVVMAQSHWPSEPSEAVRDWENQLEASMHSVLSDLHEA VPTVVGIPDGTAVVGRSFRVTIPTDLIASSGDIIKVSAAGKEALPSWLHWDSQSHTLEGL PLDTDKGVHYISVSATRLGANGSHIPQTSSVFSIEVYPEDHSELQSVRTASPDPGEVVSS ACAADEPVTVLTVILDADLTKMTPKQRIDLLHRMRSFSEVELHNMKLVPVVNNRLFDMSA FMAGPGNAKKVVENGALLSWKLGCSLNQNSVPDIHGVEAPAREGAMSAQLGYPVVGWHIA NKKPPLPKRVRRQIHATPTPVTAIGPPTTAIQEPPSRIVPTPTSPAIAPPTETMAPPVRD PVPGKPTVTIRTRGAIIQTPTLGPIQPTRVSEAGTTVPGQIRPTMTIPGYVEPTAVATPP TTTTKKPRVSTPKPATPSTDSTTTTTRRPTKKPRTPRPVPRVTTKVSITRLETASPPTRI RTTTSGVPRGGEPNQRPELKNHIDRVDAWVGTYFEVKIPSDTFYDHEDTTTDKLKLTLKL REQQLVGEKSWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDKGGLSAVDAFEIHVHRRPQ GDRAPARFKAKFVGDPALVLNDIHKKIALVKKLAFAFGDRNCSTITLQNITRGSIVVEWT NNTLPLEPCPKEQIAGLSRRIAEDDGKPRPAFSNALEPDFKATSITVTGSGSCRHLQFIP VVPPRRVPSEAPPTEVPDRDPEKSSEDDVYLHTVIPAVVVAAILLIAGIIAMICYRKKRK GKLTLEDQATFIKKGVPIIFADELDDSKPPPSSSMPLILQEEKAPLPPPEYPNQSVPETT PLNQDTMGEYTPLRDEDPNAPPYQPPPPFTAPMEGKGSRPKNMTPYRSPPPYVPP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "DAG1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_140" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "α-dystroglycan" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#dmf_Q14118" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#host>
                "HCT116 cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-140" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "α-Dystroglycan (αDG) lost upon endogenous processing via furin-like cleavage was introduced T322R mutation, truncated and fused with Fc at R373 by standard PCR and genetic engineering techniques using the expression plasmids. HCT116 cells were grown overnight and transfected using Polyethylenimine Max. The encoding sequence of isoprenoid synthase domain containing (ISPD) open reading frame was amplified by PCR and cloned into pCMV14-3xFLAG vector. The gRNAs flanking the target enhancer region (ATTGAAAATTGACCTGTGGCGGG) was designed by ToolGen dRGEN synthesis services. The gRNA plasmids (pRGEN-U6-sgRNA) and a plasmid expressing Cas9-GFP were transiently transfected into HCT116 cells with a Cas9. After post-transfection, cells were identified using fluorescence-activated cell sorting. Sorted cells were plated and then re-plated as single cells. The protein was expressed in Dulbecco’s modified Eagle’s medium supplemented with fetal bovine serum. The sample was purified using a Protein G affinity column. The sample was separated by SDS-PAGE and subjected to in-gel tryptic digestion and recovery of peptides/glycopeptides from the gel." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to reduction with dithiothreitol, alkylation with iodoacetamide in ammonium bicarbonate buffer, destaining with acetonitrile in ammonium bicarbonate buffer and then digestion overnight with trypsin. The sample was sequentially extracted with distilled water, formic acid, and acetonitrile/formic acid, dried down, and then redissolved in formic acid for further cleaned up by ZipTip C18. The sample was analyzed by nanospray LC-MS/MS. The sample was loaded onto an Acclaim PepMap RSLC column and separated. HCD and CID MS<sup>2</sup> data sets were filtered for candidate glycopeptide spectra based on the presence of MS<sup>2</sup> ions corresponding to the expected tryptic peptide core containing the target <i>O</i>-glycosylation sites and/or peptide fragment ions. The data was interpreted and assigned manually. And some MS<sup>2</sup> ions were further analyzed by CID MS<sup>3</sup>." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Fc-fused α-dystroglycan (αDG) recombinant proteins, amino acid substitutions and deletion mutants of αDG (αDG373(T322R)) were made by standard PCR and genetic engineering techniques using the expression plasmids in isoprenoid synthase domain containing (ISPD)- knockout HCT116 cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_141  a  gn:DS_141_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-09-10" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q14118|DAG1_HUMAN Dystroglycan OS=Homo sapiens OX=9606 GN=DAG1 PE=1 SV=2 MRMSVGLSLLLPLSGRTFLLLLSVVMAQSHWPSEPSEAVRDWENQLEASMHSVLSDLHEA VPTVVGIPDGTAVVGRSFRVTIPTDLIASSGDIIKVSAAGKEALPSWLHWDSQSHTLEGL PLDTDKGVHYISVSATRLGANGSHIPQTSSVFSIEVYPEDHSELQSVRTASPDPGEVVSS ACAADEPVTVLTVILDADLTKMTPKQRIDLLHRMRSFSEVELHNMKLVPVVNNRLFDMSA FMAGPGNAKKVVENGALLSWKLGCSLNQNSVPDIHGVEAPAREGAMSAQLGYPVVGWHIA NKKPPLPKRVRRQIHATPTPVTAIGPPTTAIQEPPSRIVPTPTSPAIAPPTETMAPPVRD PVPGKPTVTIRTRGAIIQTPTLGPIQPTRVSEAGTTVPGQIRPTMTIPGYVEPTAVATPP TTTTKKPRVSTPKPATPSTDSTTTTTRRPTKKPRTPRPVPRVTTKVSITRLETASPPTRI RTTTSGVPRGGEPNQRPELKNHIDRVDAWVGTYFEVKIPSDTFYDHEDTTTDKLKLTLKL REQQLVGEKSWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDKGGLSAVDAFEIHVHRRPQ GDRAPARFKAKFVGDPALVLNDIHKKIALVKKLAFAFGDRNCSTITLQNITRGSIVVEWT NNTLPLEPCPKEQIAGLSRRIAEDDGKPRPAFSNALEPDFKATSITVTGSGSCRHLQFIP VVPPRRVPSEAPPTEVPDRDPEKSSEDDVYLHTVIPAVVVAAILLIAGIIAMICYRKKRK GKLTLEDQATFIKKGVPIIFADELDDSKPPPSSSMPLILQEEKAPLPPPEYPNQSVPETT PLNQDTMGEYTPLRDEDPNAPPYQPPPPFTAPMEGKGSRPKNMTPYRSPPPYVPP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "DAG1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_141" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "α-dystroglycan" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#dmf_Q14118" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#host>
                "HCT116 cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-141" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "α-Dystroglycan (αDG) lost upon endogenous processing via furin-like cleavage was introduced T322R mutation, truncated and fused with Fc at R373 by standard PCR and genetic engineering techniques using the expression plasmids. HCT116 cells were grown overnight and transfected using Polyethylenimine Max. The encoding sequence of fukutin (FKTN) open reading frame was amplified by PCR and cloned into pCMV14-3xFLAG vector. The gRNAs flanking the target enhancer region (GAGTAGAATCAATAAGAACGTGG) was designed by ToolGen dRGEN synthesis services. The gRNA plasmids (pRGEN-U6-sgRNA) and a plasmid expressing Cas9-GFP were transiently transfected into HCT116 cells with a Cas9. After post-transfection, cells were identified using fluorescence-activated cell sorting. Sorted cells were plated and then re-plated as single cells. The protein was expressed in Dulbecco’s modified Eagle’s medium supplemented with fetal bovine serum. The sample was purified using a Protein G affinity column. The sample was separated by SDS-PAGE and subjected to in-gel tryptic digestion and recovery of peptides/glycopeptides from the gel." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to reduction with dithiothreitol, alkylation with iodoacetamide in ammonium bicarbonate buffer, destaining with acetonitrile in ammonium bicarbonate buffer and then digestion overnight with trypsin. The sample was sequentially extracted with distilled water, formic acid, and acetonitrile/formic acid, dried down, and then redissolved in formic acid for further cleaned up by ZipTip C18. The sample was analyzed by nanospray LC-MS/MS. The sample was loaded onto an Acclaim PepMap RSLC column and separated. HCD and CID MS<sup>2</sup> data sets were filtered for candidate glycopeptide spectra based on the presence of MS<sup>2</sup> ions corresponding to the expected tryptic peptide core containing the target <i>O</i>-glycosylation sites and/or peptide fragment ions. The data was interpreted and assigned manually. And some MS<sup>2</sup> ions were further analyzed by CID MS<sup>3</sup>." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Fc-fused α-dystroglycan (αDG) recombinant proteins, amino acid substitutions and deletion mutants of αDG (αDG373(T322R)) were made by standard PCR and genetic engineering techniques using the expression plasmids in fukutin (FKTN)- knockout HCT116 cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_142  a  gn:DS_142_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-09-10" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q14118|DAG1_HUMAN Dystroglycan OS=Homo sapiens OX=9606 GN=DAG1 PE=1 SV=2 MRMSVGLSLLLPLSGRTFLLLLSVVMAQSHWPSEPSEAVRDWENQLEASMHSVLSDLHEA VPTVVGIPDGTAVVGRSFRVTIPTDLIASSGDIIKVSAAGKEALPSWLHWDSQSHTLEGL PLDTDKGVHYISVSATRLGANGSHIPQTSSVFSIEVYPEDHSELQSVRTASPDPGEVVSS ACAADEPVTVLTVILDADLTKMTPKQRIDLLHRMRSFSEVELHNMKLVPVVNNRLFDMSA FMAGPGNAKKVVENGALLSWKLGCSLNQNSVPDIHGVEAPAREGAMSAQLGYPVVGWHIA NKKPPLPKRVRRQIHATPTPVTAIGPPTTAIQEPPSRIVPTPTSPAIAPPTETMAPPVRD PVPGKPTVTIRTRGAIIQTPTLGPIQPTRVSEAGTTVPGQIRPTMTIPGYVEPTAVATPP TTTTKKPRVSTPKPATPSTDSTTTTTRRPTKKPRTPRPVPRVTTKVSITRLETASPPTRI RTTTSGVPRGGEPNQRPELKNHIDRVDAWVGTYFEVKIPSDTFYDHEDTTTDKLKLTLKL REQQLVGEKSWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDKGGLSAVDAFEIHVHRRPQ GDRAPARFKAKFVGDPALVLNDIHKKIALVKKLAFAFGDRNCSTITLQNITRGSIVVEWT NNTLPLEPCPKEQIAGLSRRIAEDDGKPRPAFSNALEPDFKATSITVTGSGSCRHLQFIP VVPPRRVPSEAPPTEVPDRDPEKSSEDDVYLHTVIPAVVVAAILLIAGIIAMICYRKKRK GKLTLEDQATFIKKGVPIIFADELDDSKPPPSSSMPLILQEEKAPLPPPEYPNQSVPETT PLNQDTMGEYTPLRDEDPNAPPYQPPPPFTAPMEGKGSRPKNMTPYRSPPPYVPP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "DAG1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_142" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "α-dystroglycan" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#dmf_Q14118" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#host>
                "HCT116 cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-142" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "α-Dystroglycan (αDG) lost upon endogenous processing via furin-like cleavage was introduced T322R mutation, truncated and fused with Fc at R373 by standard PCR and genetic engineering techniques using the expression plasmids. HCT116 cells were grown overnight and transfected using Polyethylenimine Max. The encoding sequence of fukutin-related protein (FKRP) open reading frame was amplified by PCR and cloned into pCMV14-3xFLAG vector. The gRNAs flanking the target enhancer region (CATGCGGCTCACCCGCTGCCAGG) was designed by ToolGen dRGEN synthesis services. The gRNA plasmids (pRGEN-U6-sgRNA) and a plasmid expressing Cas9-GFP were transiently transfected into HCT116 cells with a Cas9. After post-transfection, cells were identified using fluorescence-activated cell sorting. Sorted cells were plated and then re-plated as single cells. The protein was expressed in Dulbecco’s modified Eagle’s medium supplemented with fetal bovine serum. The sample was purified using a Protein G affinity column. The sample was separated by SDS-PAGE and subjected to in-gel tryptic digestion and recovery of peptides/glycopeptides from the gel." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to reduction with dithiothreitol, alkylation with iodoacetamide in ammonium bicarbonate buffer, destaining with acetonitrile in ammonium bicarbonate buffer and then digestion overnight with trypsin. The sample was sequentially extracted with distilled water, formic acid, and acetonitrile/formic acid, dried down, and then redissolved in formic acid for further cleaned up by ZipTip C18. The sample was analyzed by nanospray LC-MS/MS. The sample was loaded onto an Acclaim PepMap RSLC column and separated. HCD and CID MS<sup>2</sup> data sets were filtered for candidate glycopeptide spectra based on the presence of MS<sup>2</sup> ions corresponding to the expected tryptic peptide core containing the target <i>O</i>-glycosylation sites and/or peptide fragment ions. The data was interpreted and assigned manually. And some MS<sup>2</sup> ions were further analyzed by CID MS<sup>3</sup>." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Fc-fused α-dystroglycan (αDG) recombinant proteins, amino acid substitutions and deletion mutants of αDG (αDG373(T322R)) were made by standard PCR and genetic engineering techniques using the expression plasmids in fukutin-related protein (FKRP)- knockout HCT116 cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_143  a  gn:DS_143_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-09-10" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q14118|DAG1_HUMAN Dystroglycan OS=Homo sapiens OX=9606 GN=DAG1 PE=1 SV=2 MRMSVGLSLLLPLSGRTFLLLLSVVMAQSHWPSEPSEAVRDWENQLEASMHSVLSDLHEA VPTVVGIPDGTAVVGRSFRVTIPTDLIASSGDIIKVSAAGKEALPSWLHWDSQSHTLEGL PLDTDKGVHYISVSATRLGANGSHIPQTSSVFSIEVYPEDHSELQSVRTASPDPGEVVSS ACAADEPVTVLTVILDADLTKMTPKQRIDLLHRMRSFSEVELHNMKLVPVVNNRLFDMSA FMAGPGNAKKVVENGALLSWKLGCSLNQNSVPDIHGVEAPAREGAMSAQLGYPVVGWHIA NKKPPLPKRVRRQIHATPTPVTAIGPPTTAIQEPPSRIVPTPTSPAIAPPTETMAPPVRD PVPGKPTVTIRTRGAIIQTPTLGPIQPTRVSEAGTTVPGQIRPTMTIPGYVEPTAVATPP TTTTKKPRVSTPKPATPSTDSTTTTTRRPTKKPRTPRPVPRVTTKVSITRLETASPPTRI RTTTSGVPRGGEPNQRPELKNHIDRVDAWVGTYFEVKIPSDTFYDHEDTTTDKLKLTLKL REQQLVGEKSWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDKGGLSAVDAFEIHVHRRPQ GDRAPARFKAKFVGDPALVLNDIHKKIALVKKLAFAFGDRNCSTITLQNITRGSIVVEWT NNTLPLEPCPKEQIAGLSRRIAEDDGKPRPAFSNALEPDFKATSITVTGSGSCRHLQFIP VVPPRRVPSEAPPTEVPDRDPEKSSEDDVYLHTVIPAVVVAAILLIAGIIAMICYRKKRK GKLTLEDQATFIKKGVPIIFADELDDSKPPPSSSMPLILQEEKAPLPPPEYPNQSVPETT PLNQDTMGEYTPLRDEDPNAPPYQPPPPFTAPMEGKGSRPKNMTPYRSPPPYVPP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "DAG1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_143" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "α-dystroglycan" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#d_Q14118" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#host>
                "HCT116 cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-143" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "α-Dystroglycan (αDG) lost upon endogenous processing via furin-like cleavage was introduced T322R mutation, truncated and fused with Fc at R373 by standard PCR and genetic engineering techniques using the expression plasmids. HCT116 cells were grown overnight and transfected using Polyethylenimine Max. The encoding sequence of transmembrane protein 5 (TMEM5) open reading frame was amplified by PCR and cloned into pCMV14-3xFLAG vector. TMEM5 gene (1.5-kb fragment) used for the 5' arm was amplified by PCR from HCT116 cell genomic DNA using the primers 5'-ggggtacCAAATTATGCAGTCATTTGC-3' and 5'-ctagctagcGATAAGAAACGAGCAGAGCC-3', and then subcloned between the KpnI and NheI sites to create the pKO 5' arm (hTMEM5). TMEM5 gene used for the 3' arm was amplified similarly using the primers 5'-ataagaatgcggccGCCCTGTACTGCCTATTCTC-3' and 5'-ataagaatgcggccgcGTTGACATATGCATTGCAATC-3', and then subcloned into the NotI site of hTMEM5 to create pKO-hTMEM5. The target DNA sequence (GCCCGAAGAAGACGTGGTAGG) of the guide RNA (gRNA) was inserted into the pX330 vector to create pX330-guide-TMEM5. pX330-guide-TMEM5 and vector, pKO-TMEM5 were transiently transfected into HCT116 cells by Lipofectamine 2000. After post-transfection, cells were incubated in puromycin. The sample was purified using a Protein G affinity column. The sample was separated by SDS-PAGE and subjected to in-gel tryptic digestion and recovery of peptides/glycopeptides from the gel." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to reduction with dithiothreitol, alkylation with iodoacetamide in ammonium bicarbonate buffer, destaining with acetonitrile in ammonium bicarbonate buffer and then digestion overnight with trypsin. The sample was sequentially extracted with distilled water, formic acid, and acetonitrile/formic acid, dried down, and then redissolved in formic acid for further cleaned up by ZipTip C18. The sample was analyzed by nanospray LC-MS/MS. The sample was loaded onto an Acclaim PepMap RSLC column and separated. HCD and CID MS<sup>2</sup> data sets were filtered for candidate glycopeptide spectra based on the presence of MS<sup>2</sup> ions corresponding to the expected tryptic peptide core containing the target <i>O</i>-glycosylation sites and/or peptide fragment ions. The data was interpreted and assigned manually. And some MS<sup>2</sup> ions were further analyzed by CID MS<sup>3</sup>." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Fc-fused α-dystroglycan (αDG) recombinant proteins, amino acid substitutions and deletion mutants of αDG (αDG373(T322R)) were made by standard PCR and genetic engineering techniques using the expression plasmids in transmembrane protein 5 (TMEM5)- knockout HCT116 cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_137  a  gn:DS_137_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-09-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q14118|DAG1_HUMAN Dystroglycan OS=Homo sapiens OX=9606 GN=DAG1 PE=1 SV=2 MRMSVGLSLLLPLSGRTFLLLLSVVMAQSHWPSEPSEAVRDWENQLEASMHSVLSDLHEA VPTVVGIPDGTAVVGRSFRVTIPTDLIASSGDIIKVSAAGKEALPSWLHWDSQSHTLEGL PLDTDKGVHYISVSATRLGANGSHIPQTSSVFSIEVYPEDHSELQSVRTASPDPGEVVSS ACAADEPVTVLTVILDADLTKMTPKQRIDLLHRMRSFSEVELHNMKLVPVVNNRLFDMSA FMAGPGNAKKVVENGALLSWKLGCSLNQNSVPDIHGVEAPAREGAMSAQLGYPVVGWHIA NKKPPLPKRVRRQIHATPTPVTAIGPPTTAIQEPPSRIVPTPTSPAIAPPTETMAPPVRD PVPGKPTVTIRTRGAIIQTPTLGPIQPTRVSEAGTTVPGQIRPTMTIPGYVEPTAVATPP TTTTKKPRVSTPKPATPSTDSTTTTTRRPTKKPRTPRPVPRVTTKVSITRLETASPPTRI RTTTSGVPRGGEPNQRPELKNHIDRVDAWVGTYFEVKIPSDTFYDHEDTTTDKLKLTLKL REQQLVGEKSWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDKGGLSAVDAFEIHVHRRPQ GDRAPARFKAKFVGDPALVLNDIHKKIALVKKLAFAFGDRNCSTITLQNITRGSIVVEWT NNTLPLEPCPKEQIAGLSRRIAEDDGKPRPAFSNALEPDFKATSITVTGSGSCRHLQFIP VVPPRRVPSEAPPTEVPDRDPEKSSEDDVYLHTVIPAVVVAAILLIAGIIAMICYRKKRK GKLTLEDQATFIKKGVPIIFADELDDSKPPPSSSMPLILQEEKAPLPPPEYPNQSVPETT PLNQDTMGEYTPLRDEDPNAPPYQPPPPFTAPMEGKGSRPKNMTPYRSPPPYVPP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "DAG1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_137" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "α-dystroglycan" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#df_Q14118" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "COS7 cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-137" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The mouse AGO61 encoded sequence was amplified by PCR and cloned into pcDNA3.1/V5-His-TOPO (C-terminal hexahistidine and V5 tags). α-DG428 was made using standard PCR and genetic engineering techniques. The sample was cloned into pFC14K HaloTag CMV Flexi vectors (C-terminal HALO tags). COS7 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) added with fetal bovine serum (FBS). For cDNA transfection, cells were grown overnight and transfected using Lipofectamine 2000. The samples were purified using a HaloTag protein purification system from cell lysates co-transfected with α-DG428-HALO and AGO61. The tag was removed using HaloTEV protease and the sample was separated by SDS-PAGE." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The samples were generated 3 types of α-DG deletion mutants with C-terminal HALO tags (α-DG373, α-DG428 and α-DG485). The samples were collected using HALO resin and digested with TEV protease. The samples were treated with β-<i>N</i>-acetylhexosaminidase, β-<i>N</i>-acetylglucosaminidase, or α-<i>N</i>-acetylgalactosaminidase, and then analyzed by Western blot using anti-<i>O</i>-GlcNAc antibody (clone: CTD110.6) mAb. In-gel digested with trypsin recombinant samples were solubilized in formic acid and analyzed by nanospray LC-MS/MS directly." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Deletion mutant of α-dystroglycan (α-DG428) with HALO tags." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_43  a   gn:DS_43_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:12132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_43" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "77" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Upper respiratory tract, lung, kidney, joints and additional symptoms (unwell) were affected at presentation. Patient 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "active Wegener's granulomatosis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-43" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG was isolated from a patient's serum with active Wegener's granulomatosis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_44  a   gn:DS_44_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:12132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_44" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "77" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Upper respiratory tract, lung, kidney, joints and additional symptoms (unwell) were affected at presentation. Patient 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "active Wegener's granulomatosis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-44" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was applied to a DEAE-cellulose column. The sample was dialysed and added mercuripapain then loaded onto a DE52-column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fab fragment was isolated from a patient's serum with active Wegener's granulomatosis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_45  a   gn:DS_45_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:12132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_45" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "77" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Upper respiratory tract, lung, kidney, joints and additional symptoms (unwell) were affected at presentation. Patient 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "active Wegener's granulomatosis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-45" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-F(ab')<sub>2</sub> caused in the retained fluid after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-F(ab')<sub>2</sub> fragment was isolated from a patient's serum with active Wegener's granulomatosis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_46  a   gn:DS_46_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:12132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_46" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "77" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Upper respiratory tract, lung, kidney, joints and additional symptoms (unwell) were affected at presentation. Patient 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "active Wegener's granulomatosis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-46" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-Fc peptides was caused in the flow through solution after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fc peptides was isolated from a patient's serum with active Wegener's granulomatosis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_47  a   gn:DS_47_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:12132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_47" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "61" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Upper respiratory tract, lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "active Wegener's granulomatosis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-47" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG was isolated from a patient's serum with active Wegener's granulomatosis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_48  a   gn:DS_48_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:12132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_48" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "61" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Upper respiratory tract, lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "active Wegener's granulomatosis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-48" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was applied to a DEAE-cellulose column. The sample was dialysed and added mercuripapain then loaded onto a DE52-column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fab fragment was isolated from a patient's serum with active Wegener's granulomatosis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_49  a   gn:DS_49_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:12132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_49" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "61" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Upper respiratory tract, lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "active Wegener's granulomatosis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-49" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-F(ab')<sub>2</sub> caused in the retained fluid after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-F(ab')<sub>2</sub> fragment was isolated from a patient's serum with active Wegener's granulomatosis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_50  a   gn:DS_50_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:12132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_50" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "61" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Upper respiratory tract, lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "active Wegener's granulomatosis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-50" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-Fc peptides was caused in the flow through solution after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fc peptides was isolated from a patient's serum with active Wegener's granulomatosis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_51  a   gn:DS_51_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_51" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D055953" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "74" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Kidney, skin and additional symptoms (unwell) were affected at presentation. Patient 15." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "microscopic polyangiitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-51" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG was isolated from a patient's serum with microscopic polyangiitis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_52  a   gn:DS_52_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_52" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D055953" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "74" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Kidney, skin and additional symptoms (unwell) were affected at presentation. Patient 15." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "microscopic polyangiitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-52" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was applied to a DEAE-cellulose column. The sample was dialysed and added mercuripapain then loaded onto a DE52-column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fab fragment was isolated from a patient's serum with microscopic polyangiitis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_53  a   gn:DS_53_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_53" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D055953" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "74" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Kidney, skin and additional symptoms (unwell) were affected at presentation. Patient 15." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "microscopic polyangiitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-53" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-F(ab')<sub>2</sub> caused in the retained fluid after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-F(ab')<sub>2</sub> fragment was isolated from a patient's serum with microscopic polyangiitis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_54  a   gn:DS_54_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_54" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D055953" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "74" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Kidney, skin and additional symptoms (unwell) were affected at presentation. Patient 15." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "microscopic polyangiitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-54" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-Fc peptides was caused in the flow through solution after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fc peptides was isolated from a patient's serum with microscopic polyangiitis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_55  a   gn:DS_55_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_55" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D055953" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "17" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 19." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "microscopic polyangiitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-55" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG was isolated from a patient's serum with microscopic polyangiitis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_56  a   gn:DS_56_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_56" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D055953" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "17" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 19." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "microscopic polyangiitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-56" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was applied to a DEAE-cellulose column. The sample was dialysed and added mercuripapain then loaded onto a DE52-column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fab fragment was isolated from a patient's serum with microscopic polyangiitis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_57  a   gn:DS_57_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_57" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D055953" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "17" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 19." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "microscopic polyangiitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-57" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-F(ab')<sub>2</sub> caused in the retained fluid after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-F(ab')<sub>2</sub> fragment was isolated from a patient's serum with microscopic polyangiitis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_58  a   gn:DS_58_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_58" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D055953" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "17" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 19." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "microscopic polyangiitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-58" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-Fc peptides was caused in the flow through solution after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fc peptides was isolated from a patient's serum with microscopic polyangiitis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_59  a   gn:DS_59_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_59" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Control 1." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-59" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG was isolated from the healthy control serum." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_60  a   gn:DS_60_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_60" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Control 1." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-60" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4  degree Celsius. The sample was applied to a DEAE-cellulose column. The sample was dialysed and added mercuripapain then loaded onto a DE52-column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fab fragment was isolated from the healthy control serum." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_61  a   gn:DS_61_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_61" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Control 1." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-61" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-F(ab')<sub>2</sub> caused in the retained fluid after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-F(ab')<sub>2</sub> fragment was isolated from the healthy control serum." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_62  a   gn:DS_62_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_62" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Control 1." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-62" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-Fc peptides was caused in the flow through solution after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fc peptides was isolated from the healthy control serum." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_63  a   gn:DS_63_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_63" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Control 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-63" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG was isolated from the healthy control serum." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_64  a   gn:DS_64_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_64" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Control 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-64" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4  degree Celsius. The sample was applied to a DEAE-cellulose column. The sample was dialysed and added mercuripapain then loaded onto a DE52-column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fab fragment was isolated from the healthy control serum." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_65  a   gn:DS_65_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_65" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Control 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-65" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-F(ab')<sub>2</sub> caused in the retained fluid after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-F(ab')<sub>2</sub> fragment was isolated from the healthy control serum." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_66  a   gn:DS_66_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_66" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Control 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-66" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-Fc peptides was caused in the flow through solution after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fc peptides was isolated from the healthy control serum." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_67  a   gn:DS_67_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:12132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_67" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "Mean=(77+61)/2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Upper respiratory tract, lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 2 and patient 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "active Wegener's granulomatosis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-67" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG was isolated from patients' sera with active Wegener's granulomatosis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female n=2" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_68  a   gn:DS_68_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:12132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_68" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "Mean=(77+61)/2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Upper respiratory tract, lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 2 and patient 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "active Wegener's granulomatosis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-68" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was applied to a DEAE-cellulose column. The sample was dialysed and added mercuripapain then loaded onto a DE52-column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fab fragment was isolated from patients' sera with active Wegener's granulomatosis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female n=2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_69  a   gn:DS_69_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:12132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_69" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "Mean=(77+61)/2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Upper respiratory tract, lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 2 and patient 8." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "active Wegener's granulomatosis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-69" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-Fc peptides was caused in the flow through solution after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fc peptides was isolated from patients' sera with active Wegener's granulomatosis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female n=2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_70  a   gn:DS_70_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_70" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D055953" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "Mean=(74+17)/2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 15 and patient 19." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "microscopic polyangiitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-70" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG was isolated from patients' sera with microscopic polyangiitis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male n=1, female n=1" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_71  a   gn:DS_71_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_71" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D055953" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "Mean=(74+17)/2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 15 and patient 19." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "microscopic polyangiitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-71" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was applied to a DEAE-cellulose column. The sample was dialysed and added mercuripapain then loaded onto a DE52-column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fab fragment was isolated from patients' sera with microscopic polyangiitis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male n=1, female n=1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_72  a   gn:DS_72_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_72" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D055953" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "Mean=(74+17)/2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Lung, kidney, skin, joints and additional symptoms (unwell) were affected at presentation. Patient 15 and patient 19." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "microscopic polyangiitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-72" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. Thawed serum was diluted 1:1 with PBS, filtered and applied to protein G column. The column was washed with PBS and bounded IgG eluted with glycine/HCl. The  collected sample adding Tris Base was dialysed v PBS for ~12 h at 4 °C. The sample was concentrated using Vivaspin concentrators and filtered and stored at 4 °C. The sample was dialysed and digested with pepsin. IgG-Fc peptides was caused in the flow through solution after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fc peptides was isolated from patients' sera with microscopic polyangiitis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male n=1, female n=1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_73  a   gn:DS_73_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_73" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "n=2. Control 1 and control 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-73" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. The sample was applied to protein G column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG was isolated from the healthy control sera." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_74  a   gn:DS_74_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_74" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "n=2. Control 1 and control 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-74" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. The sample was applied to protein G column. IgG purified by protein G sepharose was applied to a DEAE-cellulose column. The sample was dialysed and added mercuripapain then loaded onto a DE52-column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fab fragment was isolated from the healthy control sera." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_75  a   gn:DS_75_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-04" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_75" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#p_P0DOX5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "n=2. Control 1 and control 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-75" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The plasma fluid from a patient admitted with acute disease and receiving prednisolone and cyclophosphamide therapy for 24-48 h prior to plasma exchange was frozen. Thawed plasma was converted to serum by the addition sterile calcium chloride. The clarified serum was collected and frozen. The sample was applied to protein G column. Purified IgG was dialysed and digested with pepsin. IgG-Fc peptides was caused in the flow through solution after the centrifugation in Vivaspin concentrators." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested with chymotrypsin and trypsin and then with glycoamidase A. The sample was aminated with a 2-aminopyridine, using sodium cyanoborohydride and purified by a Sephadex G-15 column. The sample was separated by HPLC on a TSK gel DEAE-5PW column, on a Shim-pack HRC-octadecyl silica (ODS) column and further on a TSK-gel Amide-80 column if need. The <i>N</i>-glycan  structures were  identified in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "IgG-Fc peptides was isolated from the healthy control sera." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_231  a  gn:DS_231_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-27" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_231" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_231" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The serum was precipitated with ammonium sulfate, subjected to DEAE-cellulose (Whatman DE-52) and Sephadex G-200 chromatography." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (IgG) from one of three healthy individuals." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_232  a  gn:DS_232_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_232" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_232" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The serum was precipitated with ammonium sulfate, subjected to DEAE-cellulose (Whatman DE-52) and Sephadex G-200 chromatography." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (IgG) from one of three healthy individuals." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_233  a  gn:DS_233_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_233" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_233" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The serum was precipitated with ammonium sulfate, subjected to DEAE-cellulose (Whatman DE-52) and Sephadex G-200 chromatography." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (IgG) from one of three healthy individuals." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_234  a  gn:DS_234_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_234" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG1)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_234" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was equilibrated and eluted in the same buffer with KCl. The IgG fraction was further purified by gel filtration on Sephadex G-100 in Tris-HCl, NaCl, and NaN<sub>3</sub> (pH 8.0). The sample was dissolved in sodium acetate buffer (pH 4.5) and then digested with pepsin for 24 h at 37  degree Celsius. The sample was purified on a DEAE-cellulose column followed by gel filtration." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (subclass IgG1) from one of ten patients with myeloma, named Yot." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_235  a  gn:DS_235_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_235" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG1)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_235" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was equilibrated and eluted in the same buffer with KCl. The IgG fraction was further purified by gel filtration on Sephadex G-100 in Tris-HCl, NaCl, and NaN<sub>3</sub> (pH 8.0). The sample was dissolved in sodium acetate buffer (pH 4.5) and then digested with pepsin for 24 h at 37  degree Celsius. The sample was purified on a DEAE-cellulose column followed by gel filtration." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (subclass IgG1) from one of ten patients with myeloma, named Kyo." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_236  a  gn:DS_236_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_236" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG1)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_236" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was equilibrated and eluted in the same buffer with KCl. The IgG fraction was further purified by gel filtration on Sephadex G-100 in Tris-HCl, NaCl, and NaN<sub>3</sub> (pH 8.0). The sample was dissolved in sodium acetate buffer (pH 4.5) and then digested with pepsin for 24 h at 37  degree Celsius. The sample was purified on a DEAE-cellulose column followed by gel filtration." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (subclass IgG1) from one of ten patients with myeloma, named Han." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_237  a  gn:DS_237_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_237" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG1)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_237" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was equilibrated and eluted in the same buffer with KCl. The IgG fraction was further purified by gel filtration on Sephadex G-100 in Tris-HCl, NaCl, and NaN<sub>3</sub> (pH 8.0). The sample was dissolved in sodium acetate buffer (pH 4.5) and then digested with pepsin for 24 h at 37  degree Celsius. The sample was purified on a DEAE-cellulose column followed by gel filtration." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (subclass IgG1) from one of ten patients with myeloma, named Ogo." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_238  a  gn:DS_238_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01860|IGHG3_HUMAN Immunoglobulin heavy constant gamma 3 OS=Homo sapiens OX=9606 GN=IGHG3 PE=1 SV=2 ASTKGPSVFPLAPCSRSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS GLYSLSSVVTVPSSSLGTQTYTCNVNHKPSNTKVDKRVELKTPLGDTTHTCPRCPEPKSC DTPPPCPRCPEPKSCDTPPPCPRCPEPKSCDTPPPCPRCPAPELLGGPSVFLFPPKPKDT LMISRTPEVTCVVVDVSHEDPEVQFKWYVDGVEVHNAKTKPREEQYNSTFRVVSVLTVLH QDWLNGKEYKCKVSNKALPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVK GFYPSDIAVEWESSGQPENNYNTTPPMLDSDGSFFLYSKLTVDKSRWQQGNIFSCSVMHE" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "IGHG3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_238" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG3)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01860&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Dr. Y. Arata of Tokyo University" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_238" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (subclass IgG3) from one of ten patients with myeloma, named Jir." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_239  a  gn:DS_239_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:9538&&&DOID:2917" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_239" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG1)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "myeloma&&&cryoglobulinemia" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_239" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The serum was cold precipitated repeatedly and purified." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (subclass IgG1) from one of ten patients with myeloma, named Tam. Tam was type I cryoglobulinemia." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_240  a  gn:DS_240_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_240" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG1)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_240" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was equilibrated and eluted in the same buffer with KCl. The IgG fraction was further purified by gel filtration on Sephadex G-100 in Tris-HCl, NaCl, and NaN<sub>3</sub> (pH 8.0). The sample was dissolved in sodium acetate buffer (pH 4.5) and then digested with pepsin for 24 h at 37  degree Celsius. The sample was purified on a DEAE-cellulose column followed by gel filtration." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (subclass IgG1) from one of ten patients with myeloma, named Ike." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_241  a  gn:DS_241_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01860|IGHG3_HUMAN Immunoglobulin heavy constant gamma 3 OS=Homo sapiens OX=9606 GN=IGHG3 PE=1 SV=2 ASTKGPSVFPLAPCSRSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS GLYSLSSVVTVPSSSLGTQTYTCNVNHKPSNTKVDKRVELKTPLGDTTHTCPRCPEPKSC DTPPPCPRCPEPKSCDTPPPCPRCPEPKSCDTPPPCPRCPAPELLGGPSVFLFPPKPKDT LMISRTPEVTCVVVDVSHEDPEVQFKWYVDGVEVHNAKTKPREEQYNSTFRVVSVLTVLH QDWLNGKEYKCKVSNKALPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVK GFYPSDIAVEWESSGQPENNYNTTPPMLDSDGSFFLYSKLTVDKSRWQQGNIFSCSVMHE" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "IGHG3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_241" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG3)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01860&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Dr. H. Nakamura of the University of OEH School of Medicine, Kitakyushu, Japan" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_241" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (subclass IgG3) from one of ten patients with myeloma, named Gab." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_242  a  gn:DS_242_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_242" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG1)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "GS_242" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was equilibrated and eluted in the same buffer with KCl. The IgG fraction was further purified by gel filtration on Sephadex G-100 in Tris-HCl, NaCl, and NaN<sub>3</sub> (pH 8.0). The sample was dissolved in sodium acetate buffer (pH 4.5) and then digested with pepsin for 24 h at 37  degree Celsius. The sample was purified on a DEAE-cellulose column followed by gel filtration." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (subclass IgG1) from one of ten patients with myeloma, named Saw." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_243  a  gn:DS_243_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:9538" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_243" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G (IgG1)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7,P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Dr. T. E. Michaelsen of Statens Institute for Folkehelse, Oslo, Norway" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "myeloma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-243" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to hydrazinolysis for 10 hr. The sample was added 6'-sialyllactose as an internal standard and subjected to the paper chromatography with 1-butanol:ethanol:water. Zero to five cm area from the origin was cut off and eluted with distilled water. The sample was evaporated, reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 hr. The sample was then added NaBH<sub>4</sub> in NaOH and incubated at 30 degree Celsius for another 2 hr. The sample was added acetic acid, applied to Dowex 50W (H<sup>+</sup>) columns and the column was washed with distilled water. The mixture of eluate and washing was evaporated under reduced pressure and evaporated repeatedly with methanol to remove boric acid. The sample was subjected to paper chromatography by using ethylacetate:pyridine:acetic acid:water for 1 day. The sample was subjected to radiochromatoscanning (data not shown). The acidic fraction was digested with sialidase. The sample was heated in HCI at 100 degree Celsius for 3 min and subjected to paper electrophoresis. The sialidase digested sample was also analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to sequential exoglycosidase digestion, with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown) and a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase (once or twice). The sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human immunoglobulin G (subclass IgG1) from one of ten patients with myeloma, named R<sub>phi</sub>V." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_12  a   gn:DS_12_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-15" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02679|FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens OX=9606 GN=FGG PE=1 SV=3 MSWSLHPRNLILYFYALLFLSSTCVAYVATRDNCCILDERFGSYCPTTCGIADFLSTYQT KVDKDLQSLEDILHQVENKTSEVKQLIKAIQLTYNPDESSKPNMIDAATLKSRKMLEEIM KYEASILTHDSSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQ DIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEG FGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKY RLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGW WMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRLTI GEGQQHHLGGAKQVRPEHPAETEYDSLYPEDDL" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "FGG" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "C033536" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "fibrinogen gamma subunit" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02679" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "plasma " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "fibrinogen Nagoya" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Abnormal fibrinogen Nagoya was prepared from pooled patients' plasma and subjected to a lysine-Sepharose 6B column. The sample was achieved by <i>S</i>-carboxymethylation and then resolved by chromatography on a CM-cellulose column. The sample was dialyzed for two days against ammonium bicarbonate buffer, pH 8.0, and then lyophilized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and heated at 100 degree Celsius for 9 h. The sample was evaporated to dryness under reduced pressure over concentrated H<sub>2</sub>SO<sub>4</sub>. The sample was repeatedly evaporated with toluene, dissolved in saturated aqueous NaHCO<sub>3</sub> solution, and acetylated with acetic anhydride. The sample was applied on Dowex 50 W (H<sup>+</sup>)  column and then washed with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was added 6'-sialyllactose. The sample was subjected to paper chromatography with development with 1-butanol/ethanol/water (solvent II) for 2 days. The area corresponding to 0-5 cm from the origin was cut out and the sample was eluted with distilled water. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 h. Then the sample was added NaB<sup>2</sup>H<sub>4</sub> in NaOH incubated at 30 degree Celsius for another 2 h. The remaining sample was reduced with NaB<sup>2</sup>H<sub>4</sub> in NaOH under the same conditions. Then the sample was  added acetic acid and passed through Dowex 50 W (H<sup>+</sup>) column and the sample was eluted with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was evaporated repeatedly with methanol and then subjected to paper chromatography using ethylacetate/pyridine/acetic acid/water (solvent I) for 1 day. The radioactivity of sample was measured with a liquid scintillation spectrometer. The remained at the origin of the deuterium-labeled sample was eluted with water and added the radioactive sample for easy detection. The acidic sample was incubated with sialidase and subjected to electrophoresis paper. The sample was eluted with water and subjected to Bio-Gel P-4 column chromatography. The sample was subjected to paper chromatography using solvent I. The sample was eluted with water. The sample was hydrolyzed in HCl at 100 degree Celsius for 2 h and subjected to paper electrophoresis using borate buffer. The sample was subjected to sequential exoglycosidase digestion; incubated with β-galactosidase, with β-<i>N</i>-acetylhexosaminidase, α-mannosidase, or β-mannosidase, or β-<i>N</i>-acetylhexosaminidase, with a mixture of diplococcal β-galactosidase and β-<i>N</i>-acetylhexosaminidase. The sample was analyzed on a Bio-Gel P-4 column at each step. The deuterium-labeled sample was subjected to methylation analysis. Radioactive sample was treated with a mixture of β-galactosidase and β-<i>N</i>-acetylhexosaminidase, heated at 100 degree Celsius for 3 min, adjusted to pH 5.0, and then digested with sialidase. The sample was subjected to paper electrophoresis at pH 5.4, eluted, and then separated by Bio-Gel P-4 column chromatography. The sample was incubated with  β-galactosidase (data not shown). The sample was incubated with jack bean α-mannosidase adding gamma-<sub>D</sub>-galactonolactone for which  prevented the action of β-galactosidase contaminated.  The sample was analyzed on a Bio-Gel P-4 column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Abnormal fibrinogen Nagoya gamma subunit named gamma<sub>X</sub> of abnormal fibrinogen or fibrinogen Nagoya." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_13  a   gn:DS_13_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02679|FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens OX=9606 GN=FGG PE=1 SV=3 MSWSLHPRNLILYFYALLFLSSTCVAYVATRDNCCILDERFGSYCPTTCGIADFLSTYQT KVDKDLQSLEDILHQVENKTSEVKQLIKAIQLTYNPDESSKPNMIDAATLKSRKMLEEIM KYEASILTHDSSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQ DIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEG FGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKY RLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGW WMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRLTI GEGQQHHLGGAKQVRPEHPAETEYDSLYPEDDL" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "FGG" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_13" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "C033536" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "fibrinogen gamma subunit" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02679" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "plasma " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "fibrinogen Nagoya" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-13" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Abnormal fibrinogen Nagoya was prepared from pooled patients' plasma and subjected to a lysine-Sepharose 6B column. The sample was achieved by <i>S</i>-carboxymethylation and then resolved by chromatography on a CM-cellulose column. The sample was dialyzed for two days against ammonium bicarbonate buffer, pH 8.0, and then lyophilized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and heated at 100 degree Celsius for 9 h. The sample was evaporated to dryness under reduced pressure over concentrated H<sub>2</sub>SO<sub>4</sub>. The sample was repeatedly evaporated with toluene, dissolved in saturated aqueous NaHCO<sub>3</sub> solution, and acetylated with acetic anhydride. The sample was applied on Dowex 50 W (H<sup>+</sup>)  column and then washed with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was added 6'-sialyllactose. The sample was subjected to paper chromatography with development with 1-butanol/ethanol/water (solvent II) for 2 days. The area corresponding to 0-5 cm from the origin was cut out and the sample was eluted with distilled water. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 h. Then the sample was added NaB<sup>2</sup>H<sub>4</sub> in NaOH incubated at 30 degree Celsius for another 2 h. The remaining sample was reduced with NaB<sup>2</sup>H<sub>4</sub> in NaOH under the same conditions. Then the sample was  added acetic acid and passed through Dowex 50 W (H<sup>+</sup>) column and the sample was eluted with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was evaporated repeatedly with methanol and then subjected to paper chromatography using ethylacetate/pyridine/acetic acid/water (solvent I) for 1 day. The radioactivity of sample was measured with a liquid scintillation spectrometer. The remained at the origin of the deuterium-labeled sample was eluted with water and added the radioactive sample for easy detection. The acidic sample was incubated with sialidase and subjected to electrophoresis paper. The sample was eluted with water and subjected to Bio-Gel P-4 column chromatography. The sample was subjected to paper chromatography using solvent I. The sample was eluted with water. The sample was hydrolyzed in HCl at 100 degree Celsius for 2 h and subjected to paper electrophoresis using borate buffer. The sample was subjected to sequential exoglycosidase digestion; incubated with β-galactosidase, with β-<i>N</i>-acetylhexosaminidase, α-mannosidase, or β-mannosidase, or β-<i>N</i>-acetylhexosaminidase, with a mixture of diplococcal β-galactosidase and β-<i>N</i>-acetylhexosaminidase. The sample was analyzed on a Bio-Gel P-4 column at each step. The deuterium-labeled sample was subjected to methylation analysis. Radioactive sample was treated with a mixture of β-galactosidase and β-<i>N</i>-acetylhexosaminidase, heated at 100 degree Celsius for 3 min, adjusted to pH 5.0, and then digested with sialidase. The sample was subjected to paper electrophoresis at pH 5.4, eluted, and then separated by Bio-Gel P-4 column chromatography. The sample was incubated with  β-galactosidase (data not shown). The sample was incubated with jack bean α-mannosidase adding gamma-<sub>D</sub>-galactonolactone for which  prevented the action of β-galactosidase contaminated.  The sample was analyzed on a Bio-Gel P-4 column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Abnormal fibrinogen Nagoya gamma subunit named gamma<sub>L</sub> of abnormal fibrinogen or fibrinogen Nagoya." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_249  a  gn:DS_249_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02679|FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens OX=9606 GN=FGG PE=1 SV=3 MSWSLHPRNLILYFYALLFLSSTCVAYVATRDNCCILDERFGSYCPTTCGIADFLSTYQT KVDKDLQSLEDILHQVENKTSEVKQLIKAIQLTYNPDESSKPNMIDAATLKSRKMLEEIM KYEASILTHDSSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQ DIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEG FGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKY RLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGW WMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRLTI GEGQQHHLGGAKQVRPEHPAETEYDSLYPEDDL" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "FGG" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_249" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "C033536" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "fibrinogen gamma subunit" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02679" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "plasma " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "fibrinogen Nagoya" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-249" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Abnormal fibrinogen Nagoya was prepared from pooled patients' plasma and subjected to a lysine-Sepharose 6B column. The sample was achieved by <i>S</i>-carboxymethylation and then resolved by chromatography on a CM-cellulose column. The sample was dialyzed for two days against ammonium bicarbonate buffer, pH 8.0, and then lyophilized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and heated at 100 degree Celsius for 9 h. The sample was evaporated to dryness under reduced pressure over concentrated H<sub>2</sub>SO<sub>4</sub>. The sample was repeatedly evaporated with toluene, dissolved in saturated aqueous NaHCO<sub>3</sub> solution, and acetylated with acetic anhydride. The sample was applied on Dowex 50 W (H<sup>+</sup>)  column and then washed with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was added 6'-sialyllactose. The sample was subjected to paper chromatography with development with 1-butanol/ethanol/water (solvent II) for 2 days. The area corresponding to 0-5 cm from the origin was cut out and the sample was eluted with distilled water. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 h. Then the sample was added NaB<sup>2</sup>H<sub>4</sub> in NaOH incubated at 30 degree Celsius for another 2 h. The remaining sample was reduced with NaB<sup>2</sup>H<sub>4</sub> in NaOH under the same conditions. Then the sample was  added acetic acid and passed through Dowex 50 W (H<sup>+</sup>) column and the sample was eluted with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was evaporated repeatedly with methanol and then subjected to paper chromatography using ethylacetate/pyridine/acetic acid/water (solvent I) for 1 day. The radioactivity of sample was measured with a liquid scintillation spectrometer. The remained at the origin of the deuterium-labeled sample was eluted with water and added the radioactive sample for easy detection. The acidic sample was incubated with sialidase and subjected to electrophoresis paper. The sample was eluted with water and subjected to Bio-Gel P-4 column chromatography. The sample was subjected to paper chromatography using solvent I. The sample was eluted with water. The sample was hydrolyzed in HCl at 100 degree Celsius for 2 h and subjected to paper electrophoresis using borate buffer. The sample was subjected to sequential exoglycosidase digestion; incubated with β-galactosidase, with β-<i>N</i>-acetylhexosaminidase, α-mannosidase, or β-mannosidase, or β-<i>N</i>-acetylhexosaminidase, with a mixture of diplococcal β-galactosidase and β-<i>N</i>-acetylhexosaminidase. The sample was analyzed on a Bio-Gel P-4 column at each step. The deuterium-labeled sample was subjected to methylation analysis. Radioactive sample was treated with a mixture of β-galactosidase and β-<i>N</i>-acetylhexosaminidase, heated at 100 degree Celsius for 3 min, adjusted to pH 5.0, and then digested with sialidase. The sample was subjected to paper electrophoresis at pH 5.4, eluted, and then separated by Bio-Gel P-4 column chromatography. The sample was incubated with  β-galactosidase (data not shown). The sample was incubated with jack bean α-mannosidase adding gamma-<sub>D</sub>-galactonolactone for which  prevented the action of β-galactosidase contaminated.  The sample was analyzed on a Bio-Gel P-4 column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Abnormal fibrinogen Nagoya gamma subunit named gamma<sub>R</sub> of abnormal fibrinogen or fibrinogen Nagoya." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_250  a  gn:DS_250_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02675|FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens OX=9606 GN=FGB PE=1 SV=2 MKRMVSWSFHKLKTMKHLLLLLLCVFLVKSQGVNDNEEGFFSARGHRPLDKKREEAPSLR PAPPPISGGGYRARPAKAAATQKKVERKAPDAGGCLHADPDLGVLCPTGCQLQEALLQQE RPIRNSVDELNNNVEAVSQTSSSSFQYMYLLKDLWQKRQKQVKDNENVVNEYSSELEKHQ LYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKE CEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYK QGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFT VQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDP RKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKM SMKIRPFFPQQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "FGB" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_250" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "C033536" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "fibrinogen Bβ subunit" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02675" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "plasma " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "fibrinogen Nagoya" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-250" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Abnormal fibrinogen Nagoya was prepared from pooled patients' plasma and subjected to a lysine-Sepharose 6B column. The sample was achieved by <i>S</i>-carboxymethylation and then resolved by chromatography on a CM-cellulose column. The sample was dialyzed for two days against ammonium bicarbonate buffer, pH 8.0, and then lyophilized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and heated at 100 degree Celsius for 9 h. The sample was evaporated to dryness under reduced pressure over concentrated H<sub>2</sub>SO<sub>4</sub>. The sample was repeatedly evaporated with toluene, dissolved in saturated aqueous NaHCO<sub>3</sub> solution, and acetylated with acetic anhydride. The sample was applied on Dowex 50 W (H<sup>+</sup>)  column and then washed with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was added 6'-sialyllactose. The sample was subjected to paper chromatography with development with 1-butanol/ethanol/water (solvent II) for 2 days. The area corresponding to 0-5 cm from the origin was cut out and the sample was eluted with distilled water. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 h. Then the sample was added NaB<sup>2</sup>H<sub>4</sub> in NaOH incubated at 30 degree Celsius for another 2 h. The remaining sample was reduced with NaB<sup>2</sup>H<sub>4</sub> in NaOH under the same conditions. Then the sample was  added acetic acid and passed through Dowex 50 W (H<sup>+</sup>) column and the sample was eluted with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was evaporated repeatedly with methanol and then subjected to paper chromatography using ethylacetate/pyridine/acetic acid/water (solvent I) for 1 day. The radioactivity of sample was measured with a liquid scintillation spectrometer. The remained at the origin of the deuterium-labeled sample was eluted with water and added the radioactive sample for easy detection. The acidic sample was incubated with sialidase and subjected to electrophoresis paper. The sample was eluted with water and subjected to Bio-Gel P-4 column chromatography. The sample was subjected to paper chromatography using solvent I. The sample was eluted with water. The sample was hydrolyzed in HCl at 100 degree Celsius for 2 h and subjected to paper electrophoresis using borate buffer. The sample was subjected to sequential exoglycosidase digestion; incubated with β-galactosidase, with β-<i>N</i>-acetylhexosaminidase, α-mannosidase, or β-mannosidase, or β-<i>N</i>-acetylhexosaminidase, with a mixture of diplococcal β-galactosidase and β-<i>N</i>-acetylhexosaminidase. The sample was analyzed on a Bio-Gel P-4 column at each step. The deuterium-labeled sample was subjected to methylation analysis. Radioactive sample was treated with a mixture of β-galactosidase and β-<i>N</i>-acetylhexosaminidase, heated at 100 degree Celsius for 3 min, adjusted to pH 5.0, and then digested with sialidase. The sample was subjected to paper electrophoresis at pH 5.4, eluted, and then separated by Bio-Gel P-4 column chromatography. The sample was incubated with  β-galactosidase (data not shown). The sample was incubated with jack bean α-mannosidase adding gamma-<sub>D</sub>-galactonolactone for which  prevented the action of β-galactosidase contaminated.  The sample was analyzed on a Bio-Gel P-4 column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Abnormal fibrinogen Nagoya β subunit named Bβ<sub>L</sub> of abnormal fibrinogen or fibrinogen Nagoya." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_251  a  gn:DS_251_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02675|FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens OX=9606 GN=FGB PE=1 SV=2 MKRMVSWSFHKLKTMKHLLLLLLCVFLVKSQGVNDNEEGFFSARGHRPLDKKREEAPSLR PAPPPISGGGYRARPAKAAATQKKVERKAPDAGGCLHADPDLGVLCPTGCQLQEALLQQE RPIRNSVDELNNNVEAVSQTSSSSFQYMYLLKDLWQKRQKQVKDNENVVNEYSSELEKHQ LYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKE CEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYK QGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFT VQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDP RKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKM SMKIRPFFPQQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "FGB" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_251" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "C033536" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "fibrinogen Bβ subunit" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02675" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "plasma " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "fibrinogen Nagoya" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-251" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Abnormal fibrinogen Nagoya was prepared from pooled patients' plasma and subjected to a lysine-Sepharose 6B column. The sample was achieved by <i>S</i>-carboxymethylation and then resolved by chromatography on a CM-cellulose column. The sample was dialyzed for two days against ammonium bicarbonate buffer, pH 8.0, and then lyophilized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and heated at 100 degree Celsius for 9 h. The sample was evaporated to dryness under reduced pressure over concentrated H<sub>2</sub>SO<sub>4</sub>. The sample was repeatedly evaporated with toluene, dissolved in saturated aqueous NaHCO<sub>3</sub> solution, and acetylated with acetic anhydride. The sample was applied on Dowex 50 W (H<sup>+</sup>)  column and then washed with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was added 6'-sialyllactose. The sample was subjected to paper chromatography with development with 1-butanol/ethanol/water (solvent II) for 2 days. The area corresponding to 0-5 cm from the origin was cut out and the sample was eluted with distilled water. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 h. Then the sample was added NaB<sup>2</sup>H<sub>4</sub> in NaOH incubated at 30 degree Celsius for another 2 h. The remaining sample was reduced with NaB<sup>2</sup>H<sub>4</sub> in NaOH under the same conditions. Then the sample was  added acetic acid and passed through Dowex 50 W (H<sup>+</sup>) column and the sample was eluted with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was evaporated repeatedly with methanol and then subjected to paper chromatography using ethylacetate/pyridine/acetic acid/water (solvent I) for 1 day. The radioactivity of sample was measured with a liquid scintillation spectrometer. The remained at the origin of the deuterium-labeled sample was eluted with water and added the radioactive sample for easy detection. The acidic sample was incubated with sialidase and subjected to electrophoresis paper. The sample was eluted with water and subjected to Bio-Gel P-4 column chromatography. The sample was subjected to paper chromatography using solvent I. The sample was eluted with water. The sample was hydrolyzed in HCl at 100 degree Celsius for 2 h and subjected to paper electrophoresis using borate buffer. The sample was subjected to sequential exoglycosidase digestion; incubated with β-galactosidase, with β-<i>N</i>-acetylhexosaminidase, α-mannosidase, or β-mannosidase, or β-<i>N</i>-acetylhexosaminidase, with a mixture of diplococcal β-galactosidase and β-<i>N</i>-acetylhexosaminidase. The sample was analyzed on a Bio-Gel P-4 column at each step. The deuterium-labeled sample was subjected to methylation analysis. Radioactive sample was treated with a mixture of β-galactosidase and β-<i>N</i>-acetylhexosaminidase, heated at 100 degree Celsius for 3 min, adjusted to pH 5.0, and then digested with sialidase. The sample was subjected to paper electrophoresis at pH 5.4, eluted, and then separated by Bio-Gel P-4 column chromatography. The sample was incubated with  β-galactosidase (data not shown). The sample was incubated with jack bean α-mannosidase adding gamma-<sub>D</sub>-galactonolactone for which  prevented the action of β-galactosidase contaminated.  The sample was analyzed on a Bio-Gel P-4 column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Abnormal fibrinogen Nagoya β subunit named Bβ<sub>R</sub> of abnormal fibrinogen or fibrinogen Nagoya." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_252  a  gn:DS_252_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02679|FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens OX=9606 GN=FGG PE=1 SV=3 MSWSLHPRNLILYFYALLFLSSTCVAYVATRDNCCILDERFGSYCPTTCGIADFLSTYQT KVDKDLQSLEDILHQVENKTSEVKQLIKAIQLTYNPDESSKPNMIDAATLKSRKMLEEIM KYEASILTHDSSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQ DIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEG FGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKY RLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGW WMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRLTI GEGQQHHLGGAKQVRPEHPAETEYDSLYPEDDL" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "FGG" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_252" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "fibrinogen gamma subunit" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02679" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "plasma " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-252" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Normal fibrinogen was prepared from pooled human plasma and subjected to a lysine-Sepharose 6B column. The sample was achieved by <i>S</i>-carboxymethylation and then resolved by chromatography on a CM-cellulose column. The sample was dialyzed for two days against ammonium bicarbonate buffer, pH 8.0, and then lyophilized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and heated at 100 degree Celsius for 9 h. The sample was evaporated to dryness under reduced pressure over concentrated H<sub>2</sub>SO<sub>4</sub>. The sample was repeatedly evaporated with toluene, dissolved in saturated aqueous NaHCO<sub>3</sub> solution, and acetylated with acetic anhydride. The sample was applied on Dowex 50 W (H<sup>+</sup>)  column and then washed with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was added 6'-sialyllactose. The sample was subjected to paper chromatography with development with 1-butanol/ethanol/water (solvent II) for 2 days. The area corresponding to 0-5 cm from the origin was cut out and the sample was eluted with distilled water. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 h. Then the sample was added NaB<sup>2</sup>H<sub>4</sub> in NaOH incubated at 30 degree Celsius for another 2 h. The remaining sample was reduced with NaB<sup>2</sup>H<sub>4</sub> in NaOH under the same conditions. Then the sample was  added acetic acid and passed through Dowex 50 W (H<sup>+</sup>) column and the sample was eluted with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was evaporated repeatedly with methanol and then subjected to paper chromatography using ethylacetate/pyridine/acetic acid/water (solvent I) for 1 day. The radioactivity of sample was measured with a liquid scintillation spectrometer. The remained at the origin of the deuterium-labeled sample was eluted with water and added the radioactive sample for easy detection. The acidic sample was incubated with sialidase and subjected to electrophoresis paper. The sample was eluted with water and subjected to Bio-Gel P-4 column chromatography. The sample was subjected to paper chromatography using solvent I. The sample was eluted with water. The sample was hydrolyzed in HCl at 100 degree Celsius for 2 h and subjected to paper electrophoresis using borate buffer. The sample was subjected to sequential exoglycosidase digestion; incubated with β-galactosidase, with β-<i>N</i>-acetylhexosaminidase, α-mannosidase, or β-mannosidase, or β-<i>N</i>-acetylhexosaminidase, with a mixture of diplococcal β-galactosidase and β-<i>N</i>-acetylhexosaminidase. The sample was analyzed on a Bio-Gel P-4 column at each step. The deuterium-labeled sample was subjected to methylation analysis. Radioactive sample was treated with a mixture of β-galactosidase and β-<i>N</i>-acetylhexosaminidase, heated at 100 degree Celsius for 3 min, adjusted to pH 5.0, and then digested with sialidase. The sample was subjected to paper electrophoresis at pH 5.4, eluted, and then separated by Bio-Gel P-4 column chromatography. The sample was incubated with  β-galactosidase (data not shown). The sample was incubated with jack bean α-mannosidase adding gamma-<sub>D</sub>-galactonolactone for which  prevented the action of β-galactosidase contaminated.  The sample was analyzed on a Bio-Gel P-4 column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Healthy fibrinogen gamma subunit named gamma<sub>L</sub> of normal fibrinogen." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_253  a  gn:DS_253_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02679|FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens OX=9606 GN=FGG PE=1 SV=3 MSWSLHPRNLILYFYALLFLSSTCVAYVATRDNCCILDERFGSYCPTTCGIADFLSTYQT KVDKDLQSLEDILHQVENKTSEVKQLIKAIQLTYNPDESSKPNMIDAATLKSRKMLEEIM KYEASILTHDSSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQ DIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEG FGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKY RLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGW WMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRLTI GEGQQHHLGGAKQVRPEHPAETEYDSLYPEDDL" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "FGG" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_253" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "fibrinogen gamma subunit" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02679" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "plasma " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-253" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Normal fibrinogen was prepared from pooled human plasma and subjected to a lysine-Sepharose 6B column. The sample was achieved by <i>S</i>-carboxymethylation and then resolved by chromatography on a CM-cellulose column. The sample was dialyzed for two days against ammonium bicarbonate buffer, pH 8.0, and then lyophilized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and heated at 100 degree Celsius for 9 h. The sample was evaporated to dryness under reduced pressure over concentrated H<sub>2</sub>SO<sub>4</sub>. The sample was repeatedly evaporated with toluene, dissolved in saturated aqueous NaHCO<sub>3</sub> solution, and acetylated with acetic anhydride. The sample was applied on Dowex 50 W (H<sup>+</sup>)  column and then washed with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was added 6'-sialyllactose. The sample was subjected to paper chromatography with development with 1-butanol/ethanol/water (solvent II) for 2 days. The area corresponding to 0-5 cm from the origin was cut out and the sample was eluted with distilled water. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 h. Then the sample was added NaB<sup>2</sup>H<sub>4</sub> in NaOH incubated at 30 degree Celsius for another 2 h. The remaining sample was reduced with NaB<sup>2</sup>H<sub>4</sub> in NaOH under the same conditions. Then the sample was  added acetic acid and passed through Dowex 50 W (H<sup>+</sup>) column and the sample was eluted with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was evaporated repeatedly with methanol and then subjected to paper chromatography using ethylacetate/pyridine/acetic acid/water (solvent I) for 1 day. The radioactivity of sample was measured with a liquid scintillation spectrometer. The remained at the origin of the deuterium-labeled sample was eluted with water and added the radioactive sample for easy detection. The acidic sample was incubated with sialidase and subjected to electrophoresis paper. The sample was eluted with water and subjected to Bio-Gel P-4 column chromatography. The sample was subjected to paper chromatography using solvent I. The sample was eluted with water. The sample was hydrolyzed in HCl at 100 degree Celsius for 2 h and subjected to paper electrophoresis using borate buffer. The sample was subjected to sequential exoglycosidase digestion; incubated with β-galactosidase, with β-<i>N</i>-acetylhexosaminidase, α-mannosidase, or β-mannosidase, or β-<i>N</i>-acetylhexosaminidase, with a mixture of diplococcal β-galactosidase and β-<i>N</i>-acetylhexosaminidase. The sample was analyzed on a Bio-Gel P-4 column at each step. The deuterium-labeled sample was subjected to methylation analysis. Radioactive sample was treated with a mixture of β-galactosidase and β-<i>N</i>-acetylhexosaminidase, heated at 100 degree Celsius for 3 min, adjusted to pH 5.0, and then digested with sialidase. The sample was subjected to paper electrophoresis at pH 5.4, eluted, and then separated by Bio-Gel P-4 column chromatography. The sample was incubated with  β-galactosidase (data not shown). The sample was incubated with jack bean α-mannosidase adding gamma-<sub>D</sub>-galactonolactone for which  prevented the action of β-galactosidase contaminated.  The sample was analyzed on a Bio-Gel P-4 column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Healthy fibrinogen gamma subunit named gamma<sub>R</sub> of normal fibrinogen." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_254  a  gn:DS_254_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02675|FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens OX=9606 GN=FGB PE=1 SV=2 MKRMVSWSFHKLKTMKHLLLLLLCVFLVKSQGVNDNEEGFFSARGHRPLDKKREEAPSLR PAPPPISGGGYRARPAKAAATQKKVERKAPDAGGCLHADPDLGVLCPTGCQLQEALLQQE RPIRNSVDELNNNVEAVSQTSSSSFQYMYLLKDLWQKRQKQVKDNENVVNEYSSELEKHQ LYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKE CEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYK QGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFT VQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDP RKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKM SMKIRPFFPQQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "FGB" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_254" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "fibrinogen Bβ subunit" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02675" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "plasma " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-254" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Normal fibrinogen was prepared from pooled human plasma and subjected to a lysine-Sepharose 6B column. The sample was achieved by <i>S</i>-carboxymethylation and then resolved by chromatography on a CM-cellulose column. The sample was dialyzed for two days against ammonium bicarbonate buffer, pH 8.0, and then lyophilized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and heated at 100 degree Celsius for 9 h. The sample was evaporated to dryness under reduced pressure over concentrated H<sub>2</sub>SO<sub>4</sub>. The sample was repeatedly evaporated with toluene, dissolved in saturated aqueous NaHCO<sub>3</sub> solution, and acetylated with acetic anhydride. The sample was applied on Dowex 50 W (H<sup>+</sup>)  column and then washed with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was added 6'-sialyllactose. The sample was subjected to paper chromatography with development with 1-butanol/ethanol/water (solvent II) for 2 days. The area corresponding to 0-5 cm from the origin was cut out and the sample was eluted with distilled water. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 h. Then the sample was added NaB<sup>2</sup>H<sub>4</sub> in NaOH incubated at 30 degree Celsius for another 2 h. The remaining sample was reduced with NaB<sup>2</sup>H<sub>4</sub> in NaOH under the same conditions. Then the sample was  added acetic acid and passed through Dowex 50 W (H<sup>+</sup>) column and the sample was eluted with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was evaporated repeatedly with methanol and then subjected to paper chromatography using ethylacetate/pyridine/acetic acid/water (solvent I) for 1 day. The radioactivity of sample was measured with a liquid scintillation spectrometer. The remained at the origin of the deuterium-labeled sample was eluted with water and added the radioactive sample for easy detection. The acidic sample was incubated with sialidase and subjected to electrophoresis paper. The sample was eluted with water and subjected to Bio-Gel P-4 column chromatography. The sample was subjected to paper chromatography using solvent I. The sample was eluted with water. The sample was hydrolyzed in HCl at 100 degree Celsius for 2 h and subjected to paper electrophoresis using borate buffer. The sample was subjected to sequential exoglycosidase digestion; incubated with β-galactosidase, with β-<i>N</i>-acetylhexosaminidase, α-mannosidase, or β-mannosidase, or β-<i>N</i>-acetylhexosaminidase, with a mixture of diplococcal β-galactosidase and β-<i>N</i>-acetylhexosaminidase. The sample was analyzed on a Bio-Gel P-4 column at each step. The deuterium-labeled sample was subjected to methylation analysis. Radioactive sample was treated with a mixture of β-galactosidase and β-<i>N</i>-acetylhexosaminidase, heated at 100 degree Celsius for 3 min, adjusted to pH 5.0, and then digested with sialidase. The sample was subjected to paper electrophoresis at pH 5.4, eluted, and then separated by Bio-Gel P-4 column chromatography. The sample was incubated with  β-galactosidase (data not shown). The sample was incubated with jack bean α-mannosidase adding gamma-<sub>D</sub>-galactonolactone for which  prevented the action of β-galactosidase contaminated.  The sample was analyzed on a Bio-Gel P-4 column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Healthy fibrinogen β subunit named Bβ<sub>L</sub> of normal fibrinogen." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_255  a  gn:DS_255_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02675|FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens OX=9606 GN=FGB PE=1 SV=2 MKRMVSWSFHKLKTMKHLLLLLLCVFLVKSQGVNDNEEGFFSARGHRPLDKKREEAPSLR PAPPPISGGGYRARPAKAAATQKKVERKAPDAGGCLHADPDLGVLCPTGCQLQEALLQQE RPIRNSVDELNNNVEAVSQTSSSSFQYMYLLKDLWQKRQKQVKDNENVVNEYSSELEKHQ LYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKE CEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYK QGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFT VQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDP RKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKM SMKIRPFFPQQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "FGB" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_255" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "fibrinogen Bβ subunit" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02675" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "plasma " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-255" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Normal fibrinogen was prepared from pooled human plasma and subjected to a lysine-Sepharose 6B column. The sample was achieved by <i>S</i>-carboxymethylation and then resolved by chromatography on a CM-cellulose column. The sample was dialyzed for two days against ammonium bicarbonate buffer, pH 8.0, and then lyophilized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and heated at 100 degree Celsius for 9 h. The sample was evaporated to dryness under reduced pressure over concentrated H<sub>2</sub>SO<sub>4</sub>. The sample was repeatedly evaporated with toluene, dissolved in saturated aqueous NaHCO<sub>3</sub> solution, and acetylated with acetic anhydride. The sample was applied on Dowex 50 W (H<sup>+</sup>)  column and then washed with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was added 6'-sialyllactose. The sample was subjected to paper chromatography with development with 1-butanol/ethanol/water (solvent II) for 2 days. The area corresponding to 0-5 cm from the origin was cut out and the sample was eluted with distilled water. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 h. Then the sample was added NaB<sup>2</sup>H<sub>4</sub> in NaOH incubated at 30 degree Celsius for another 2 h. The remaining sample was reduced with NaB<sup>2</sup>H<sub>4</sub> in NaOH under the same conditions. Then the sample was  added acetic acid and passed through Dowex 50 W (H<sup>+</sup>) column and the sample was eluted with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was evaporated repeatedly with methanol and then subjected to paper chromatography using ethylacetate/pyridine/acetic acid/water (solvent I) for 1 day. The radioactivity of sample was measured with a liquid scintillation spectrometer. The remained at the origin of the deuterium-labeled sample was eluted with water and added the radioactive sample for easy detection. The acidic sample was incubated with sialidase and subjected to electrophoresis paper. The sample was eluted with water and subjected to Bio-Gel P-4 column chromatography. The sample was subjected to paper chromatography using solvent I. The sample was eluted with water. The sample was hydrolyzed in HCl at 100 degree Celsius for 2 h and subjected to paper electrophoresis using borate buffer. The sample was subjected to sequential exoglycosidase digestion; incubated with β-galactosidase, with β-<i>N</i>-acetylhexosaminidase, α-mannosidase, or β-mannosidase, or β-<i>N</i>-acetylhexosaminidase, with a mixture of diplococcal β-galactosidase and β-<i>N</i>-acetylhexosaminidase. The sample was analyzed on a Bio-Gel P-4 column at each step. The deuterium-labeled sample was subjected to methylation analysis. Radioactive sample was treated with a mixture of β-galactosidase and β-<i>N</i>-acetylhexosaminidase, heated at 100 degree Celsius for 3 min, adjusted to pH 5.0, and then digested with sialidase. The sample was subjected to paper electrophoresis at pH 5.4, eluted, and then separated by Bio-Gel P-4 column chromatography. The sample was incubated with  β-galactosidase (data not shown). The sample was incubated with jack bean α-mannosidase adding gamma-<sub>D</sub>-galactonolactone for which  prevented the action of β-galactosidase contaminated.  The sample was analyzed on a Bio-Gel P-4 column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Healthy fibrinogen β subunit named Bβ<sub>R</sub> of normal fibrinogen." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_222  a  gn:DS_222_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02671|FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens OX=9606 GN=FGA PE=1 SV=2 MFSMRIVCLVLSVVGTAWTADSGEGDFLAEGGGVRGPRVVERHQSACKDSDWPFCSDEDW NYKCPSGCRMKGLIDEVNQDFTNRINKLKNSLFEYQKNNKDSHSLTTNIMEILRGDFSSA NNRDNTYNRVSEDLRSRIEVLKRKVIEKVQHIQLLQKNVRAQLVDMKRLEVDIDIKIRSC RGSCSRALAREVDLKDYEDQQKQLEQVIAKDLLPSRDRQHLPLIKMKPVPDLVPGNFKSQ LQKVPPEWKALTDMPQMRMELERPGGNEITRGGSTSYGTGSETESPRNPSSAGSWNSGSS GPGSTGNRNPGSSGTGGTATWKPGSSGPGSTGSWNSGSSGTGSTGNQNPGSPRPGSTGTW NPGSSERGSAGHWTSESSVSGSTGQWHSESGSFRPDSPGSGNARPNNPDWGTFEEVSGNV SPGTRREYHTEKLVTSKGDKELRTGKEKVTSGSTTTTRRSCSKTVTKTVIGPDGHKEVTK EVVTSEDGSDCPEAMDLGTLSGIGTLDGFRHRHPDEAAFFDTASTGKTFPGFFSPMLGEF VSETESRGSESGIFTNTKESSSHHPGIAEFPSRGKSSSYSKQFTSSTSYNRGDSTFESKS YKMADEAGSEADHEGTHSTKRGHAKSRPVRDCDDVLQTHPSGTQSGIFNIKLPGSSKIFS VYCDQETSLGGWLLIQQRMDGSLNFNRTWQDYKRGFGSLNDEGEGEFWLGNDYLHLLTQR GSVLRVELEDWAGNEAYAEYHFRVGSEAEGYALQVSSYEGTAGDALIEGSVEEGAEYTSH NNMQFSTFDRDADQWEENCAEVYGGGWWYNNCQAANLNGIYYPGGSYDPRNNSPYEIENG VVWVSFRGADYSLRAVRMKIRPLVTQ >sp|P02675|FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens OX=9606 GN=FGB PE=1 SV=2 MKRMVSWSFHKLKTMKHLLLLLLCVFLVKSQGVNDNEEGFFSARGHRPLDKKREEAPSLR PAPPPISGGGYRARPAKAAATQKKVERKAPDAGGCLHADPDLGVLCPTGCQLQEALLQQE RPIRNSVDELNNNVEAVSQTSSSSFQYMYLLKDLWQKRQKQVKDNENVVNEYSSELEKHQ LYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKE CEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYK QGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFT VQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDP RKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKM SMKIRPFFPQQ >sp|P02679|FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens OX=9606 GN=FGG PE=1 SV=3 MSWSLHPRNLILYFYALLFLSSTCVAYVATRDNCCILDERFGSYCPTTCGIADFLSTYQT KVDKDLQSLEDILHQVENKTSEVKQLIKAIQLTYNPDESSKPNMIDAATLKSRKMLEEIM KYEASILTHDSSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQ DIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEG FGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKY RLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGW WMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRLTI GEGQQHHLGGAKQVRPEHPAETEYDSLYPEDDL" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_222" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "fibrinogen" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02671&P02675&P02679" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "plasma " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-222" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Normal fibrinogen was prepared from pooled human plasma and subjected to a lysine-Sepharose 6B column. The sample was achieved by <i>S</i>-carboxymethylation and then resolved by chromatography on a CM-cellulose column. The sample was dialyzed for two days against ammonium bicarbonate buffer, pH 8.0, and then lyophilized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and heated at 100 degree Celsius for 9 h. The sample was evaporated to dryness under reduced pressure over concentrated H<sub>2</sub>SO<sub>4</sub>. The sample was repeatedly evaporated with toluene, dissolved in saturated aqueous NaHCO<sub>3</sub> solution, and acetylated with acetic anhydride. The sample was applied on Dowex 50 W (H<sup>+</sup>)  column and then washed with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was added 6'-sialyllactose. The sample was subjected to paper chromatography with development with 1-butanol/ethanol/water (solvent II) for 2 days. The area corresponding to 0-5 cm from the origin was cut out and the sample was eluted with distilled water. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 h. Then the sample was added NaB<sup>2</sup>H<sub>4</sub> in NaOH incubated at 30 degree Celsius for another 2 h. The remaining sample was reduced with NaB<sup>2</sup>H<sub>4</sub> in NaOH under the same conditions. Then the sample was  added acetic acid and passed through Dowex 50 W (H<sup>+</sup>) column and the sample was eluted with distilled water. Both eluates and washings were combined and evaporated to dryness under reduced pressure. The sample was evaporated repeatedly with methanol and then subjected to paper chromatography using ethylacetate/pyridine/acetic acid/water (solvent I) for 1 day. The radioactivity of sample was measured with a liquid scintillation spectrometer. The remained at the origin of the deuterium-labeled sample was eluted with water and added the radioactive sample for easy detection. The acidic sample was incubated with sialidase and subjected to electrophoresis paper. The sample was eluted with water and subjected to Bio-Gel P-4 column chromatography. The sample was subjected to paper chromatography using solvent I. The sample was eluted with water. The sample was hydrolyzed in HCl at 100 degree Celsius for 2 h and subjected to paper electrophoresis using borate buffer. The sample was subjected to sequential exoglycosidase digestion; incubated with β-galactosidase, with β-<i>N</i>-acetylhexosaminidase, α-mannosidase, or β-mannosidase, or β-<i>N</i>-acetylhexosaminidase, with a mixture of diplococcal β-galactosidase and β-<i>N</i>-acetylhexosaminidase. The sample was analyzed on a Bio-Gel P-4 column at each step. The deuterium-labeled sample was subjected to methylation analysis. Radioactive sample was treated with a mixture of β-galactosidase and β-<i>N</i>-acetylhexosaminidase, heated at 100 degree Celsius for 3 min, adjusted to pH 5.0, and then digested with sialidase. The sample was subjected to paper electrophoresis at pH 5.4, eluted, and then separated by Bio-Gel P-4 column chromatography. The sample was incubated with  β-galactosidase (data not shown). The sample was incubated with jack bean α-mannosidase adding gamma-<sub>D</sub>-galactonolactone for which  prevented the action of β-galactosidase contaminated.  The sample was analyzed on a Bio-Gel P-4 column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Healthy fibrinogen named Intact or normal fibrinogen." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_18  a   gn:DS_18_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-16" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "mean 34" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Eiji Miyoshi lab, Osaka University" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Haptoglobin beta chain was purified from sera of healthy using an anti-haptoglobin afﬁnity column coupled with anti human haptoglobin antibody." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The fraction was subjected to SDS-PAGE and stained with CBB or blotted onto a nitrocellulose membrane followed by lectin blot analyses using aleuria aurantia lectin (AAL) or aspergillus oryzae lectin (AOL). The samples were digested with trypsin and was treated with <i>N</i>-Glycosidase F rec. [<i>E. coli</i>]. The samples were modified with pyridylamino and analyzed by LC-ESI-MS and MALDI-TOF-MS." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of healthy." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male n=16, female n=14" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_19  a   gn:DS_19_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1793" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-16" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_19" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "mean 62" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka National Hospital, Osaka University Hospital and Osaka Medical Center for Cancer and CVD." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "pancreatic cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-19" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Haptoglobin beta chain was purified from sera of healthy using an anti-haptoglobin afﬁnity column coupled with anti human haptoglobin antibody." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The fraction was subjected to SDS-PAGE and stained with CBB or blotted onto a nitrocellulose membrane followed by lectin blot analyses using aleuria aurantia lectin (AAL) or aspergillus oryzae lectin (AOL). The samples were digested with trypsin and was treated with <i>N</i>-Glycosidase F rec. [<i>E. coli</i>]. The samples were modified with pyridylamino and analyzed by LC-ESI-MS and MALDI-TOF-MS." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of patients with pancreatic cancer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male n=31, female n=18" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_20  a   gn:DS_20_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:684" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-16" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_20" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "mean 69" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka National Hospital, Osaka University Hospital and Osaka Medical Center for Cancer and CVD." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hepatocellular carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-20" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Haptoglobin beta chain was purified from sera of healthy using an anti-haptoglobin afﬁnity column coupled with anti human haptoglobin antibody." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The fraction was subjected to SDS-PAGE and stained with CBB or blotted onto a nitrocellulose membrane followed by lectin blot analyses using aleuria aurantia lectin (AAL) or aspergillus oryzae lectin (AOL)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of patients with hepatocellular carcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male n=17, female n=6" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_21  a   gn:DS_21_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:5082" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-16" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_21" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "mean 63" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka National Hospital, Osaka University Hospital and Osaka Medical Center for Cancer and CVD." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "liver cirrhosis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-21" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Haptoglobin beta chain was purified from sera of healthy using an anti-haptoglobin afﬁnity column coupled with anti human haptoglobin antibody." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The fraction was subjected to SDS-PAGE and stained with CBB or blotted onto a nitrocellulose membrane followed by lectin blot analyses using aleuria aurantia lectin (AAL) or aspergillus oryzae lectin (AOL)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of patients with liver cirrhosis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male n=9, female n=3" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_22  a   gn:DS_22_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:10534" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-17" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "mean 59" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka National Hospital, Osaka University Hospital and Osaka Medical Center for Cancer and CVD." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "gastric cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Haptoglobin beta chain was purified from sera of healthy using an anti-haptoglobin afﬁnity column coupled with anti human haptoglobin antibody." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The fraction was subjected to SDS-PAGE and stained with CBB or blotted onto a nitrocellulose membrane followed by lectin blot analyses using aleuria aurantia lectin (AAL) or aspergillus oryzae lectin (AOL)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of patients with gastric cancer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male n=5, female n=5" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_23  a   gn:DS_23_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:219" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-17" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_23" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "mean 61" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka National Hospital, Osaka University Hospital and Osaka Medical Center for Cancer and CVD." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "colon cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-23" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Haptoglobin beta chain was purified from sera of healthy using an anti-haptoglobin afﬁnity column coupled with anti human haptoglobin antibody." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The fraction was subjected to SDS-PAGE and stained with CBB or blotted onto a nitrocellulose membrane followed by lectin blot analyses using aleuria aurantia lectin (AAL) or aspergillus oryzae lectin (AOL)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of patients with colon cancer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male n=10, female n=7" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_24  a   gn:DS_24_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1793" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_24" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka National Hospital, Osaka University Hospital and Osaka Medical Center for Cancer and CVD." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "pancreatic cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "I, II" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-24" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Haptoglobin beta chain was purified from sera of healthy using an anti-haptoglobin afﬁnity column coupled with anti human haptoglobin antibody." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The fraction was subjected to SDS-PAGE and stained with CBB or blotted onto a nitrocellulose membrane followed by lectin blot analyses using aleuria aurantia lectin (AAL) or aspergillus oryzae lectin (AOL)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of patients with pancreatic cancer at stage I and II." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_25  a   gn:DS_25_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1793" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-18" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1 MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRT EGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTE GDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMV SHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHP NYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVM LPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFA VHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "HP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka National Hospital, Osaka University Hospital and Osaka Medical Center for Cancer and CVD." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "pancreatic cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "III, IV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Haptoglobin beta chain was purified from sera of healthy using an anti-haptoglobin afﬁnity column coupled with anti human haptoglobin antibody." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The fraction was subjected to SDS-PAGE and stained with CBB or blotted onto a nitrocellulose membrane followed by lectin blot analyses using aleuria aurantia lectin (AAL) or aspergillus oryzae lectin (AOL)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Haptoglobin beta chain purified from sera of patients with pancreatic cancer at stage III and IV. " .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_26  a   gn:DS_26_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1793" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_26" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "ATCC (American Type Culture Collection), or the Institute of Development, Aging and Cancer, Tohoku University." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "PSN-1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "pancreatic cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-26" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Cultured cells were extracted RNA using trizol, chloroform, 2-propanol and diethylpyrocarbonate. PSN-1 and MIAPaCa-2 cells were cultured in serum-free medium for 2 days. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "RT-PCR was performed and its products were run on an agarose gel. Western blot analysis using an anti-human haptoglobin antibody was performed." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "RNA extract from human pancreatic carcinoma cell lines (PSN-1, KLM-1, MiaPaCa-2, PK8, PK59, PANC-1) and haptoglobin induction by pancreatic cancer cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_148  a  gn:DS_148_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1793" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-15" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_148" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "ATCC (American Type Culture Collection), or the Institute of Development, Aging and Cancer, Tohoku University." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "KLM-1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "pancreatic cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-148" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Cultured cells were extracted RNA using trizol, chloroform, 2-propanol and diethylpyrocarbonate. PSN-1 and MIAPaCa-2 cells were cultured in serum-free medium for 2 days. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "RT-PCR was performed and its products were run on an agarose gel. Western blot analysis using an anti-human haptoglobin antibody was performed." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "RNA extract from human pancreatic carcinoma cell lines (PSN-1, KLM-1, MiaPaCa-2, PK8, PK59, PANC-1) and haptoglobin induction by pancreatic cancer cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_149  a  gn:DS_149_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1793" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-15" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_149" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "ATCC (American Type Culture Collection), or the Institute of Development, Aging and Cancer, Tohoku University." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "MIA PaCa-2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "pancreatic cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-149" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Cultured cells were extracted RNA using trizol, chloroform, 2-propanol and diethylpyrocarbonate. PSN-1 and MIAPaCa-2 cells were cultured in serum-free medium for 2 days." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "RT-PCR was performed and its products were run on an agarose gel. Western blot analysis using an anti-human haptoglobin antibody was performed." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "RNA extract from human pancreatic carcinoma cell lines (PSN-1, KLM-1, MiaPaCa-2, PK8, PK59, PANC-1) and haptoglobin induction by pancreatic cancer cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_150  a  gn:DS_150_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1793" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-15" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_150" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "ATCC (American Type Culture Collection), or the Institute of Development, Aging and Cancer, Tohoku University." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "PK8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "pancreatic cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-150" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Cultured cells were extracted RNA using trizol, chloroform, 2-propanol and diethylpyrocarbonate. PSN-1 and MIAPaCa-2 cells were cultured in serum-free medium for 2 days." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "RT-PCR was performed and its products were run on an agarose gel. Western blot analysis using an anti-human haptoglobin antibody was performed." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "RNA extract from human pancreatic carcinoma cell lines (PSN-1, KLM-1, MiaPaCa-2, PK8, PK59, PANC-1) and haptoglobin induction by pancreatic cancer cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_151  a  gn:DS_151_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1793" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-15" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_151" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "ATCC (American Type Culture Collection), or the Institute of Development, Aging and Cancer, Tohoku University." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "PK59" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "pancreatic cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-151" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Cultured cells were extracted RNA using trizol, chloroform, 2-propanol and diethylpyrocarbonate. PSN-1 and MIAPaCa-2 cells were cultured in serum-free medium for 2 days." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "RT-PCR was performed and its products were run on an agarose gel. Western blot analysis using an anti-human haptoglobin antibody was performed." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "RNA extract from human pancreatic carcinoma cell lines (PSN-1, KLM-1, MiaPaCa-2, PK8, PK59, PANC-1) and haptoglobin induction by pancreatic cancer cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_152  a  gn:DS_152_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1793" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-15" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_152" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "ATCC (American Type Culture Collection), or the Institute of Development, Aging and Cancer, Tohoku University." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "PANC-1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "pancreatic cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-152" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Cultured cells were extracted RNA using trizol, chloroform, 2-propanol and diethylpyrocarbonate. PSN-1 and MIAPaCa-2 cells were cultured in serum-free medium for 2 days." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "RT-PCR was performed and its products were run on an agarose gel. Western blot analysis using an anti-human haptoglobin antibody was performed." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "RNA extract from human pancreatic carcinoma cell lines (PSN-1, KLM-1, MiaPaCa-2, PK8, PK59, PANC-1) and haptoglobin induction by pancreatic cancer cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_27  a   gn:DS_27_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DB_Memo>
                "There are 2 possibilities of mechanisms increased fucosylation of haptoglobin in the sera of patients with pancreatic cancer. One is that fucosylated haptoglobin is produced by pancreatic cancer cells. Haptoglobin mRNA was expressed only in PSN-1 cells. Both core fucosylation and the α 1-3/α 1-4 fucosylation of haptoglobin were observed in the conditioned media of PSN-1 cells using LC-ESI-MS analysis (data not shown). The other is that a factor induced the production of fucosylated haptoglobin from the liver may be produced by pancreatic cancer. This possibility is supported from that haptoglobin production was increased in a hepatoma cell line, Hep3B added media from pancreatic cancer cells PSN-1 and MIA PaCa-2." , "Edited Memo" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:684" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_27" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Haptoglobin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P00738" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "ATCC (American Type Culture Collection), or the Institute of Development, Aging and Cancer, Tohoku University." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "Hep3B" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hepatocellular carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-27" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Cultured cell line was extracted RNA using trizol, chloroform, 2-propanol and diethylpyrocarbonate. Hep3B cell was cultured in serum-free medium for 2 days. After collecting the medium, media from PSN-1 or MIAPaCa-2 cells were added and the suspension was further incubated for 2 days. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "RT-PCR was performed and its products were run on an agarose gel. Western blot analysis using an anti-human haptoglobin antibody was performed." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "RNA extract from human hepatoma cell line (Hep3B)  and haptoglobin induction by pancreatic cancer cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_134  a  gn:DS_134_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-10" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=3 MGPPSAPPCRLHVPWKEVLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLAHNLPQ NRIGYSWYKGERVDGNSLIVGYVIGTQQATPGPAYSGRETIYPNASLLIQNVTQNDTGFY TLQVIKSDLVNEEATGQFHVYPELPKPSISSNNSNPVEDKDAVAFTCEPEVQNTTYLWWV NGQSLPVSPRLQLSNGNMTLTLLSVKRNDAGSYECEIQNPASANRSDPVTLNVLYGPDGP TISPSKANYRPGENLNLSCHAASNPPAQYSWFINGTFQQSTQELFIPNITVNNSGSYMCQ AHNSATGLNRTTVTMITVSGSAPVLSAVATVGITIGVLARVALI" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "CEACAM6" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_134" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Nonspecific cross-reacting antigen-2 (NCA-2)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P40199" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "meconium" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_type>
                "various types" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-134" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was adsorbed to goat anti-CEA adsorbent and eluted with glycine-HCl buffer, after treatment with perchloric acid. The sample was purified by serial chromatography on a Sepharose 6B and a Sephadex G-200 column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and heated at 100 degree Celsius for 8 h. Some of the sample was added lactose and reduced with NaB<sup>3</sup>H<sub>4</sub>. [<sup>3</sup>H]Lactitol and tritium labeled sample was separated by paper chromatography. The labeled sample was also dissolved in distilled water and applied to Con A-Sepharose, L-PHA-Sepharose or E-PHA-Sepharose columns. The eluted samples were applied to a DSA-Sepharose column and eluted. The sample was mounted to either an AAL-Sepharose, an RCA-I agarose or a WFA-agarose column equilibrated with phosphate-buffered saline, containing NaN<sub>3</sub>, were allowed to stand at 2 degree Celsius for 30 min and then eluted with the same buffer at 2 degree Celsius, followed by the buffer containing L-fucose, lactose or <i>N</i>-acetylglucosamine, at room temperature, respectively. The remaining sample was reduced with NaB<sup>2</sup>H<sub>4</sub> for methylation study. The sample was subjected to paper electrophoresis. The acidic sample was extracted with water and treated sialidase. The sialidase resistant sample was digested by methanolysis. The sample was fractioned by Bio-Gel P-4 column chromatography. The samples were mixed and hydrolyzed three times in HCl at 100 degree Celsius for 90 min for defucosylation from outer chains.  The sample was digested with one of the following reaction mixture at 37 degree Celsius for 17 h added one drop of toluene; sialidase digestion in sodium acetate buffer; digestion with a mixture of 6646K β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase in citrate-phosphate buffer; diplococcal β-galactosidase digestion in citrate-phosphate buffer; 6646K β-galactosidase digestion in citrate-phosphate buffer; digestion with a mixture of Bacillus α-fucosidase and diplococcal β-galactosidase in citrate-phosphate buffer; digestion with a mixture of almond α-fucosidase I and diplococcal β-galactosidase in citrate-phosphate buffer; jack bean β-<i>N</i>-acetylhexosaminidase digestion in sodium citrate buffer; jack bean α-mannosidase digestion in sodium acetate buffer; snail β-mannosidase digestion in sodium citrate buffer; bovine epididymal α-fucosidase digestion in sodium citrate buffer;  <i>Eschericia freundii</i> endo-β-galactosidase digestion in sodium acetate buffer; Corynebacterium α-fucosidase digestion in sodium phosphate buffer. The sample was heated in boiling water for 2 min and analyzed by paper chromatography, paper electrophoresis or Bio-Gel P-4 column chromatography. The sample was incubated with jack bean β-<i>N</i>-acetylhexosaminidase to remove the GalNAcb1-> residues in the outer chain moieties. The sample was further separated by <i>Aleuria aurantia</i> lectin-Sepharose column chromatography and by serial chromatography with the use of four lectin columns. Partially-O-methylated hexitols and N-acetylhexosaminitols was analyzed with gas chromatograph-mass spectrometer by using a fused silica capillary column coated with cross linked SPB-35.  The molar ratio was calculated from total ion intensity in GC-MS. The radioactive sample was digested with endo-β-galactosidasea and  labeled by NaB<sup>3</sup>H<sub>4</sub> reduction. The sample was separated upon Bio-Gel P-4 column chromatography." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Nonspecific cross-reacting antigen-2 (NCA-2) obtained from meconium collected from more than 20 neonates." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_185  a  gn:DS_185_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1520" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-11-27" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=3 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPDAP TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNKLSVDHSDPVILNVLYGPDDPTI SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "CEACAM5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_185" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Carcinoembryonic antigen" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P06731" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_type>
                "A" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "colon carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "metastasis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-185" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was purified by Sepharose 6B and Sepharose 4B gel permeation chromatography followed by concanavalin A-Sepharose 4B affinity chromatography. The sample was dried." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The dried sample was suspended in anhydrous hydrazine and heated. The sample was dissolved in NaOH and reduced with NaB<sup>3</sup>H<sub>4</sub> after addition of lactose. [<sup>3</sup>H]Lactitol and tritium-labeled sample was separated by paper chromatography. The sample was reduced with NaB<sup>2</sup>H<sub>4</sub> to obtain deuterium-labeled oligosaccharide fractions for methylation analysis. The sample was incubated with galactose oxidase and horse radish peroxidase. The sample was incubated with NaB<sup>3</sup>H<sub>4</sub> and then reduced with NaBH<sub>4</sub>. The samples were incubated with (1) sialidase digestion, (2) the mixture of jack bean β-galactosidase and β-<i>N</i>-acetylhexosaminidase, β-galactosidase and β-<i>N</i>-acetylhexosaminidase digestion, (3) jack bean α-mannosidase digestion, (4) snail β-mannosidase digestion, (5) bovine epididymis α-fucosidase digestion, or (6) <i>Flavobacterium</i> endo-β-galactosidase digestion and D-galactono-gamma-lactone. Other conditions of exoglycosidase digestion were; (7) Diplococcal β-galactosidase and jack bean β-N-acetylhexosaminidase, (8) Sequential incubation with jack bean β-galactosidase and jack bean β-N-acetylhexosaminidase, (9) Sequential incubation with Bacillus α-fucosidase  and with a mixture of diplococcal β-galactosidase and jack bean β-N-acetylhexosaminidase, (10) Almond α-fucosidase I, diplococcal β-galactosidase and jack bean β-N-acetylhexosaminidase, (11) Sequential digestion with jack bean β-galactosidase and with jack bean β-N-acetylhexosaminidase, (12) Sequential digestion with Bacillus α-fucosidase and with a mixture of diplococcal β-galactosidase and jack bean β-N-acetylhexosaminidase. After incubation, the samples were heated, it was passed through Dowex 50 (H<sup>+</sup> form) and AG-3(OH<sup>-</sup> form) columns and analyzed by either paper electrophoresis or Bio-Gel P-4 column chromatography. The sample was performed a methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Mean values calculated from three carcinoembryonic antigen samples." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "liver" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_76  a   gn:DS_76_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-21" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|O75015|FCG3B_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-B OS=Homo sapiens OX=9606 GN=FCGR3B PE=1 SV=2 MWQLLLPTALLLLVSAGMRTEDLPKAVVFLEPQWYSVLEKDSVTLKCQGAYSPEDNSTQW FHNESLISSQASSYFIDAATVNDSGEYRCQTNLSTLSDPVQLEVHIGWLLLQAPRWVFKE EDPIHLRCHSWKNTALHKVTYLQNGKDRKYFHHNSDFHIPKATLKDSGSYFCRGLVGSKN VSSETVNITITQGLAVSTISSFSPPGYQVSFCLVMVLLFAVDTGLYFSVKTNI" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "FCGR3B" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_76" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "FcgammaRIIIb" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "O75015" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#author_protein_sequence>
                "STEDLPKAVVFLEPQWYSVLEKDSVTLKCQGAYSPEDNSTQW FHNESLISSQASSYFIDAATVNDSGEYRCQTNLSTLSDPVQLEVHIGWLLLQAPRWIFKE EDPIHLRCHSWKNTALHKVTYQNGKDRKYFHHNSDFHIPKATLKDSGSYFCRGLFGSKN VSSETVNITITQGLAVSTISSFFPPGYDPRLV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "baby hamster kidney (BHK) cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-76" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The human sFcgammaRIIIb-transfected baby hamster kidney (BHK) cells were grown on hollow fibers in a perfusion cell culture system. The expressed samples were purified by ion exchange and affinity chromatography. The sample was equilibrated in PBS by dialysis. The sample was spun and frozen." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was incubated with a mixture containing α-sialidase, β-galactosidase, β-<i>N</i>-acetylglucosaminidase and endoglycosidase Hf in acetate buffer at 37 degree Celsius for 48 h. The sample was incubated with 2-mercaptoethanol for 2 h in Tris–HCl buffer containing guanidine hydrochloride and ethylenediaminetetraacetic acid (EDTA). The sample was added monoiodoacetic acid and incubated for 2 h in the dark. The sample was desalted with a PD-10 column and then lyophilized. The sample was incubated with endoproteinase Glu-C in ammonium acetate buffer at 37 degree Celsius for 20 h or with chymotrypsin in ammonium bicarbonate buffer at 37 degree Celsius for 5 days. The sample was analyzed by LC/MS." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-80 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "N-linked oligosaccharides of human soluble FcgammaRIIIb encoded by NA2 allele." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_87  a   gn:DS_87_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-09" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_87" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#dev_stage>
                "10-day-old embryonated eggs" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#egg>
                "embryonated eggs" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#host>
                "chicken" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#host_taxid>
                "9031" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-87" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "influenza virus strain A/Memphis/1/71 (H3N2)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The influenza virus was inoculated into allantoic cavities of 10-day-old embryonated hen eggs and incubated.  Pooled sample was centrifuged. The supernatant was further centrifuged, and then precipitates were suspended in phosphatebuffered saline. The suspension was then centrifuged in a sucrose gradient in phosphate-buffered saline and the bottom fractions were collected. Neuraminidase activity was assayed by using <i>N</i>-acetylneuraminyllactose as substrates.  The peaks with hemagglutination and neuraminidase activity were pooled and recentrifuged. The pellet was subjected further to the sucrose density gradient centrifugation. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was proteolyzed with chymotrypsin and trypsin mixture and digested with glycoamidase A. The reducing ends of the <i>N</i>-glycans were derivatized with 2-aminopyridine and were separated by HPLC on a TSK gel DEAE-5PW column. The fractions were separated on a Shim-pack HRC-ODS column and on a TSK-gel Amide-80 column.  The <i>N</i>-glycan structures were identified using the GALAXY database (DOI: 10.4052/tigg.15.235, DOI: 10.4052/tigg.21.95). The unknown structures of the PA-glycans in the GALAXY database were characterized by HPLC mapping in conjunction with exoglycosidase treatments, desulfation, and MALDI-TOF-MS analysis with an AXIMA-CFR MALDI-TOF MS spectrometer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans derived from influenza A viruses grown in embryonated eggs." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "383586" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_88  a   gn:DS_88_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-09" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_88" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "MDCK cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-88" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "influenza virus strain A/Memphis/1/71" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Confluent monolayer MDCK cells were infected with viruses. After washing viruses with PBS, cells were incubated in serum free medium, Hybridoma-SFM containing acetylated trypsin. At 12, 16, 20 and 24 h, supernatants of sample were recovered. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was proteolyzed with chymotrypsin and trypsin mixture and digested with glycoamidase A. The reducing ends of the <i>N</i>-glycans were derivatized with 2-aminopyridine and were separated by HPLC on a TSK gel DEAE-5PW column. The fractions were separated on a Shim-pack HRC-ODS column and on a TSK-gel Amide-80 column.  The <i>N</i>-glycan structures were identified using the GALAXY database (DOI: 10.4052/tigg.15.235, DOI: 10.4052/tigg.21.95). The unknown structures of the PA-glycans in the GALAXY database were characterized by HPLC mapping in conjunction with exoglycosidase treatments, desulfation, and MALDI-TOF-MS analysis with an AXIMA-CFR MALDI-TOF MS spectrometer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans derived from influenza A viruses grown in MDCK cells." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "383586" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_89  a   gn:DS_89_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-09" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_89" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "MDCK cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-89" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "MDCK cell extract was delipidated." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was proteolyzed with chymotrypsin and trypsin mixture and digested with glycoamidase A. The reducing ends of the <i>N</i>-glycans were derivatized with 2-aminopyridine, parts of the PA-glycans were treated with α-sialidase and then separated by HPLC on a TSK gel DEAE-5PW column. The fractions were separated on a Shim-pack HRC-ODS column and on a TSK-gel Amide-80 column.  The <i>N</i>-glycan structures were identified using the GALAXY database (DOI: 10.4052/tigg.15.235, DOI: 10.4052/tigg.21.95). The unknown structures of the PA-glycans in the GALAXY database were characterized by HPLC mapping in conjunction with exoglycosidase treatments, desulfation, and MALDI-TOF-MS analysis with an AXIMA-CFR MALDI-TOF MS spectrometer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans derived from MDCK cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_14  a   gn:DS_14_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-04-27" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01005|IOVO_CHICK Ovomucoid OS=Gallus gallus OX=9031 PE=1 SV=1 MAMAGVFVLFSFVLCGFLPDAAFGAEVDCSRFPNATDKEGKDVLVCNKDLRPICGTDGVT YTNDCLLCAYSIEFGTNISKEHDGECKETVPMNCSSYANTTSEDGKVMVLCNRAFNPVCG TDGVTYDNECLLCAHKVEQGASVDKRHDGGCRKELAAVSVDCSEYPKPDCTAEDRPLCGS DNKTYGNKCNFCNAVVESNGTLTLSHFGKC" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_14" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Gallus gallus" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "ovomucoid" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01005 " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-14" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "hen" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Ovoinhibitor excluded hen ovomucoid was thoroughly dried on P<sub>2</sub>O<sub>5</sub>, <i>in vacuo</i>." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in anhydrous hydrazine and subjected to 8-h hydrazinolysis. The sample was thus dissolved in NaOH. Some of the sample was reduced with NaB[<sup>3</sup>H]<sub>4</sub> and the remaining sample was reduced with  NaB[<sup>2</sup>H]<sub>4</sub>. One-tenth of the tritium-labeled oligosaccharide fraction was added to the deuterium-labeled sample. The sample was subjected to paper electrophoresis and eluted from paper with distilled water and subjected to Bio-Gel P-4 column chromatography. Some peaks were subjected to the second Bio-Gel P-4 column chromatography. The total neutral molar ratios were calculated on the basis of their radioactivities. The sample was incubated with jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase and further sequential exoglycosidase digestion (data not shown). The sample was subjected to methylation analysis of oligosaccharides was performed as PMID: 429259 except that the hydrolysis of permethylated oligosaccharides was performed for 6 h in H<sub>2</sub>SO<sub>4</sub>, containing acetic acid. The sample was analyzed with a gas chromatography-mass spectrometer. The sample was reduced with NaB[<sup>2</sup>H]<sub>4</sub>. The sample was incubated with diplococcal β-<i>N</i>-acetylhexosaminidase and subjected to methylation analysis and periodate oxidation. The tritium-labeled sample was digested exhaustively with high concentration of jack bean β-<i>N</i>-acetylhexoaminidase. The sample was incubated with a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase. The sample was digested with jack bean α-mannosidase and subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Hen ovomucoid." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_16  a   gn:DS_16_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q0V8L2|GGT7_BOVIN Glutathione hydrolase 7 OS=Bos taurus OX=9913 GN=GGT7 PE=2 SV=1 MAAENEASQESALGAYSPVDYMSITSFPRLPEDEPAPAVPLRGRKDEDAFLGDPDTDPDS FLKSARLQRLPSSSSEMGSQDGSPLRETRKDPFSAAASECSCRQDGLTVIVTACLTFATG VTVALIMQIYFGDPQIFHQGAVVTDAARCTSLGIEVLSKQGSSVDAAVAAALCLGIVAPH SSGLGGGGVMLVHDIRRNKSHLIDFRESAPGALREEALQRSWETKPGLLVGVPGMVKGLH EAHQLYGRLPWSQVLAFAAAVAQDGFNVTHDLAQALAEQPPPNASDRFRETFLPMGHPPL PGSLLRRPDLAAVLEVLGTYGPAAFYAGGNLTLEMVAEAQHAGGVITEEDFSNYSALLEK PVCGVYRGHLVLSPRPPHTGPALISALNILEGFNLTSLVSREQALHWVAETLKIALALAS RLGDPIYDSTITESMDDMLSKVEAAYFRGQINDSQAAPVPLLPIYELNGAPTAAQVLIMG PDDFIVAMVSSLNRPFGSGLITPSGILLNSQMLDFSWPNRTANHPAPSLENSVQPGKRPL SFLLPTVVRPAEGLCGTYLALGANGAARGLSGLTQVLLNVLTLNRNLSDSLARGRLHPDL QTNLLQVDSEFTEEEIEFLEARGHHVEKVDVLSWVHGSRRTNNFIIGVKDPRSPDAAGAT MEPEAGPVLYQKLRVWEPSLESEEEEEEISEQLILDASGPHDSSGNKAGRLPGAWAQLVA ALLLLAIGFSLAVRQLCSSGASPGALGSGAPPASGHSHRPGVYHHGAIISPAAECSRLGR ELFVAGGNIVDAGVGAALCLAVVHPHTTGLGATYWGLFHNSSSGNSTALTSGPAQTLAPG LGLPSALPALHMLHTHFGRLPWPHLLVGPISLAQKGFLVDTSLASALAAQDTKGLCPLLC HANGTPLGPGTQVTNTKLAAVLHKASLAPTPDLSGDALLSLLAEDLGLEGPSVGPRPTLE PALQLPLPQGILFTTPSPSAGPELLELLEASLQSAGPSPAPCPALPQAAAAPRSSVLATV DSSGSVLLLTSSLNSSFGSGHLSPSTGVLLSNLVAESAAGAWACPLIFRDISDDTEVDVL GLVASGTPAAARVMTHALLSHLARPQTPDQQGPTESPRACAQGTLLQVAAHTEHAHVSSV PSGCCPFQGF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "GGT7" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_16" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Bos taurus" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "gamma-Glutamyltranspeptidase" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9913" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q0V8L2,A7YWM1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-16" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "bovine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample from kidney was freed of fats, dissected into small pieces and added prechilled Tris buffer containing KCl. The sample was homogenized for 3 minutes, passed through a double layer of cheese cloth and centrifuged for 15 minutes. The supernatant was centrifuged for 60 minutes and its pellet was homogenized in Tris buffer containing KCl and centrifuged for 60 minutes. The microsomal pellet was homogenized and washed in Tris buffer and resuspended in Tris buffer containing Emulphogene BC720. The sample was stirred overnight and centrifuged for 60 minutes. The supernatant was saturated with solid ammonium sulfate to 70%, stirred for 30 minutes and centrifuged for 60 minutes. The fluffy mass formed on the surface of the supernatant was gathered and dissolved in Tris buffer containing Emulphogene, and dialyzed overnight against at three times buffer changes. The sample was centrifuged for 30 minutes and the supernatant was collected and frozen. The sample was applied to ECTEOLA-cellulose column which thoroughly washed with Tris buffer containing Emulphogene. The sample was washed with the equilibrating buffer, and then eluted with  NaCl in Tris buffer containing Emulphogene. The sample was pooled, dialyzed and concentrated." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was thoroughly dried over P<sub>2</sub>O<sub>5</sub> <i>in vacuo</i> and subjected to hydrazinolysis for 8h. The oligosaccharide fraction was <i>N</i>-acetylated and dissolved in ice-cold NaOH. One-fifth of the sample was reduced with NaB[<sup>3</sup>H]<sub>4</sub> for tritium-labeled. The remaining sample was reduced with NaB[<sup>2</sup>H]<sub>4</sub> for deuterium-labeled. One-tenth of the tritium labeled sample was added to the deuterium labeled sample to facilitate detection. The sample was subjected to paper electrophoresis. The pooled acidic fractions were digested with sialidase exhaustively or also acid hydrolyzed with HCl at 100 degree Celsius for 3 min, mildly. The radioactive samples were hydrolyzed in HCI at 100 degree Celsius for 2 h and analyzed after <i>N</i>-acetylation by paper electrophoresis using borate buffer. The samples were subjected to Bio-Gel P-4 column chromatography. The neutral fraction sample was incubated with <i>Aspergillus</i> α-mannosidase and then purified by Bio-Gel P-4 column chromatography. The sample was subjected to sequential digestion with jack bean α-mannosidase and β-mannosidase, respectively (data not shown). The sample pooled a to i fractions was incubated with a mixture of jack bean β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase. The sample was subjected to sequential exoglycosidase digestion (data not shown) and methylation analysis. The sample pooled a to i fractions was digested with jack bean β-galactosidase and then subjected to methylation analysis. The combined sample of a to i fractions was subjected to methylation analysis. The sample was treated with β-galactosidase. The sample was subjected to sequential digestion with jack bean β-galactosidase, <i>diplococcal</i> β-<i>N</i>-acetylhexosaminidase and jack bean β-<i>N</i>-acetylhexosaminidase, and analyzed by Bio-Gel P-4 column chromatography. The sample was subjected to periodate oxidation twice and analyzed on a Bio-Gel P-4 column (data not shown). The sample was subjected to methylation analysis for determining the locations of sialic acid." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "gamma-Glutamyltranspeptidase obtained from bovine kidney." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "kidney" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_180  a  gn:DS_180_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-11-05" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "CGA" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_180" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "follicle-stimulating hormone" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "National Hormone Laboratory in New Zealand" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-180" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The gland removed at autopsy was frozen at -20  degree Celsius and stored at the National Hormone Laboratory in New Zealand. On the day before the extraction, the sample was batched and immersed in liquid nitrogen for 5 min before being returned to a -20  degree Celsius deep freeze. Six hundred frozen glands were homogenized in Tris-phosphate buffer and stirred for 2 h and centrifuged for 1 h. The pellet was rehomogenized with the same Tris-phosphate buffer, stirred for 1 h, and centrifuged for 1 h. The pellet was then homogenized three times with Tris-phosphate buffer and centrifuged as before. The supernatants were combined, filtered through a funnel packed with glass wool, mixed, and added acetic acid to pH 6.3. The sample was then centrifuged for 16 h. The supernatant was decanted, and the pellet was washed with extraction buffer adjusted to pH 6.3 concentrated HCl. The washings were added to the supernatant fraction. The sample was added acetic acid to reduce pH 4.9 and chilled absolute ethanol with stirring. The sample was left for 8 h and centrifuged for 1 h. The sample was decanted. The sample was frozen and provided. A crude precipitate from gland was ultracentrifuged, filtered on Sephadex G-100 and subjected to chromatography on DEAE-Sephacel. The sample was further purified by Sephadex G-100 column chromatography (Nishimura <i>et al</i>., unpublished data). The sample was subjected to the polyacrylamide gel electrophoresis and stained with Coomassie blue or periodic acid-Schiff reagent; the mobility of which was the same as that of the human chorionic gonadotropin (hCG)-α subunit and it showed that there is no human luteinizing hormone (hLH) or human thyroid-stimulating hormone (hTSH) activity, as judged on radioimmunoassaying." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was hydrazinolysis for 10h for the liberation as oligosaccharides. After <i>N</i>-acetylation, half of the sample was reduced with NaB<sup>2</sup>H<sub>4</sub> for methylation analysis. One-tenth of the tritium-labeled oligosaccharide fraction was added to the sample for the easy detection in further purification steps. Both the tritium- and deuterium-labeled oligosaccharide fractions were subjected to paper electrophoresis. The sample was incubated with sialidase and hydrolyzed with HCl at 100 degree Celsius for 3 min. The sample was first applied to a column of E-PHA-agarose. Both fractions were desalted on columns of Dowex SOW (H+) and Bio-Rad AG-3 (OH-), and then dried. Then, both fractions (passed through and elution of the remaining) were applied to a second lectin-agarose column of AAL-Sepharose. The samples bounded to the column were eluted with phosphate-buffered saline containing fucose. All fractions were desalted. The fractions contained fucose were subjected to Bio-Gel P-4 column chromatography for removing it. Then, the all fractions were applied on to ConA-Sepharose column chromatography and eluted with buffer containing a-methyl mannoside. These fractions were desalted and the α-methyl mannoside that remained in fractions was removed by Bio-Gel P-4 column chromatography. In order to determine the anomeric configuration and the sequence of each monosaccharide in the oligosaccharides, the radioactive peaks were subjected to sequential exoglycosidase digestion with jack bean β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, and then the reaction mixtures were analyzed by Bio-Gel P-4 column chromatography. The sample was then subjected to further sequential exoglycosidase digestions using jack bean α-mannosidase, snail β-mannosidase, jack bean β-<i>N</i>-acetylhexosaminidase and α-<sub>L</sub>-fucosidase. The sample was also digested with a mixture of diplococcal β-galactosidase and diplococcal β-<i>N</i>-acetylhexosaminidase. The sample was also digested with epididymal α-fucosidase (data not shown). Depends on the presence or absence of a bisecting GlcNAc, a fucose, and two α-mannosyl residues unsubstituted at positions C-3, 4, and 6, the procedures of separating sugar chains are combined with respective lectin-agarose columns. Because of the amount limitation, the sample obtained on sialidase treatment of the deuterium-labeled oligosaccharide fraction was subjected to methylation analysis without further purification by sequential chromatography. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human follicle-stimulating hormone collected by National Hormone Laboratory in New Zealand." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "gland" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_147  a  gn:DS_147_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q09327|MGAT3_HUMAN Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT3 PE=2 SV=3 MKMRRYKLFLMFCMAGLCLISFLHFFKTLSYVTFPRELASLSPNLVSSFFWNNAPVTPQA SPEPGGPDLLRTPLYSHSPLLQPLPPSKAAEELHRVDLVLPEDTTEYFVRTKAGGVCFKP GTKMLERPPPGRPEEKPEGANGSSARRPPRYLLSARERTGGRGARRKWVECVCLPGWHGP SCGVPTVVQYSNLPTKERLVPREVPRRVINAINVNHEFDLLDVRFHELGDVVDAFVVCES NFTAYGEPRPLKFREMLTNGTFEYIRHKVLYVFLDHFPPGGRQDGWIADDYLRTFLTQDG VSRLRNLRPDDVFIIDDADEIPARDGVLFLKLYDGWTEPFAFHMRKSLYGFFWKQPGTLE VVSGCTVDMLQAVYGLDGIRLRRRQYYTMPNFRQYENRTGHILVQWSLGSPLHFAGWHCS WCFTPEGIYFKLVSAQNGDFPRWGDYEDKRDLNYIRGLIRTGGWFDGTQQEYPPADPSEH MYAPKYLLKNYDRFHYLLDNPYQEPRSTAAGGWRHRGPEGRPPARGKLDEAEV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "MGAT3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_147" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q09327" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_cell_line>
                "MDA-MB-231" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-147" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Human GnT-III gene was inserted into the Gateway Entry vectors pENTR-D-Topo. The gene on the resultant plasmid was then introduced into the overexpression vector CSIV-TRE-RfA-CMV-KT constructed by the Gateway Conversion System. The obtained lentiviral vectors were transfected into 293T cells with packaging plasmids by the calcium phosphate for the preparation of viruses. The obtained viruses were then incubated with MDA-MB-231 cells for 72 h. The selected infected cells by the Kusabira Orange marker using FACS Aria II were cultured in high glucose DMEM with <sub>L</sub>-glutamine and FBS under doxycycline (DOX)-free medium as the control, and a humidified atmosphere containing CO<sub>2</sub> at 37  degree Celsius. The cells were diluted with water and extracted twice using phenol/chloroform. The water layer was purified by gel filtration on a mini-column (TSKgel Toyopearl HW-40F) and the fraction was lyophilized. The sample was further purified using a graphite carbon cartridge (GL-Pak Carbograph 300 mg). The sample was dissolved in ammonium acetate, and loaded onto the cartridge. After washing with ammonium acetate, the sample eluted using acetonitrile in the ammonium acetate buffer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to reversed phase HPLC analysis, and erythro-agglutinating phytohemagglutinin (E4-PHA) lectin blot. The sample was pull downed using concanavalin A (ConA)-agarose, followed by blotting with <i>Maackia amurensis</i> agglutinin (MAA), <i>Sambucus nigra</i> lectin (SNA) and ConA lectins. The sample was performed anion exchange HPLC treated with or without neuraminidases. The sample was analyzed by MS spectrometry." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III) cultured under doxycycline (DOX)-free medium as the control." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_212  a  gn:DS_212_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-05" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q09327|MGAT3_HUMAN Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT3 PE=2 SV=3 MKMRRYKLFLMFCMAGLCLISFLHFFKTLSYVTFPRELASLSPNLVSSFFWNNAPVTPQA SPEPGGPDLLRTPLYSHSPLLQPLPPSKAAEELHRVDLVLPEDTTEYFVRTKAGGVCFKP GTKMLERPPPGRPEEKPEGANGSSARRPPRYLLSARERTGGRGARRKWVECVCLPGWHGP SCGVPTVVQYSNLPTKERLVPREVPRRVINAINVNHEFDLLDVRFHELGDVVDAFVVCES NFTAYGEPRPLKFREMLTNGTFEYIRHKVLYVFLDHFPPGGRQDGWIADDYLRTFLTQDG VSRLRNLRPDDVFIIDDADEIPARDGVLFLKLYDGWTEPFAFHMRKSLYGFFWKQPGTLE VVSGCTVDMLQAVYGLDGIRLRRRQYYTMPNFRQYENRTGHILVQWSLGSPLHFAGWHCS WCFTPEGIYFKLVSAQNGDFPRWGDYEDKRDLNYIRGLIRTGGWFDGTQQEYPPADPSEH MYAPKYLLKNYDRFHYLLDNPYQEPRSTAAGGWRHRGPEGRPPARGKLDEAEV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "MGAT3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_212" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q09327" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_cell_line>
                "MDA-MB-231" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-212" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Human GnT-III gene was inserted into the Gateway Entry vectors pENTR-D-Topo. The gene on the resultant plasmid was then introduced into the overexpression vector CSIV-TRE-RfA-CMV-KT constructed by the Gateway Conversion System. The obtained lentiviral vectors were transfected into 293T cells with packaging plasmids by the calcium phosphate for the preparation of viruses. The obtained viruses were then incubated with MDA-MB-231 cells for 72 h. The selected infected cells by the Kusabira Orange marker using FACS Aria II were cultured in high glucose DMEM with <sub>L</sub>-glutamine and FBS under doxycycline (DOX)-added medium, and a humidified atmosphere containing CO<sub>2</sub> at 37  degree Celsius. The cells were diluted with water and extracted twice using phenol/chloroform. The water layer was purified by gel filtration on a mini-column (TSKgel Toyopearl HW-40F) and the fraction was lyophilized. The sample was further purified using a graphite carbon cartridge (GL-Pak Carbograph 300 mg). The sample was dissolved in ammonium acetate, and loaded onto the cartridge. After washing with ammonium acetate, the sample eluted using acetonitrile in the ammonium acetate buffer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to reversed phase HPLC analysis, and erythro-agglutinating phytohemagglutinin (E4-PHA) lectin blot. The sample was pull downed using concanavalin A (ConA)-agarose, followed by blotting with <i>Maackia amurensis</i> agglutinin (MAA), <i>Sambucus nigra</i> lectin (SNA) and ConA lectins. The sample was performed anion exchange HPLC treated with or without neuraminidases. The sample was analyzed by MS spectrometry." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III) cultured under doxycycline (DOX)-added medium for overexpression." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_213  a  gn:DS_213_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-05" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q09327|MGAT3_HUMAN Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT3 PE=2 SV=3 MKMRRYKLFLMFCMAGLCLISFLHFFKTLSYVTFPRELASLSPNLVSSFFWNNAPVTPQA SPEPGGPDLLRTPLYSHSPLLQPLPPSKAAEELHRVDLVLPEDTTEYFVRTKAGGVCFKP GTKMLERPPPGRPEEKPEGANGSSARRPPRYLLSARERTGGRGARRKWVECVCLPGWHGP SCGVPTVVQYSNLPTKERLVPREVPRRVINAINVNHEFDLLDVRFHELGDVVDAFVVCES NFTAYGEPRPLKFREMLTNGTFEYIRHKVLYVFLDHFPPGGRQDGWIADDYLRTFLTQDG VSRLRNLRPDDVFIIDDADEIPARDGVLFLKLYDGWTEPFAFHMRKSLYGFFWKQPGTLE VVSGCTVDMLQAVYGLDGIRLRRRQYYTMPNFRQYENRTGHILVQWSLGSPLHFAGWHCS WCFTPEGIYFKLVSAQNGDFPRWGDYEDKRDLNYIRGLIRTGGWFDGTQQEYPPADPSEH MYAPKYLLKNYDRFHYLLDNPYQEPRSTAAGGWRHRGPEGRPPARGKLDEAEV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "MGAT3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_213" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q09327" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_cell_line>
                "ST6GAL1 knock-out MDA-MB-231" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-213" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "ST6GAL1 knock-out; the sgRNAs (pSpCas9-ST6GAL1-For,CACCGATGATCATGACGCAGTCCTG; and pSpCas9 ST6GAL1-Rev, AAACCAGGACTGCGTCATGATCATC) were inserted into the plasmid pX458. The obtained plasmid was transformed into DH5α competent cells. The constructed plasmids were transfected into MDA-MB-231 cells by Cell Line Nucleofector<sup>TM</sup> kits. The transfected cells were then incubated for 72 h and selected by the GFP marker using FACS Aria II. The sample obtained by SNA lectin was removed the cells expressing α2,6-sialylation using FACS Aria II. Human GnT-III gene was inserted into the Gateway Entry vectors pENTR-D-Topo. The gene on the resultant plasmid was then introduced into the overexpression vector CSIV-TRE-RfA-CMV-KT constructed by the Gateway Conversion System. The obtained lentiviral vectors were transfected into 293T cells with packaging plasmids by the calcium phosphate for the preparation of viruses. The obtained viruses were then incubated with ST6GAL1 knock-out MDA-MB-231 cells for 72 h. The selected infected cells by the Kusabira Orange marker using FACS Aria II were cultured in high glucose DMEM with <sub>L</sub>-glutamine and FBS under doxycycline (DOX)-free medium as the control, and a humidified atmosphere containing CO<sub>2</sub> at 37  degree Celsius. The cells were diluted with water and extracted twice using phenol/chloroform. The water layer was purified by gel filtration on a mini-column (TSKgel Toyopearl HW-40F) and the fraction was lyophilized. The sample was further purified using a graphite carbon cartridge (GL-Pak Carbograph 300 mg). The sample was dissolved in ammonium acetate, and loaded onto the cartridge. After washing with ammonium acetate, the sample eluted using acetonitrile in the ammonium acetate buffer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed anion exchange HPLC treated with or without neuraminidases. The sample was analyzed by MS spectrometry." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III) cultured under doxycycline (DOX)-free medium as the ST6GAL1 knock-out control." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_214  a  gn:DS_214_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-05" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q09327|MGAT3_HUMAN Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT3 PE=2 SV=3 MKMRRYKLFLMFCMAGLCLISFLHFFKTLSYVTFPRELASLSPNLVSSFFWNNAPVTPQA SPEPGGPDLLRTPLYSHSPLLQPLPPSKAAEELHRVDLVLPEDTTEYFVRTKAGGVCFKP GTKMLERPPPGRPEEKPEGANGSSARRPPRYLLSARERTGGRGARRKWVECVCLPGWHGP SCGVPTVVQYSNLPTKERLVPREVPRRVINAINVNHEFDLLDVRFHELGDVVDAFVVCES NFTAYGEPRPLKFREMLTNGTFEYIRHKVLYVFLDHFPPGGRQDGWIADDYLRTFLTQDG VSRLRNLRPDDVFIIDDADEIPARDGVLFLKLYDGWTEPFAFHMRKSLYGFFWKQPGTLE VVSGCTVDMLQAVYGLDGIRLRRRQYYTMPNFRQYENRTGHILVQWSLGSPLHFAGWHCS WCFTPEGIYFKLVSAQNGDFPRWGDYEDKRDLNYIRGLIRTGGWFDGTQQEYPPADPSEH MYAPKYLLKNYDRFHYLLDNPYQEPRSTAAGGWRHRGPEGRPPARGKLDEAEV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "MGAT3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_214" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q09327" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_cell_line>
                "ST6GAL1 knock-out MDA-MB-231" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-214" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "ST6GAL1 knock-out; the sgRNAs (pSpCas9-ST6GAL1-For,CACCGATGATCATGACGCAGTCCTG; and pSpCas9 ST6GAL1-Rev, AAACCAGGACTGCGTCATGATCATC) were inserted into the plasmid pX458. The obtained plasmid was transformed into DH5α competent cells. The constructed plasmids were transfected into MDA-MB-231 cells by Cell Line Nucleofector<sup>TM</sup> kits. The transfected cells were then incubated for 72 h and selected by the GFP marker using FACS Aria II. The sample obtained by SNA lectin was removed the cells expressing α2,6-sialylation using FACS Aria II. Human GnT-III gene was inserted into the Gateway Entry vectors pENTR-D-Topo. The gene on the resultant plasmid was then introduced into the overexpression vector CSIV-TRE-RfA-CMV-KT constructed by the Gateway Conversion System. The obtained lentiviral vectors were transfected into 293T cells with packaging plasmids by the calcium phosphate for the preparation of viruses. The obtained viruses were then incubated with ST6GAL1 knock-out MDA-MB-231 cells for 72 h. The selected infected cells by the Kusabira Orange marker using FACS Aria II were cultured in high glucose DMEM with <sub>L</sub>-glutamine and FBS under doxycycline (DOX)-free medium as the control, and a humidified atmosphere containing CO<sub>2</sub> at 37  degree Celsius. The cells were diluted with water and extracted twice using phenol/chloroform. The water layer was purified by gel filtration on a mini-column (TSKgel Toyopearl HW-40F) and the fraction was lyophilized. The sample was further purified using a graphite carbon cartridge (GL-Pak Carbograph 300 mg). The sample was dissolved in ammonium acetate, and loaded onto the cartridge. After washing with ammonium acetate, the sample eluted using acetonitrile in the ammonium acetate buffer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was performed anion exchange HPLC treated with or without neuraminidases. The sample was analyzed by MS spectrometry." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III) cultured under doxycycline (DOX)-added medium for overexpression as the ST6GAL1 knock-out sample." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_215  a  gn:DS_215_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-06" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q09327|MGAT3_HUMAN Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT3 PE=2 SV=3 MKMRRYKLFLMFCMAGLCLISFLHFFKTLSYVTFPRELASLSPNLVSSFFWNNAPVTPQA SPEPGGPDLLRTPLYSHSPLLQPLPPSKAAEELHRVDLVLPEDTTEYFVRTKAGGVCFKP GTKMLERPPPGRPEEKPEGANGSSARRPPRYLLSARERTGGRGARRKWVECVCLPGWHGP SCGVPTVVQYSNLPTKERLVPREVPRRVINAINVNHEFDLLDVRFHELGDVVDAFVVCES NFTAYGEPRPLKFREMLTNGTFEYIRHKVLYVFLDHFPPGGRQDGWIADDYLRTFLTQDG VSRLRNLRPDDVFIIDDADEIPARDGVLFLKLYDGWTEPFAFHMRKSLYGFFWKQPGTLE VVSGCTVDMLQAVYGLDGIRLRRRQYYTMPNFRQYENRTGHILVQWSLGSPLHFAGWHCS WCFTPEGIYFKLVSAQNGDFPRWGDYEDKRDLNYIRGLIRTGGWFDGTQQEYPPADPSEH MYAPKYLLKNYDRFHYLLDNPYQEPRSTAAGGWRHRGPEGRPPARGKLDEAEV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "MGAT3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_215" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q09327" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_biomaterial_provider>
                "RIKEN Cell Bank" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_cell_line>
                "HeLa-S3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-215" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Human GnT-III gene was inserted into the Gateway Entry vectors pENTR-D-Topo. The gene on the resultant plasmid was then introduced into the overexpression vector CSIV-TRE-RfA-CMV-KT constructed by the Gateway Conversion System. The obtained lentiviral vectors were transfected into 293T cells with packaging plasmids by the calcium phosphate for the preparation of viruses. The obtained viruses were then incubated with HeLa-S3 cells for 72 h." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Cell lines were incubated with biotin-conjugated MAA or biotin-conjugated SNA or without biotin-conjugated MAA and SNA lectins, then incubated with streptavidin Alexa Fluor 647 conjugate and subjected to FACS analysis.<br>Cells were cultured for 4 days and then starved in serum-free medium for 12 h, trypsinized, and suspended with trypsin inhibitor in DMEM. The sample was centrifuged, and the supernatant was removed. The pellet was resuspended with assay medium (serum-free DMEM) and diluted. Transwells (BD BioCoat<sup>TM</sup> control inserts) were coated only on the bottom side with fibronectin (FN) at 4  degree Celsius overnight. The sample suspension was added to FN-coated Transwell and incubated at 37  degree Celsius. The upper side cells were removed by scraping with a cotton swab. The membranes in the Transwells were fixed with paraformaldehyde, stained with crystal violet for 1 h and counted the cell migration using a phase contrast microscope." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III) cultured under doxycycline (DOX)-added medium for overexpression in HeLa-S3 cell line." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_216  a  gn:DS_216_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-06" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q09327|MGAT3_HUMAN Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT3 PE=2 SV=3 MKMRRYKLFLMFCMAGLCLISFLHFFKTLSYVTFPRELASLSPNLVSSFFWNNAPVTPQA SPEPGGPDLLRTPLYSHSPLLQPLPPSKAAEELHRVDLVLPEDTTEYFVRTKAGGVCFKP GTKMLERPPPGRPEEKPEGANGSSARRPPRYLLSARERTGGRGARRKWVECVCLPGWHGP SCGVPTVVQYSNLPTKERLVPREVPRRVINAINVNHEFDLLDVRFHELGDVVDAFVVCES NFTAYGEPRPLKFREMLTNGTFEYIRHKVLYVFLDHFPPGGRQDGWIADDYLRTFLTQDG VSRLRNLRPDDVFIIDDADEIPARDGVLFLKLYDGWTEPFAFHMRKSLYGFFWKQPGTLE VVSGCTVDMLQAVYGLDGIRLRRRQYYTMPNFRQYENRTGHILVQWSLGSPLHFAGWHCS WCFTPEGIYFKLVSAQNGDFPRWGDYEDKRDLNYIRGLIRTGGWFDGTQQEYPPADPSEH MYAPKYLLKNYDRFHYLLDNPYQEPRSTAAGGWRHRGPEGRPPARGKLDEAEV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "MGAT3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_216" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q09327" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_biomaterial_provider>
                "Dr. Hideyoshi Higashi (Tohoku Pharmaceutical University, Japan)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_cell_line>
                "CHO-K1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-216" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Human GnT-III gene was inserted into the Gateway Entry vectors pENTR-D-Topo. The gene on the resultant plasmid was then introduced into the overexpression vector CSIV-TRE-RfA-CMV-KT constructed by the Gateway Conversion System. The obtained lentiviral vectors were transfected into 293T cells with packaging plasmids by the calcium phosphate for the preparation of viruses. The obtained viruses were then incubated with CHO-K1 cells for 72 h." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Cell lines were incubated with biotin-conjugated MAA or biotin-conjugated SNA or without biotin-conjugated MAA and SNA lectins, then incubated with streptavidin Alexa Fluor 647 conjugate and subjected to FACS analysis.<br>Cells were cultured for 4 days and then starved in serum-free medium for 12 h, trypsinized, and suspended with trypsin inhibitor in DMEM. The sample was centrifuged, and the supernatant was removed. The pellet was resuspended with assay medium (serum-free DMEM) and diluted. Transwells (BD BioCoat<sup>TM</sup> control inserts) were coated only on the bottom side with fibronectin (FN) at 4  degree Celsius overnight. The sample suspension was added to FN-coated Transwell and incubated at 37  degree Celsius. The upper side cells were removed by scraping with a cotton swab. The membranes in the Transwells were fixed with paraformaldehyde, stained with crystal violet for 1 h and counted the cell migration using a phase contrast microscope." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III) cultured under doxycycline (DOX)-added medium for overexpression in CHO-K1 cell line." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_217  a  gn:DS_217_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-06" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q09327|MGAT3_HUMAN Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT3 PE=2 SV=3 MKMRRYKLFLMFCMAGLCLISFLHFFKTLSYVTFPRELASLSPNLVSSFFWNNAPVTPQA SPEPGGPDLLRTPLYSHSPLLQPLPPSKAAEELHRVDLVLPEDTTEYFVRTKAGGVCFKP GTKMLERPPPGRPEEKPEGANGSSARRPPRYLLSARERTGGRGARRKWVECVCLPGWHGP SCGVPTVVQYSNLPTKERLVPREVPRRVINAINVNHEFDLLDVRFHELGDVVDAFVVCES NFTAYGEPRPLKFREMLTNGTFEYIRHKVLYVFLDHFPPGGRQDGWIADDYLRTFLTQDG VSRLRNLRPDDVFIIDDADEIPARDGVLFLKLYDGWTEPFAFHMRKSLYGFFWKQPGTLE VVSGCTVDMLQAVYGLDGIRLRRRQYYTMPNFRQYENRTGHILVQWSLGSPLHFAGWHCS WCFTPEGIYFKLVSAQNGDFPRWGDYEDKRDLNYIRGLIRTGGWFDGTQQEYPPADPSEH MYAPKYLLKNYDRFHYLLDNPYQEPRSTAAGGWRHRGPEGRPPARGKLDEAEV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "MGAT3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_217" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q09327" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_biomaterial_provider>
                "Dr. Kitazume Shinobu (RIKEN)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_cell_line>
                "Pro-5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-217" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Human GnT-III gene was inserted into the Gateway Entry vectors pENTR-<sub>D</sub>-Topo. The gene on the resultant plasmid was then introduced into the overexpression vector CSIV-TRE-RfA-CMV-KT constructed by the Gateway Conversion System. The obtained lentiviral vectors were transfected into 293T cells with packaging plasmids by the calcium phosphate for the preparation of viruses. The obtained viruses were then incubated with Pro-5 cells for 72 h." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Cell lines were incubated with biotin-conjugated MAA or biotin-conjugated SNA or without biotin-conjugated MAA and SNA lectins, then incubated with streptavidin Alexa Fluor 647 conjugate and subjected to FACS analysis.<br>Cells were cultured for 4 days and then starved in serum-free medium for 12 h, trypsinized, and suspended with trypsin inhibitor in DMEM. The sample was centrifuged, and the supernatant was removed. The pellet was resuspended with assay medium (serum-free DMEM) and diluted. Transwells (BD BioCoat<sup>TM</sup> control inserts) were coated only on the bottom side with fibronectin (FN) at 4  degree Celsius overnight. The sample suspension was added to FN-coated Transwell and incubated at 37  degree Celsius. The upper side cells were removed by scraping with a cotton swab. The membranes in the Transwells were fixed with paraformaldehyde, stained with crystal violet for 1 h and counted the cell migration using a phase contrast microscope." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III) cultured under doxycycline (DOX)-added medium for overexpression in Pro-5 cell line." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_218  a  gn:DS_218_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-06" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q09327|MGAT3_HUMAN Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT3 PE=2 SV=3 MKMRRYKLFLMFCMAGLCLISFLHFFKTLSYVTFPRELASLSPNLVSSFFWNNAPVTPQA SPEPGGPDLLRTPLYSHSPLLQPLPPSKAAEELHRVDLVLPEDTTEYFVRTKAGGVCFKP GTKMLERPPPGRPEEKPEGANGSSARRPPRYLLSARERTGGRGARRKWVECVCLPGWHGP SCGVPTVVQYSNLPTKERLVPREVPRRVINAINVNHEFDLLDVRFHELGDVVDAFVVCES NFTAYGEPRPLKFREMLTNGTFEYIRHKVLYVFLDHFPPGGRQDGWIADDYLRTFLTQDG VSRLRNLRPDDVFIIDDADEIPARDGVLFLKLYDGWTEPFAFHMRKSLYGFFWKQPGTLE VVSGCTVDMLQAVYGLDGIRLRRRQYYTMPNFRQYENRTGHILVQWSLGSPLHFAGWHCS WCFTPEGIYFKLVSAQNGDFPRWGDYEDKRDLNYIRGLIRTGGWFDGTQQEYPPADPSEH MYAPKYLLKNYDRFHYLLDNPYQEPRSTAAGGWRHRGPEGRPPARGKLDEAEV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "MGAT3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_218" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q09327" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_cell_line>
                "MDA-MB-231" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-218" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Human GnT-III gene was inserted into the Gateway Entry vectors pENTR-<sub>D</sub>-Topo. The gene on the resultant plasmid was then introduced into the overexpression vector CSIV-TRE-RfA-CMV-KT constructed by the Gateway Conversion System. The obtained lentiviral vectors were transfected into 293T cells with packaging plasmids by the calcium phosphate for the preparation of viruses. The obtained viruses were then incubated with MDA-MB-231 cells for 72 h." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Cell lines were incubated with biotin-conjugated MAA or biotin-conjugated SNA or without biotin-conjugated MAA and SNA lectins, then incubated with streptavidin Alexa Fluor 647 conjugate and subjected to FACS analysis.<br>Cells were cultured for 4 days and then starved in serum-free medium for 12 h, trypsinized, and suspended with trypsin inhibitor in DMEM. The sample was centrifuged, and the supernatant was removed. The pellet was resuspended with assay medium (serum-free DMEM) and diluted. Transwells (BD BioCoat<sup>TM</sup> control inserts) were coated only on the bottom side with fibronectin (FN) at 4  degree Celsius overnight. The sample suspension was added to FN-coated Transwell and incubated at 37  degree Celsius. The upper side cells were removed by scraping with a cotton swab. The membranes in the Transwells were fixed with paraformaldehyde, stained with crystal violet for 1 h and counted the cell migration using a phase contrast microscope." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III) cultured under doxycycline (DOX)-added medium for overexpression in MDA-MB-231 cell line." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_219  a  gn:DS_219_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-06" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q09327|MGAT3_HUMAN Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT3 PE=2 SV=3 MKMRRYKLFLMFCMAGLCLISFLHFFKTLSYVTFPRELASLSPNLVSSFFWNNAPVTPQA SPEPGGPDLLRTPLYSHSPLLQPLPPSKAAEELHRVDLVLPEDTTEYFVRTKAGGVCFKP GTKMLERPPPGRPEEKPEGANGSSARRPPRYLLSARERTGGRGARRKWVECVCLPGWHGP SCGVPTVVQYSNLPTKERLVPREVPRRVINAINVNHEFDLLDVRFHELGDVVDAFVVCES NFTAYGEPRPLKFREMLTNGTFEYIRHKVLYVFLDHFPPGGRQDGWIADDYLRTFLTQDG VSRLRNLRPDDVFIIDDADEIPARDGVLFLKLYDGWTEPFAFHMRKSLYGFFWKQPGTLE VVSGCTVDMLQAVYGLDGIRLRRRQYYTMPNFRQYENRTGHILVQWSLGSPLHFAGWHCS WCFTPEGIYFKLVSAQNGDFPRWGDYEDKRDLNYIRGLIRTGGWFDGTQQEYPPADPSEH MYAPKYLLKNYDRFHYLLDNPYQEPRSTAAGGWRHRGPEGRPPARGKLDEAEV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "MGAT3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_219" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q09327" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_cell_line>
                "MKN-45" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-219" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Human GnT-III gene was inserted into the Gateway Entry vectors pENTR-<sub>D</sub>-Topo. The gene on the resultant plasmid was then introduced into the overexpression vector CSIV-TRE-RfA-CMV-KT constructed by the Gateway Conversion System. The obtained lentiviral vectors were transfected into 293T cells with packaging plasmids by the calcium phosphate for the preparation of viruses. The obtained viruses were then incubated with MKN-45 cells for 72 h." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Cell lines were incubated with biotin-conjugated MAA or biotin-conjugated SNA or without biotin-conjugated MAA and SNA lectins, then incubated with streptavidin Alexa Fluor 647 conjugate and subjected to FACS analysis.<br>Cells were cultured for 4 days and then starved in serum-free medium for 12 h, trypsinized, and suspended with trypsin inhibitor in DMEM. The sample was centrifuged, and the supernatant was removed. The pellet was resuspended with assay medium (serum-free DMEM) and diluted. Transwells (BD BioCoat<sup>TM</sup> control inserts) were coated only on the bottom side with fibronectin (FN) at 4  degree Celsius overnight. The sample suspension was added to FN-coated Transwell and incubated at 37  degree Celsius. The upper side cells were removed by scraping with a cotton swab. The membranes in the Transwells were fixed with paraformaldehyde, stained with crystal violet for 1 h and counted the cell migration using a phase contrast microscope." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III) cultured under doxycycline (DOX)-added medium for overexpression in MKN-45 cell line." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_220  a  gn:DS_220_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-06" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q09327|MGAT3_HUMAN Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT3 PE=2 SV=3 MKMRRYKLFLMFCMAGLCLISFLHFFKTLSYVTFPRELASLSPNLVSSFFWNNAPVTPQA SPEPGGPDLLRTPLYSHSPLLQPLPPSKAAEELHRVDLVLPEDTTEYFVRTKAGGVCFKP GTKMLERPPPGRPEEKPEGANGSSARRPPRYLLSARERTGGRGARRKWVECVCLPGWHGP SCGVPTVVQYSNLPTKERLVPREVPRRVINAINVNHEFDLLDVRFHELGDVVDAFVVCES NFTAYGEPRPLKFREMLTNGTFEYIRHKVLYVFLDHFPPGGRQDGWIADDYLRTFLTQDG VSRLRNLRPDDVFIIDDADEIPARDGVLFLKLYDGWTEPFAFHMRKSLYGFFWKQPGTLE VVSGCTVDMLQAVYGLDGIRLRRRQYYTMPNFRQYENRTGHILVQWSLGSPLHFAGWHCS WCFTPEGIYFKLVSAQNGDFPRWGDYEDKRDLNYIRGLIRTGGWFDGTQQEYPPADPSEH MYAPKYLLKNYDRFHYLLDNPYQEPRSTAAGGWRHRGPEGRPPARGKLDEAEV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "MGAT3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_220" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q09327" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_biomaterial_provider>
                "Prof. Jun Nakayama (Graduate School of Medicine, Shinshu University, Japan)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_cell_line>
                "U-251 MG" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-220" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Human GnT-III gene was inserted into the Gateway Entry vectors pENTR-<sub>D</sub>-Topo. The gene on the resultant plasmid was then introduced into the overexpression vector CSIV-TRE-RfA-CMV-KT constructed by the Gateway Conversion System. The obtained lentiviral vectors were transfected into 293T cells with packaging plasmids by the calcium phosphate for the preparation of viruses. The obtained viruses were then incubated with U-251 MG cells for 72 h." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Cell lines were incubated with biotin-conjugated MAA or biotin-conjugated SNA or without biotin-conjugated MAA and SNA lectins, then incubated with streptavidin Alexa Fluor 647 conjugate and subjected to FACS analysis.<br>Cells were cultured for 4 days and then starved in serum-free medium for 12 h, trypsinized, and suspended with trypsin inhibitor in DMEM. The sample was centrifuged, and the supernatant was removed. The pellet was resuspended with assay medium (serum-free DMEM) and diluted. Transwells (BD BioCoat<sup>TM</sup> control inserts) were coated only on the bottom side with fibronectin (FN) at 4  degree Celsius overnight. The sample suspension was added to FN-coated Transwell and incubated at 37  degree Celsius. The upper side cells were removed by scraping with a cotton swab. The membranes in the Transwells were fixed with paraformaldehyde, stained with crystal violet for 1 h and counted the cell migration using a phase contrast microscope." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III) cultured under doxycycline (DOX)-added medium for overexpression in U-251 MG cell line." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_221  a  gn:DS_221_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DB_Memo>
                "The cell migratory was enhanced in glioma cells U-251 and hepatoma cells HepG2." , "With low or without α2,6-sialylation in HeLa-S3, CHO-K1 and Pro-5 the cell migration ability was suppressed after overexpression of GnT-III. " , "When GnT-III was overexpressed, bisected GlcNAc structures were clearly enhanced but α2,3-sialylated glycans were dramatically reduced." , "When GnT-III was forced expressed, α2,3-sialylation was dramatically reduced but not α2,6-sialylation." , "Edited Memo" , "The overexpression of GnT-III was dramatically suppressed α2,3-sialylation, but not α2,6-sialylation. It may be exerted at a post-transcriptional level because little difference in the expression of sialyltransferases and neuraminidases between GnT-III-overexpressing cells and the control. " , "GnT-III effect on cell migration are dependent on the cell sialylation pattern. Under low level of α2,6-sialylation GnT-III plays an anti-migratory role however under high level it could antagonize this role and the cells could migrate very much." , "The amount of sialylated N-glaycans were few decreased after GnT-III overexpression in MDA-MB-231 cells, on the other hand there was a significant reduction after GnT-III overexpression in ST6GAL1 knock-out cells." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-06" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Discussion_Memo>
                "Edited Memo" , "Discussionは後回しにしている" , "Discussion保留になったので、後回しにしている。" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q09327|MGAT3_HUMAN Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Homo sapiens OX=9606 GN=MGAT3 PE=2 SV=3 MKMRRYKLFLMFCMAGLCLISFLHFFKTLSYVTFPRELASLSPNLVSSFFWNNAPVTPQA SPEPGGPDLLRTPLYSHSPLLQPLPPSKAAEELHRVDLVLPEDTTEYFVRTKAGGVCFKP GTKMLERPPPGRPEEKPEGANGSSARRPPRYLLSARERTGGRGARRKWVECVCLPGWHGP SCGVPTVVQYSNLPTKERLVPREVPRRVINAINVNHEFDLLDVRFHELGDVVDAFVVCES NFTAYGEPRPLKFREMLTNGTFEYIRHKVLYVFLDHFPPGGRQDGWIADDYLRTFLTQDG VSRLRNLRPDDVFIIDDADEIPARDGVLFLKLYDGWTEPFAFHMRKSLYGFFWKQPGTLE VVSGCTVDMLQAVYGLDGIRLRRRQYYTMPNFRQYENRTGHILVQWSLGSPLHFAGWHCS WCFTPEGIYFKLVSAQNGDFPRWGDYEDKRDLNYIRGLIRTGGWFDGTQQEYPPADPSEH MYAPKYLLKNYDRFHYLLDNPYQEPRSTAAGGWRHRGPEGRPPARGKLDEAEV" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "MGAT3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_221" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q09327" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_cell_line>
                "HepG2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-221" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Human GnT-III gene was inserted into the Gateway Entry vectors pENTR-<sub>D</sub>-Topo. The gene on the resultant plasmid was then introduced into the overexpression vector CSIV-TRE-RfA-CMV-KT constructed by the Gateway Conversion System. The obtained lentiviral vectors were transfected into 293T cells with packaging plasmids by the calcium phosphate for the preparation of viruses. The obtained viruses were then incubated with HepG2 cells for 72 h." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Cell lines were incubated with biotin-conjugated MAA or biotin-conjugated SNA or without biotin-conjugated MAA and SNA lectins, then incubated with streptavidin Alexa Fluor 647 conjugate and subjected to FACS analysis.<br>Cells were cultured for 4 days and then starved in serum-free medium for 12 h, trypsinized, and suspended with trypsin inhibitor in DMEM. The sample was centrifuged, and the supernatant was removed. The pellet was resuspended with assay medium (serum-free DMEM) and diluted. Transwells (BD BioCoat<sup>TM</sup> control inserts) were coated only on the bottom side with fibronectin (FN) at 4  degree Celsius overnight. The sample suspension was added to FN-coated Transwell and incubated at 37  degree Celsius. The upper side cells were removed by scraping with a cotton swab. The membranes in the Transwells were fixed with paraformaldehyde, stained with crystal violet for 1 h and counted the cell migration using a phase contrast microscope." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Acetylglucosaminyltransferase III (GnT-III) cultured under doxycycline (DOX)-added medium for overexpression in HepG2 cell line." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_115  a  gn:DS_115_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-13" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_115" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#_The_sample_was_hydrazinolysed_followed_by_N-acetylation.>
                "Experimental Section_Structural Analysis of Oligosaccharides Derived from Biliary and Serum Glycoproteins_Results_Structural Analysis of PA-Oligosaccharides Derived from Rat Biliary and Serum Glycoproteins." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "11 weeks" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "bile" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-115" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "rat" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The rat bile was collected from the common bile duct cannulation after anesthetization with sodium pentbarbital. The sample was applied on PD-10 columns, and then on Protein A/G column. The sample was subjected to trichloroacetic acid precipitation and the washed with ethanol." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was pyridylaminated and applied on a Sephadex G-15 column.  The sample was treated by neuraminidase was separated by reverse phase HPLC on a Shim-pack CLC-ODS column and subsequent normal phase HPLC on a TSK-gel Amide-80 column.  The structures of eluted PA-oligosaccharides were determined from the elution positions of individual peaks on the basis of the GALAXY database (DOI: 10.4052/tigg.15.235). The unknown structures in the GALAXY database were trimmed by exoglycosidase. The samples were subjected MS spectra analysis with a MALDI-TOF mass spectrometer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Glycoproteins in bile from healthy rat." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#strain>
                "LEC/Hok" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "10116" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_116  a  gn:DS_116_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:2237" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_116" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#_The_sample_was_hydrazinolysed_followed_by_N-acetylation.>
                "Experimental Section_Animals" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "26 weeks" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "bile" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "chronic hepatitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "CH stage" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-116" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "rat" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The rat bile was collected from the common bile duct cannulation after anesthetization with sodium pentbarbital. The sample was applied on PD-10 columns, and then on Protein A/G column. The sample was subjected to trichloroacetic acid precipitation and the washed with ethanol." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was pyridylaminated and applied on a Sephadex G-15 column.  The sample was treated by neuraminidase was separated by reverse phase HPLC on a Shim-pack CLC-ODS column and subsequent normal phase HPLC on a TSK-gel Amide-80 column.  The structures of eluted PA-oligosaccharides were determined from the elution positions of individual peaks on the basis of the GALAXY database (DOI: 10.4052/tigg.15.235). The unknown structures in the GALAXY database were trimmed by exoglycosidase. The samples were subjected MS spectra analysis with a MALDI-TOF mass spectrometer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Glycoproteins in bile from chronic hepatitis rat." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#strain>
                "LEC/Hok" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "10116" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_117  a  gn:DS_117_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:684" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_117" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#_The_sample_was_hydrazinolysed_followed_by_N-acetylation.>
                "Experimental Section_Animals" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "56-64 weeks" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "bile" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hepatocellular carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "HCC stage" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-117" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "rat" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The rat bile was collected from the common bile duct cannulation after anesthetization with sodium pentbarbital. The sample was applied on PD-10 columns, and then on Protein A/G column. The sample was subjected to trichloroacetic acid precipitation and the washed with ethanol." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was pyridylaminated and applied on a Sephadex G-15 column.  The sample was treated by neuraminidase was separated by reverse phase HPLC on a Shim-pack CLC-ODS column and subsequent normal phase HPLC on a TSK-gel Amide-80 column.  The structures of eluted PA-oligosaccharides were determined from the elution positions of individual peaks on the basis of the GALAXY database (DOI: 10.4052/tigg.15.235). The unknown structures in the GALAXY database were trimmed by exoglycosidase. The samples were subjected MS spectra analysis with a MALDI-TOF mass spectrometer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Glycoproteins in bile from hepatocellular carcinoma rat." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#strain>
                "LEC/Hok" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "10116" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_118  a  gn:DS_118_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_118" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "11 weeks" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-118" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "rat" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The rat serum was collected after anesthetization with sodium pentbarbital. The sample was applied on PD-10 columns, and then on Protein A/G column. The sample was subjected to trichloroacetic acid precipitation and the washed with ethanol. The sample was hydrazinolysed followed by N-acetylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was pyridylaminated and applied on a Sephadex G-15 column.  The sample was treated by neuraminidase was separated by reverse phase HPLC on a Shim-pack CLC-ODS column and subsequent normal phase HPLC on a TSK-gel Amide-80 column.  The structures of eluted PA-oligosaccharides were determined from the elution positions of individual peaks on the basis of the GALAXY database (DOI: 10.4052/tigg.15.235). The unknown structures in the GALAXY database were trimmed by exoglycosidase. The samples were subjected MS spectra analysis with a MALDI-TOF mass spectrometer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Glycoproteins in serum from healthy rat." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#strain>
                "LEC/Hok" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "10116" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_119  a  gn:DS_119_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:2237" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_119" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "26 weeks" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "chronic hepatitis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "CH stage" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-119" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "rat" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The rat serum was collected after anesthetization with sodium pentbarbital. The sample was applied on PD-10 columns, and then on Protein A/G column. The sample was subjected to trichloroacetic acid precipitation and the washed with ethanol. The sample was hydrazinolysed followed by N-acetylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was pyridylaminated and applied on a Sephadex G-15 column.  The sample was treated by neuraminidase was separated by reverse phase HPLC on a Shim-pack CLC-ODS column and subsequent normal phase HPLC on a TSK-gel Amide-80 column.  The structures of eluted PA-oligosaccharides were determined from the elution positions of individual peaks on the basis of the GALAXY database (DOI: 10.4052/tigg.15.235). The unknown structures in the GALAXY database were trimmed by exoglycosidase. The samples were subjected MS spectra analysis with a MALDI-TOF mass spectrometer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Glycoproteins in serum from chronic hepatitis rat." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#strain>
                "LEC/Hok" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "10116" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_120  a  gn:DS_120_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:684" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_120" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "56-64 weeks" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hepatocellular carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "HCC stage" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-120" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "rat" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The rat serum was collected after anesthetization with sodium pentbarbital. The sample was applied on PD-10 columns, and then on Protein A/G column. The sample was subjected to trichloroacetic acid precipitation and the washed with ethanol. The sample was hydrazinolysed followed by N-acetylation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was pyridylaminated and applied on a Sephadex G-15 column.  The sample was treated by neuraminidase was separated by reverse phase HPLC on a Shim-pack CLC-ODS column and subsequent normal phase HPLC on a TSK-gel Amide-80 column.  The structures of eluted PA-oligosaccharides were determined from the elution positions of individual peaks on the basis of the GALAXY database (DOI: 10.4052/tigg.15.235). The unknown structures in the GALAXY database were trimmed by exoglycosidase. The samples were subjected MS spectra analysis with a MALDI-TOF mass spectrometer." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Glycoproteins in serum from hepatocellular carcinoma rat." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#strain>
                "LEC/Hok" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "10116" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_10  a   gn:DS_10_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-15" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01588|EPO_HUMAN Erythropoietin OS=Homo sapiens OX=9606 GN=EPO PE=1 SV=1 MGVHECPAWLWLLLSLLSLPLGLPVLGAPPRLICDSRVLERYLLEAKEAENITTGCAEHC SLNENITVPDTKVNFYAWKRMEVGQQAVEVWQGLALLSEAVLRGQALLVNSSQPWEPLQL HVDKAVSGLRSLTTLLRALGAQKEAISPPDAASAAPLRTITADTFRKLFRVYSNFLRGKL KLYTGEACRTGDR" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "EPO" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_10" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "erythropoietin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01588" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "Chinese hamster ovary (CHO) cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-10" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Human erythropoietin was expressed in Chinese hamster ovary (CHO) cells. Then it was purified from the media of recombinant CHO cells culture by sequential chromatography." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to hydrazinolysis. The sample was freed from the mucin-type oligosaccharides by paper chromatography. Some of the sample was labelled with tritium by NaB[<sup>3</sup>H]<sub>4</sub> reduction. The remaining sample was also reduced with NaB[<sup>2</sup>H]<sub>4</sub>. After digestion by sialidase from <i>Arthrobacter ureafaciens</i>, the sample was subjected to paper electrophoresis. The sample was applied to a column of ConA-Sepharose. The passed through fraction was then separated using a DSA-Sepharose column. Whole fractions were separated by a column of AAL-Sepharose. The sample was then analyzed by a column of Bio-Gel P-4. The sample was digested with exoglycosidase and performed Smith degradation and methylation analysis. Then after the sample was subjected to sequential exoglycosidase digestion (jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, diplococcal β-galactosidase, diplococcal β-<i>N</i>-acetylhexosaminidase, α-mannosidase II from <i>Aspergillus saitoi</i>, endo-β-galactosidase and jack bean α-mannosidase), it was analyzed by Bio-Gel P-4 column chromatography." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human erythropoietins purified from the culture medium of recombinant Chinese Hamster Ovary (CHO) Cells." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_11  a   gn:DS_11_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:12449" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-15" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01588|EPO_HUMAN Erythropoietin OS=Homo sapiens OX=9606 GN=EPO PE=1 SV=1 MGVHECPAWLWLLLSLLSLPLGLPVLGAPPRLICDSRVLERYLLEAKEAENITTGCAEHC SLNENITVPDTKVNFYAWKRMEVGQQAVEVWQGLALLSEAVLRGQALLVNSSQPWEPLQL HVDKAVSGLRSLTTLLRALGAQKEAISPPDAASAAPLRTITADTFRKLFRVYSNFLRGKL KLYTGEACRTGDR" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "EPO" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "erythropoietin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01588" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "aplastic anemia" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was concentrated from urine of aplastic anemia patients by the phenol p-amino salicylate treatment followed by ethanol precipitation. Then the sample was purified by affinity chromatography using an immobilized monoclonal antibody column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to hydrazinolysis. The sample was freed from the mucin-type oligosaccharides by paper chromatography. Some of the sample was labelled with tritium by NaB[<sup>3</sup>H]<sub>4</sub> reduction. The remaining sample was also reduced with NaB[<sup>2</sup>H]<sub>4</sub>. After digestion by sialidase from <i>Arthrobacter ureafaciens</i>, the sample was subjected to paper electrophoresis. The sample was applied to a column of ConA-Sepharose. The passed through fraction was then separated using a DSA-Sepharose column. Whole fractions were separated by a column of AAL-Sepharose. The sample was then analyzed by a column of Bio-Gel P-4. The sample was digested with exoglycosidase and performed Smith degradation and methylation analysis. Then after the sample was subjected to sequential exoglycosidase digestion (jack bean β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, diplococcal β-galactosidase, diplococcal β-<i>N</i>-acetylhexosaminidase, α-mannosidase II from <i>Aspergillus saitoi</i>, endo-β-galactosidase and jack bean α-mannosidase), it was analyzed by Bio-Gel P-4 column chromatography." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Urinary human erythropoietin from the patients with aplastic anemia." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_5  a    gn:DS_5_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3590" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Kobe University Hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the three patients of complete hydatidiform mole, Ama. After cervical dilatation and evacuation of the uterine contents, the patient was not given specific therapy and the hCG titer determined by hCG β radioimmunoassay, declined to below 5 mIU/ml within 70 days after uterine evacuation. She was well." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "complete hydatidiform mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from urine collected before cervical dilatation and evacuation of the uterine contents. The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was quantitatively liberated as oligosaccharides by hydrazinolysis. After adding 2-deoxyribose, some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> and then with NaBH<sub>4</sub>. Then the sample was separated from radioactive 2-deoxyribitol by paper chromatography in 1-butanol:ethanol:water. The remaining sample was also reduced with NaB<sup>2</sup>H<sub>4</sub>. After digestion by sialidase, the sample was separated by Bio-Gel P-4 column chromatography. Then the sample was subjected to sequential exoglycosidase digestion with β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase and diplococcal β-<i>N</i>-acetylhexosaminidase. After treatment with periodate oxidation and then β-mannosidase, the samples were applied to a Bio-Gel P-4 column chromatography. The sample was further applied to a concanavalin A-Sepharose column chromatography, and diplococcal β-<i>N</i>-acetylhexosaminidase treatment. After β-galactosidase digestion, the sample was incubated with diplococcal β-<i>N</i>-acetylhexosaminidase treatment and applied to Bio-Gel P-4 column." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the complete hydatidiform mole patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_6  a    gn:DS_6_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_6" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the two different batches of pooled urine, pool 2." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-6" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was quantitatively liberated as oligosaccharides by hydrazinolysis. After adding 2-deoxyribose, some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> and then with NaBH<sub>4</sub>. Then the sample was separated from radioactive 2-deoxyribitol by paper chromatography in 1-butanol:ethanol:water. The remaining sample was also reduced with NaB<sup>2</sup>H<sub>4</sub>. After digestion by sialidase, the sample was separated by Bio-Gel P-4 column chromatography. Then the sample was subjected to sequential exoglycosidase digestion. The sample was applied to a concanavalin A-Sepharose column chromatography, and periodate oxidation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the pooled urine from the healthy pregnant women." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_144  a  gn:DS_144_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3590" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-09-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_144" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Kobe University Hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the three patients of complete hydatidiform mole, Yam. After cervical dilatation and evacuation of the uterine contents, the patient was not given specific therapy and the hCG titer determined by hCG β radioimmunoassay, declined to below 5 mIU/ml within 70 days after uterine evacuation. She was well." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "complete hydatidiform mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-144" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from urine collected before cervical dilatation and evacuation of the uterine contents. The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was quantitatively liberated as oligosaccharides by hydrazinolysis. After adding 2-deoxyribose, some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> and then with NaBH<sub>4</sub>. Then the sample was separated from radioactive 2-deoxyribitol by paper chromatography in 1-butanol:ethanol:water. The remaining sample was also reduced with NaB<sup>2</sup>H<sub>4</sub>. After digestion by sialidase, the sample was separated by Bio-Gel P-4 column chromatography. Then the sample was subjected to sequential exoglycosidase digestion. The sample was applied to a concanavalin A-Sepharose column chromatography, and periodate oxidation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the complete hydatidiform mole patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_145  a  gn:DS_145_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3590" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-09-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_145" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Kobe University Hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the three patients of complete hydatidiform mole, Ito. After cervical dilatation and evacuation of the uterine contents, the patient was not given specific therapy and the hCG titer determined by hCG β radioimmunoassay, declined to below 5 mIU/ml within 70 days after uterine evacuation. She was well." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "complete hydatidiform mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-145" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from urine collected before cervical dilatation and evacuation of the uterine contents. The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was quantitatively liberated as oligosaccharides by hydrazinolysis. After adding 2-deoxyribose, some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> and then with NaBH<sub>4</sub>. Then the sample was separated from radioactive 2-deoxyribitol by paper chromatography in 1-butanol:ethanol:water. The remaining sample was also reduced with NaB<sup>2</sup>H<sub>4</sub>. After digestion by sialidase, the sample was separated by Bio-Gel P-4 column chromatography. Then the sample was subjected to sequential exoglycosidase digestion. The sample was applied to a concanavalin A-Sepharose column chromatography, and periodate oxidation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the complete hydatidiform mole patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_146  a  gn:DS_146_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-09-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_146" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the two different batches of pooled urine, pool 1." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-146" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was quantitatively liberated as oligosaccharides by hydrazinolysis. After adding 2-deoxyribose, some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> and then with NaBH<sub>4</sub>. Then the sample was separated from radioactive 2-deoxyribitol by paper chromatography in 1-butanol:ethanol:water. The remaining sample was also reduced with NaB<sup>2</sup>H<sub>4</sub>. After digestion by sialidase, the sample was separated by Bio-Gel P-4 column chromatography. Then the sample was subjected to sequential exoglycosidase digestion. The sample was applied to a concanavalin A-Sepharose column chromatography, and periodate oxidation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the pooled urine from the healthy pregnant women." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_4  a    gn:DS_4_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3594" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_4" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the two choriocarcinoma patients, Kur." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "choriocarcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-4" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was quantitatively liberated as oligosaccharides by hydrazinolysis. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> and then with NaB<sup>2</sup>H<sub>4</sub>. The remaining sample was also reduced with NaB<sup>2</sup>H<sub>4</sub>. After digestion by sialidase, the sample was separated by Bio-Gel P-4 column chromatography. The sample was acid hydrolyzed in HCl at 100 degree Celsius for 3 min. Then after the sample was subjected to sequential exoglycosidase digestion (β-galactosidase, jack bean β-<i>N</i>-acetylhexosaminidase, α-mannosidase, β-mannosidase, α-L-fucosidase) and periodate oxidation, it was analyzed by Bio-Gel P-4 column chromatography. The sample was applied to a concanavalin A-Sepharose column chromatography, and incubated with diplococcal β-<i>N</i>-acetylhexosaminidase. And then the sample was separated by Bio-Gel P-4 column chromatography." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the choriocarcinoma patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_2  a    gn:DS_2_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3594" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "49" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Kobe University Hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the three choriocarcinoma patients, Mat. Gravida 7, para 3. The patient was admitted to the hospital with molar pregnancy on March 20, 1978. After evacuation of the mole, the patient underwent a simple hysterectomy following pelvic angiography one month after initial treatment. The diagnosis was invasive mole. The patient was given 3 courses of methotrexate post-operatively and achieved a complete, sustained remission. The patient was readmitted because of progressive dyspnea and cough on June 8, 1980. On June 20, 1980, a thoracotomy was performed to establish a definitive diagnosis of multiple discrete lesions in the right lung field and biopsy revealed metastatic choriocarcinoma. The patient was treated post-operatively with methotrexate, actinomycin D and vinblastine but died on August 16, 1980, at that time the hCG titer continued to rise from 4,800 to 18,000 mIU/ml. At autopsy, the patient had metastatic lesions of choriocarcinoma in the lung, liver, kidney, adrenal, intestine and skin. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "metastatic choriocarcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-2" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from urine collected in the course of the readmission. The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in freshly distilled anhydrous hydrazine and heated at 100 degree Celsius for 10 hr, it made quantitative liberation of oligosaccharides. After adding 2-deoxyribose, some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> and then with NaBH<sub>4</sub>. Then the sample was separated from radioactive 2-deoxyribitol by paper chromatography in 1-butanol:ethanol:water. The sample was heated in HCl at 100 degree Celsius for 3min. The remaining sample was also reduced with NaB<sup>2</sup>H<sub>4</sub>. After digestion by sialidase, the sample was separated by Bio-Gel P-4 column chromatography. Then the sample was subjected to sequential exoglycosidase digestion. The sample was applied to a concanavalin A-Sepharose column chromatography, and periodate oxidation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the choriocarcinoma patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_1  a    gn:DS_1_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3594" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "38" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Kobe University Hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the three choriocarcinoma patients, Mae. Gravida 2, para 1. The patient underwent dilatation and evacuation of a hydatidiform mole on July 15, 1975, then hCG titers were declined below 5 mIU/ml 7 weeks after evacuation. On September 1, 1982, the patient was admitted to hospital because chest X-ray revealed abnormal round shadows in the right lung field. The patient underwent a thoracotomy on September 18, 1982, and a pathological diagnosis of choriocarcinoma was made. She was treated with methotrexate, actinomycin D and vinblastine post-operatively, and the hCG titer declined from 2,800 mIU/ml to below 5 mIU/ml on December 20, 1982.  After that she was in good health. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "choriocarcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from urine collected before thoracotomy. The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in freshly distilled anhydrous hydrazine and heated at 100 degree Celsius for 10 hr, it made quantitative liberation of oligosaccharides. After adding 2-deoxyribose, some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> and then with NaBH<sub>4</sub>. Then the sample was separated from radioactive 2-deoxyribitol by paper chromatography in 1-butanol:ethanol:water.  The sample was heated in HCl at 100 degree Celsius for 3min. The remaining sample was also reduced with NaB<sup>2</sup>H<sub>4</sub>. After digestion by sialidase, the sample was separated by Bio-Gel P-4 column chromatography. Then the sample was subjected to sequential exoglycosidase digestion. The sample was applied to a concanavalin A-Sepharose column chromatography, and periodate oxidation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the choriocarcinoma patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_3  a    gn:DS_3_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3594" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Kobe University Hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the three choriocarcinoma patients, Kun. Gravida 2, para 2. The patient was admitted to the hospital in August, 1983, with abnormal vaginal bleeding three months after a full-term normal delivery. A pregnancy test was positive on admission and the concentration of urinary hCG was about 75,000 mIU/ml. Normal pregnancy was excluded by ultrasonography, and uterine curettage was carried out which was highly suggestive of choriocarcinoma on pathological examination. The patient underwent simple hysterectomy and post-operative pathological examination showed intrauterine choriocarcinoma. After operation, the patient was treated with 5 courses of Etoposide (NK 171) and 2 courses of actinomycin D; 90 days later hCG could no longer be detected in serum samples by specific hCG β radioimmunoassay. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "intrauterine choriocarcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from urine collected before hysterectomy. The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was suspended in freshly distilled anhydrous hydrazine and heated at 100 degree Celsius for 10 hr, it made quantitative liberation of oligosaccharides. After adding 2-deoxyribose, some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> and then with NaBH<sub>4</sub>. Then the sample was separated from radioactive 2-deoxyribitol by paper chromatography in 1-butanol:ethanol:water. The sample was heated in HCl at 100 degree Celsius for 3min. The remaining sample was also reduced with NaB<sup>2</sup>H<sub>4</sub>. After digestion by sialidase, the sample was separated by Bio-Gel P-4 column chromatography. Then the sample was subjected to sequential exoglycosidase digestion. The sample was applied to a concanavalin A-Sepharose column chromatography, and periodate oxidation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the choriocarcinoma patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_182  a  gn:DS_182_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-11-20" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens OX=9606 GN=LAMA3 PE=1 SV=2 MAAAARPRGRALGPVLPPTPLLLLVLRVLPACGATARDPGAAAGLSLHPTYFNLAEAARI WATATCGERGPGEGRPQPELYCKLVGGPTAPGSGHTIQGQFCDYCNSEDPRKAHPVTNAI DGSERWWQSPPLSSGTQYNRVNLTLDLGQLFHVAYILIKFANSPRPDLWVLERSVDFGST YSPWQYFAHSKVDCLKEFGREANMAVTRDDDVLCVTEYSRIVPLENGEVVVSLINGRPGA KNFTFSHTLREFTKATNIRLRFLRTNTLLGHLISKAQRDPTVTRRYYYSIKDISIGGQCV CNGHAEVCNINNPEKLFRCECQHHTCGETCDRCCTGYNQRRWRPAAWEQSHECEACNCHG HASNCYYDPDVERQQASLNTQGIYAGGGVCINCQHNTAGVNCEQCAKGYYRPYGVPVDAP DGCIPCSCDPEHADGCEQGSGRCHCKPNFHGDNCEKCAIGYYNFPFCLRIPIFPVSTPSS EDPVAGDIKGCDCNLEGVLPEICDAHGRCLCRPGVEGPRCDTCRSGFYSFPICQACWCSA LGSYQMPCSSVTGQCECRPGVTGQRCDRCLSGAYDFPHCQGSSSACDPAGTINSNLGYCQ CKLHVEGPTCSRCKLLYWNLDKENPSGCSECKCHKAGTVSGTGECRQGDGDCHCKSHVGG DSCDTCEDGYFALEKSNYFGCQGCQCDIGGALSSMCSGPSGVCQCREHVVGKVCQRPENN YYFPDLHHMKYEIEDGSTPNGRDLRFGFDPLAFPEFSWRGYAQMTSVQNDVRITLNVGKS SGSLFRVILRYVNPGTEAVSGHITIYPSWGAAQSKEIIFLPSKEPAFVTVPGNGFADPFS ITPGIWVACIKAEGVLLDYLVLLPRDYYEASVLQLPVTEPCAYAGPPQENCLLYQHLPVT RFPCTLACEARHFLLDGEPRPVAVRQPTPAHPVMVDLSGREVELHLRLRIPQVGHYVVVV EYSTEAAQLFVVDVNVKSSGSVLAGQVNIYSCNYSVLCRSAVIDHMSRIAMYELLADADI QLKGHMARFLLHQVCIIPIEEFSAEYVRPQVHCIASYGRFVNQSATCVSLAHETPPTALI LDVLSGRPFPHLPQQSSPSVDVLPGVTLKAPQNQVTLRGRVPHLGRYVFVIHFYQAAHPT FPAQVSVDGGWPRAGSFHASFCPHVLGCRDQVIAEGQIEFDISEPEVAATVKVPEGKSLV LVRVLVVPAENYDYQILHKKSMDKSLEFITNCGKNSFYLDPQTASRFCKNSARSLVAFYH KGALPCECHPTGATGPHCSPEGGQCPCQPNVIGRQCTRCATGHYGFPRCKPCSCGRRLCE EMTGQCRCPPRTVRPQCEVCETHSFSFHPMAGCEGCNCSRRGTIEAAMPECDRDSGQCRC KPRITGRQCDRCASGFYRFPECVPCNCNRDGTEPGVCDPGTGACLCKENVEGTECNVCRE GSFHLDPANLKGCTSCFCFGVNNQCHSSHKRRTKFVDMLGWHLETADRVDIPVSFNPGSN SMVADLQELPATIHSASWVAPTSYLGDKVSSYGGYLTYQAKSFGLPGDMVLLEKKPDVQL TGQHMSIIYEETNTPRPDRLHHGRVHVVEGNFRHASSRAPVSREELMTVLSRLADVRIQG LYFTETQRLTLSEVGLEEASDTGSGRIALAVEICACPPAYAGDSCQGCSPGYYRDHKGLY TGRCVPCNCNGHSNQCQDGSGICVNCQHNTAGEHCERCQEGYYGNAVHGSCRACPCPHTN SFATGCVVNGGDVRCSCKAGYTGTQCERCAPGYFGNPQKFGGSCQPCSCNSNGQLGSCHP LTGDCINQEPKDSSPAEECDDCDSCVMTLLNDLATMGEQLRLVKSQLQGLSASAGLLEQM RHMETQAKDLRNQLLNYRSAISNHGSKIEGLERELTDLNQEFETLQEKAQVNSRKAQTLN NNVNRATQSAKELDVKIKNVIRNVHILLKQISGTDGEGNNVPSGDFSREWAEAQRMMREL RNRNFGKHLREAEADKRESQLLLNRIRTWQKTHQGENNGLANSIRDSLNEYEAKLSDLRA RLQEAAAQAKQANGLNQENERALGAIQRQVKEINSLQSDFTKYLTTADSSLLQTNIALQL MEKSQKEYEKLAASLNEARQELSDKVRELSRSAGKTSLVEEAEKHARSLQELAKQLEEIK RNASGDELVRCAVDAATAYENILNAIKAAEDAANRAASASESALQTVIKEDLPRKAKTLS SNSDKLLNEAKMTQKKLKQEVSPALNNLQQTLNIVTVQKEVIDTNLTTLRDGLHGIQRGD IDAMISSAKSMVRKANDITDEVLDGLNPIQTDVERIKDTYGRTQNEDFKKALTDADNSVN KLTNKLPDLWRKIESINQQLLPLGNISDNMDRIRELIQQARDAASKVAVPMRFNGKSGVE VRLPNDLEDLKGYTSLSLFLQRPNSRENGGTENMFVMYLGNKDASRDYIGMAVVDGQLTC VYNLGDREAELQVDQILTKSETKEAVMDRVKFQRIYQFARLNYTKGATSSKPETPGVYDM DGRNSNTLLNLDPENVVFYVGGYPPDFKLPSRLSFPPYKGCIELDDLNENVLSLYNFKKT FNLNTTEVEPCRRRKEESDKNYFEGTGYARVPTQPHAPIPTFGQTIQTTVDRGLLFFAEN GDRFISLNIEDGKLMVRYKLNSELPKERGVGDAINNGRDHSIQIKIGKLQKRMWINVDVQ NTIIDGEVFDFSTYYLGGIPIAIRERFNISTPAFRGCMKNLKKTSGVVRLNDTVGVTKKC SEDWKLVRSASFSRGGQLSFTDLGLPPTDHLQASFGFQTFQPSGILLDHQTWTRNLQVTL EDGYIELSTSDSGSPIFKSPQTYMDGLLHYVSVISDNSGLRLLIDDQLLRNSKRLKHISS SRQSLRLGGSNFEGCISNVFVQRLSLSPEVLDLTSNSLKRDVSLGGCSLNKPPFLMLLKG STRFNKTKTFRINQLLQDTPVASPRSVKVWQDACSPLPKTQANHGALQFGDIPTSHLLFK LPQELLKPRSQFAVDMQTTSSRGLVFHTGTKNSFMALYLSKGRLVFALGTDGKKLRIKSK EKCNDGKWHTVVFGHDGEKGRLVVDGLRAREGSLPGNSTISIRAPVYLGSPPSGKPKSLP TNSFVGCLKNFQLDSKPLYTPSSSFGVSSCLGGPLEKGIYFSEEGGHVVLAHSVLLGPEF KLVFSIRPRSLTGILIHIGSQPGKHLCVYLEAGKVTASMDSGAGGTSTSVTPKQSLCDGQ WHSVAVTIKQHILHLELDTDSSYTAGQIPFPPASTQEPLHLGGAPANLTTLRIPVWKSFF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "LAMA3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_182" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Laminin-332" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "Q16787&Q13751&Q13753" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#cell_line>
                "MKN45 cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-182" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Human <i>N</i>-acetylglucosaminyltransferase III (GnT-III) and <i>N</i>-acetylglucosaminyltransferase V (GnT-V) were inserted into a pCXN vector and transfected into MKN45 cells by Lipofectamine reagent. After a 2-week neomycin selection in RPMI 1640 medium containing 10% fetal calf serum, penicillin, and streptomycin sulfate, resistance clones were isolated by serially limited dilution and then selected positive cells by immunoblotting." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "human Laminin-332." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_183  a  gn:DS_183_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-11-20" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_183" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "The complex on the cell surface proteins which contained Laminin-332." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-183" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The complex on the cell surface proteins which contained Laminin-332 under normal conditions." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_184  a  gn:DS_184_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-11-21" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_184" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "The complex on the cell surface proteins that contained Laminin-332 which introduced bisecting GlcNAc (GnT-III-Lm332)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-184" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The complex on the cell surface proteins that contained Laminin-332 which introduced bisecting GlcNAc (GnT-III-Lm332) under overexpression of <i>N</i>-acetylglucosaminyltransferase III (GnT-III)." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_78  a   gn:DS_78_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-27" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_78" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-78" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "quail" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Acetone powdered sample of intestinal epithelial tissue of the quail." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was treated with pepsin plus glycoamidase A in citrate–phosphate buffer at 37  degree Celsius overnight. The sample was further digested by pronase in Tris-HCl buffer at 37  degree Celsius overnight. The sample was applied to a BIO-GEL P-2 gel column and then reductively aminated with 2-aminopyridine by the use of sodium cyanoborohydride. The sample was loaded to a DEAE column, an ODS column, and then an amide-silica column. The sample was analyzed by MALDI-TOF-MS. The <i>N</i>-glycan  structures were  identified based on GU and mass values in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans derived from intestinal epithelial tissues of the quail." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "93934" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "intestinal epithelial cell" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_79  a   gn:DS_79_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_79" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-79" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "chicken" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Acetone powdered sample of intestinal epithelial tissue of the chicken." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was treated with pepsin plus glycoamidase A in citrate–phosphate buffer at 37  degree Celsius overnight. The sample was further digested by pronase in Tris-HCl buffer at 37  degree Celsius overnight. The sample was applied to a BIO-GEL P-2 gel column and then reductively aminated with 2-aminopyridine by the use of sodium cyanoborohydride. The sample was loaded to a DEAE column, an ODS column, and then an amide-silica column. The sample was analyzed by MALDI-TOF-MS. The <i>N</i>-glycan  structures were  identified based on GU and mass values in comparison to PA-glycans in the GALAXY database (DOI: 10.4052/tigg.15.235)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans derived from intestinal epithelial tissues of the chicken." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9031" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "intestinal epithelial cell" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_96  a   gn:DS_96_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_96" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#dev_stage>
                "embryonic day 14.5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#embryo>
                "ICR mouse embryos" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-96" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "mouse" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Single cell suspensions prepared from 14.5-embyonic-day mouse were cultured in Neurobasal-A medium containing B27 serum-free supplement, <sub>L</sub>-glutamine, basic FGF, and epidermal growth factor. After 5–6 days, neurospheres were collected." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Cell lysates were hydrazinolysed for delipidataion and released <i>N</i>-glycans were labeled with 2-aminopyridine. The PA-glycans were separated on a TSKgel DEAE-5PW column. The anionic samples were treated with α-sialidase and subjected to the DEAE column. The neutral and neo-neutral samples were further applied to a Shim-pack HRC ODS column. The fractions were subjected to MALDI-TOF-MS analysis. If it needs, <i>N</i>-glycans were further separated using an amide column.  <i>N</i>-glycan structures was identified using the GALAXY database (DOI: 10.4052/tigg.15.235). Unknown PA-glycans in the the GALAXY database were characterized by exoglycosidase treatments and mass spectrometric techniques (PMID: 20044081, PMID: 18439991)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans dereived from neural stem cells (NSCs) of mouse before differentiation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_type>
                "NSC Culture" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#strain>
                "ICR" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "10090" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_97  a   gn:DS_97_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-12" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_97" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "NSCs were isolated from the striata of mouse embryos (embryonic day 14.5) in the form of neuro spheres, floating clonal aggregates formed by NSCs in vitro (24, 35)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#dev_stage>
                "embryonic day 14.5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-97" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "mouse" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Single cell suspensions prepared from 14.5-embyonic-day mouse were cultured in Neurobasal-A medium containing B27 serum-free supplement, <sub>L</sub>-glutamine, basic FGF, and epidermal growth factor. After 5–6 days, neurospheres were collected. The NSCs were cultured for 10 days in Neurobasal-A medium containing B27, L-glutamine, and1% fetal bovine serum in the absence of basic FGF and EGF." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Cell lysates were hydrazinolysed for delipidataion and released <i>N</i>-glycans were labeled with 2-aminopyridine. The PA-glycans were separated on a TSKgel DEAE-5PW column, and then applied to a Shim-pack HRC ODS column. The fractions were subjected to MALDI-TOF-MS analysis. If it needs, <i>N</i>-glycans were further separated using an amide column.  <i>N</i>-glycan structures was identified using the GALAXY database (DOI: 10.4052/tigg.15.235). Unknown PA-glycans in the the GALAXY database were characterized by exoglycosidase treatments and mass spectrometric techniques (PMID: 20044081, PMID: 18439991)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans dereived from neural stem cells (NSCs) of mouse after differentiation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#strain>
                "ICR" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "10090" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_35  a   gn:DS_35_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:10283" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_35" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Glycosphingolipids and free oligosaccharides" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "84" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka University Medical School-related hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Histological diagnosis was adenocarcinoma, histological differentiation was moderate, Gleason score was 4+4=8, depth of invasion was TxN0M1b and PSA (ng/ml) was 705." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "prostate cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-35" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from the tissues using chloroform/methanol and chloroform/methanol/water. The extract was loaded onto a DEAE-Sephadex A25. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Column-through fractions (neutral oligosaccharides) and subsequently eluted with ammonium acetate in methanol (acidic oligosaccharides) were digested with recombinant endoglycoceramidase II from <i>Rhodococcus</i> Sp.. Then sample's ends were tagged with the 2-aminopyridine. The sample was analyzed by size-fractionation high-performance liquid chromatography (HPLC) performed on a TSK gel Amide-80 column. The sample was further analyzed by reverse-phase HPLC on a TSK gel octadecyl silyl (ODS)-80Ts column. The sample was subjected to liquid chromatography/electrospray ionization MS/MS (LC/ESI MS<sup>2</sup>) analysis. Some of the PA-oligosaccharides were analyzed after digestion with <i>N</i>-acetylneuraminidase, α-mannosidase and KDNase by 2D mapping. KDNase digested PA-oligosaccharides were also analyzed after transfer of KDN by α2,6-sialyltransferase I recombinant protein and α2,3-sialyltransferase." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Glycosphingolipids and free oligosaccharides extracted from bone metastatic lesion of the same prostate cancer patient as GS_36 using needle biopsy." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "prostate tissues" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_36  a   gn:DS_36_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:10283" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_36" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Glycosphingolipids and free oligosaccharides" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "73" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka University Medical School-related hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Histological diagnosis was adenocarcinoma, histological differentiation was poor, Gleason score was 4+5=9, depth of invasion was T3bN1M1b and PSA (ng/ml) was 913." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "prostate cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-36" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from the tissues using chloroform/methanol and chloroform/methanol/water. The extract was loaded onto a DEAE-Sephadex A25. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Column-through fractions (neutral oligosaccharides) and subsequently eluted with ammonium acetate in methanol (acidic oligosaccharides) were digested with recombinant endoglycoceramidase II from <i>Rhodococcus</i> Sp.. Then sample's ends were tagged with the 2-aminopyridine. The sample was analyzed by size-fractionation high-performance liquid chromatography (HPLC) performed on a TSK gel Amide-80 column. The sample was further analyzed by reverse-phase HPLC on a TSK gel octadecyl silyl (ODS)-80Ts column. The sample was subjected to liquid chromatography/electrospray ionization MS/MS (LC/ESI MS<sup>2</sup>) analysis. Some of the PA-oligosaccharides were analyzed after digestion with <i>N</i>-acetylneuraminidase, α-mannosidase and KDNase by 2D mapping. KDNase digested PA-oligosaccharides were also analyzed after transfer of KDN by α2,6-sialyltransferase I recombinant protein and α2,3-sialyltransferase." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Glycosphingolipids and free oligosaccharides extracted from primary lesion of the same prostate cancer patient as GS_35 using needle biopsy." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "prostate tissues" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_37  a   gn:DS_37_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:10283" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_37" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Glycosphingolipids and free oligosaccharides" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "79" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka University Medical School-related hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Histological diagnosis was adenocarcinoma, histological differentiation was uncollected, Gleason score was uncollected, depth of invasion was T3bN0M0 and PSA (ng/ml) was 35." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "prostate cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-37" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from the tissues using chloroform/methanol and chloroform/methanol/water. The extract was loaded onto a DEAE-Sephadex A25. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Column-through fractions (neutral oligosaccharides) and subsequently eluted with ammonium acetate in methanol (acidic oligosaccharides) were digested with recombinant endoglycoceramidase II from <i>Rhodococcus</i> Sp.. Then sample's ends were tagged with the 2-aminopyridine. The sample was analyzed by size-fractionation high-performance liquid chromatography (HPLC) performed on a TSK gel Amide-80 column. The sample was further analyzed by reverse-phase HPLC on a TSK gel octadecyl silyl (ODS)-80Ts column. The sample was subjected to liquid chromatography/electrospray ionization MS/MS (LC/ESI MS<sup>2</sup>) analysis. Some of the PA-oligosaccharides were analyzed after digestion with <i>N</i>-acetylneuraminidase, α-mannosidase and KDNase by 2D mapping. KDNase digested PA-oligosaccharides were also analyzed after transfer of KDN by α2,6-sialyltransferase I recombinant protein and α2,3-sialyltransferase." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Glycosphingolipids and free oligosaccharides extracted from primary lesion of the prostate cancer patient using needle biopsy." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "prostate tissues" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_38  a   gn:DS_38_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:10283" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_38" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Glycosphingolipids and free oligosaccharides" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "63" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka University Medical School-related hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Histological diagnosis was adenocarcinoma, histological differentiation was poor, Gleason score was 5+4=9, depth of invasion was T4N1M1b and PSA (ng/ml) was 3045." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "prostate cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-38" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from the tissues using chloroform/methanol and chloroform/methanol/water. The extract was loaded onto a DEAE-Sephadex A25. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Column-through fractions (neutral oligosaccharides) and subsequently eluted with ammonium acetate in methanol (acidic oligosaccharides) were digested with recombinant endoglycoceramidase II from <i>Rhodococcus</i> Sp.. Then sample's ends were tagged with the 2-aminopyridine. The sample was analyzed by size-fractionation high-performance liquid chromatography (HPLC) performed on a TSK gel Amide-80 column. The sample was further analyzed by reverse-phase HPLC on a TSK gel octadecyl silyl (ODS)-80Ts column. The sample was subjected to liquid chromatography/electrospray ionization MS/MS (LC/ESI MS<sup>2</sup>) analysis. Some of the PA-oligosaccharides were analyzed after digestion with <i>N</i>-acetylneuraminidase, α-mannosidase and KDNase by 2D mapping. KDNase digested PA-oligosaccharides were also analyzed after transfer of KDN by α2,6-sialyltransferase I recombinant protein and α2,3-sialyltransferase." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Glycosphingolipids and free oligosaccharides extracted from primary lesion of the prostate cancer patient using needle biopsy." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "prostate tissues" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_39  a   gn:DS_39_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:10283" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-25" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_39" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Glycosphingolipids and free oligosaccharides" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "78" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Osaka University Medical School-related hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Histological diagnosis was adenocarcinoma, histological differentiation was poor, Gleason score was 5+4=9, depth of invasion was T4N1M0 and PSA (ng/ml) was 3." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "prostate cancer" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-39" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from the tissues using chloroform/methanol and chloroform/methanol/water. The extract was loaded onto a DEAE-Sephadex A25. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Column-through fractions (neutral oligosaccharides) and subsequently eluted with ammonium acetate in methanol (acidic oligosaccharides) were digested with recombinant endoglycoceramidase II from <i>Rhodococcus</i> Sp.. Then sample's ends were tagged with the 2-aminopyridine. The sample was analyzed by size-fractionation high-performance liquid chromatography (HPLC) performed on a TSK gel Amide-80 column. The sample was further analyzed by reverse-phase HPLC on a TSK gel octadecyl silyl (ODS)-80Ts column. The sample was subjected to liquid chromatography/electrospray ionization MS/MS (LC/ESI MS<sup>2</sup>) analysis. Some of the PA-oligosaccharides were analyzed after digestion with <i>N</i>-acetylneuraminidase, α-mannosidase and KDNase by 2D mapping. KDNase digested PA-oligosaccharides were also analyzed after transfer of KDN by α2,6-sialyltransferase I recombinant protein and α2,3-sialyltransferase." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Glycosphingolipids and free oligosaccharides extracted from primary lesion of the prostate cancer patient using needle biopsy." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "prostate tissues" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_92  a   gn:DS_92_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_92" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "ST6Gal1" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "#df_P13721" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host>
                "silkworm" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_description>
                "1<sup>st</sup> day fifth-instar hybrid Kinsyu×Syowa silkworm larvae was injected BmNPV bacmids DNA." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_diet>
                "artificial diet (Silkmate 2S)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_life_stage>
                "larvae" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#lab_host_taxid>
                "7091" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-92" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Rat ST6Gal1 (delta1–189) gene was amplified from a rat liver cDNA library using the ST6Gal1 primer set. Polymerase chain reaction (PCR) was performed. The sample was purified using a GFX PCR purification kit, digested with a <i>Bam</i>HI and <i>Eco</i>RI restriction kit and ligated using T4 ligase into pBlueBacHis2 digested with <i>Bam</i>HI and <i>Eco</i>RI (pBH/ST6Gal1). The signal sequence from bombyxin (bx) was added to ST6Gal1. PCR was carried out. FLAG-tagged ST6Gal1 genes was amplified using the CACC-bx-FLAG-ST6Gal1 primer sets. PCR was performed. The sample was cloned into pENTR. The sample was cloned into pDEST8. A cysteine protease and chitinase-deficient <i>B. mori</i> multiple nucleopolyhedrovirus (BmNPV-<i>CP</i><sup>-</sup><i>Chi</i><sup>-</sup>) bacmid was used. The plasmid was transformed into <i>E. coli</i> DH10BacBm-<i>CP</i><sup>-</sup><i>Chi</i><sup>-</sup>, cultivated on LB plates. White colonies were picked, and positive clones were selected. BmNPV bacmids DNA were injected directly into 1<sup>st</sup> day fifth-instar hybrid Kinsyu×Syowa silkworm larvae. BmNPV bacmid and 10 1,2-dimyristyloxypropyl-3-dimethyl-hydroxy ethyl ammonium bromide (DMRIE)-C reagent were dissolved in PBS, then, the mixture was injected into dorsal of the larvae. The larvae were reared on an artificial diet. After 6.5 days postinjection, the larval hemolymph was harvested by cutting a caudal leg in 1-phenyl-2-thiourea, and centrifuged. The silkworm larval hemolymph was diluted with MOPS buffer. The sample was precipitated in ammonium sulphate. After centrifugation, solid ammonium sulphate was added to the supernatant. The precipitate was dissolved with same buffer. After using with a Sephadex G-25M PD-10 column, the sample was applied to an anti-FLAG M2 column. The column was washed with binding buffer, followed by elute buffer containing NaCl, Triton X-100 and FLAG peptide. The collected sample was dialyzed against MOPS buffer, and stored at 4 degree Celsius." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was proteolyzed with trypsin and chymotrypsin, and further digested with PNGase F. After using Sep-Pack reversed-phase cartridges, the reducing ends of the <i>N</i>-glycans were derivatized with 2-aminopyridine. The sample was separated by an octadecyl silica (ODS) column and the elution time recorded which represents the glucose unit (GU) value. The sample was analyzed by MALDI-TOF-MS. The identification of <i>N</i>-glycan structures was based on their GUs and mapping in the GALAXY database (DOI: 10.4052/tigg.15.235). The sample was analyzed by MALDI-TOF-MS and co-chromatographed with reference to PA-oligosaccharides on the columns to confirm their identities." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "4 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Rat recombinant FLAG-tagged ST6Gal1 (delta1–189) expressed in silkworm larval hemolymph." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_121  a  gn:DS_121_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-31" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_121" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-121" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The eluted sample was evaporated and subjected to paper chromatography by using solvent I for 16 h. The slow moved samples than <i>N</i>-acetylgalactosaminitol were extracted from the paper with water. The sample was subjected to descending paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II) for 8 h. The sample was also subjected to a Bio-Gel P-4 column and methylation analysis. The samples were digested with one of the following mixtures at 37  degree Celsius for 18 h adding one drop of toluene: 1) <i>Arthrobacter ureafaciens</i> (<i>A. ureafaciens</i>) sialidase in sodium acetate buffer; 2) jack bean β-galactosidase in sodium citrate buffer; 3) jack bean β-<i>N</i>-acetylhexosaminidase in sodium citrate buffer; 4) diplococcal β-galactosidase in sodium citrate buffer. The samples were then heated for 3 min. The samples were analyzed by Bio-Gel P-4 column chromatography. The sample and NaB<sup>3</sup>H<sub>4</sub> in NaBH<sub>4</sub> and NaOH were kept at 48  degree Celsius for 16 h then added acetic acid. The sample was loaded a column of AG 50(H<sup>+</sup>) and the column was washed with water. The eluted sample was evaporated with methyl alcohol and subjected to paper chromatography using solvent I for 16 h. The sample was passed through a concanavalin A-Sepharose column. Before and after sialidase (<i>A. ureafaciens</i>) digestion, the sample was subjected to methylation analysis. The samples were incubated with New Castle Disease Virus sialidase in cacodylate buffer at 37  degree Celsius for 2 h. The samples were passed through a filter of mole cut and the filtrate was evaporated to dryness, then dissolved in water, and subjected to anion exchange column chromatography. After that, the samples were eluted by sodium acetate buffer and subjected to paper chromatography. The remaining samples resistant to the enzyme digestion was subjected to periodate oxidation and analyzed by paper chromatography." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the pooled urine of healthy pregnant women." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_122  a  gn:DS_122_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3594" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-31" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_122" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "choriocarcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-122" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The eluted sample was evaporated and subjected to paper chromatography by using solvent I for 16 h. The slow moved samples than <i>N</i>-acetylgalactosaminitol were extracted from the paper with water. The sample was subjected to descending paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II) for 8 h. The sample was also subjected to a Bio-Gel P-4 column and methylation analysis. The samples were digested with one of the following mixtures at 37  degree Celsius for 18 h adding one drop of toluene: 1) <i>Arthrobacter ureafaciens</i> (<i>A. ureafaciens</i>) sialidase in sodium acetate buffer; 2) jack bean β-galactosidase in sodium citrate buffer; 3) jack bean β-<i>N</i>-acetylhexosaminidase in sodium citrate buffer; 4) diplococcal β-galactosidase in sodium citrate buffer. The samples were then heated for 3 min. The samples were analyzed by Bio-Gel P-4 column chromatography. The sample and NaB<sup>3</sup>H<sub>4</sub> in NaBH<sub>4</sub> and NaOH were kept at 48  degree Celsius for 16 h then added acetic acid. The sample was loaded a column of AG 50(H<sup>+</sup>) and the column was washed with water. The eluted sample was evaporated with methyl alcohol and subjected to paper chromatography using solvent I for 16 h. The sample was passed through a concanavalin A-Sepharose column. Before and after sialidase (<i>A. ureafaciens</i>) digestion, the sample was subjected to methylation analysis. The samples were incubated with New Castle Disease Virus sialidase in cacodylate buffer at 37  degree Celsius for 2 h. The samples were passed through a filter of mole cut and the filtrate was evaporated to dryness, then dissolved in water, and subjected to anion exchange column chromatography. After that, the samples were eluted by sodium acetate buffer and subjected to paper chromatography. The remaining samples resistant to the enzyme digestion was subjected to periodate oxidation and analyzed by paper chromatography." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from urine of the patient with choriocarcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_153  a  gn:DS_153_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_153" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the two healthy pregnant women, YNA. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-153" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The sample was analyzed by paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from urine of healthy pregnant women. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_154  a  gn:DS_154_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_154" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the two healthy pregnant women, YNB. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-154" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The sample was analyzed by paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from urine of healthy pregnant women. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_155  a  gn:DS_155_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3590" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_155" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Kobe University Hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the four patients of complete hydatidiform mole, YAM.  After cervical dilatation and evacuation of the uterine contents, the patient was not given specific therapy and the hCG titer determined by hCG β radioimmunoassay, declined to below 5 mIU/ml within 70 days after uterine evacuation. She is well." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "complete hydatidiform mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-155" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The sample was analyzed by paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the complete hydatidiform mole patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_156  a  gn:DS_156_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3590" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_156" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Kobe University Hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the four patients of complete hydatidiform mole, ITO. After cervical dilatation and evacuation of the uterine contents, the patient was not given specific therapy and the hCG titer determined by hCG β radioimmunoassay, declined to below 5 mIU/ml within 70 days after uterine evacuation. She is well." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "complete hydatidiform mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-156" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The sample was analyzed by paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the complete hydatidiform mole patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_157  a  gn:DS_157_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3590" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_157" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Kobe University Hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the four patients of complete hydatidiform mole, AMA. After cervical dilatation and evacuation of the uterine contents, the patient was not given specific therapy and the hCG titer determined by hCG β radioimmunoassay, declined to below 5 mIU/ml within 70 days after uterine evacuation. She is well." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "complete hydatidiform mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-157" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The sample was analyzed by paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the complete hydatidiform mole patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_158  a  gn:DS_158_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3590" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_158" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the four patients of complete hydatidiform mole, HAG. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "complete hydatidiform mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-158" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The sample was analyzed by paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the complete hydatidiform mole patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_159  a  gn:DS_159_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_159" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D002820" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "48" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Kobe University Hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the two patients of invasive mole, KAM. gravida 5, para 2. The patient was admitted to Kobe University Hospital with genital bleeding on August 29, 1985. The concentration of urinary human chorionic gonadotropin (HCG) was about 4,500,000 units/liter. The patient was suspectedly diagnosed as trophoblastic disease from the findings of the pelvic angiography and the ultrasonography. After a simple hysterectomy and the pathological diagnosis was invasive mole. The HCG titer rapidly decreased to below 1 mIU/ml 40 days after the operation." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "invasive mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-159" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from urine collected before the hysterectomy. The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The sample was analyzed by paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the invasive mole patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_160  a  gn:DS_160_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_160" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#MESH>
                "D002820" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "34" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Kobe University Hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the two patients of invasive mole, SHI. gravida 4, para 3. The patient was admitted to the hospital with molar pregnancy on October 7,1985. After cervical dilation and evacuation of the uterine content, and the patient was diagnosed as total hydatidiform mole pathologically. At 20-30 days after the evacuation, the level of human chorionic gonadotropin (HCG) began to increase gradually. The patient was diagnosed as metastatic lesion in the right lung by chest X-rays and to have clinical invasive mole by the criteria of Japan Society of Obstetrics and Gynecology. Following 3 courses of etoposide (1 course, 100 mg/day for 5 days), the level of HCG decreased below 1 mIU/ml and the metastatic lesion was no longer seen in chest X-rays. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "invasive mole" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-160" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted from urine collected before the hysterectomy. The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The sample was analyzed by paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the invasive mole patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_161  a  gn:DS_161_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:2025" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_161" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the three patients of choriocarcinoma, MIT. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "gestational choriocarcinomas" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-161" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The sample was analyzed by paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the choriocarcinomas patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_162  a  gn:DS_162_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:3594" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_162" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "49" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Kobe University Hospital" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the three patients of choriocarcinoma, MAT. Gravida 7, para 3. The patient was admitted to the hospital with molar pregnancy on March 20, 1978. After evacuation of the mole, the patient underwent a simple hysterectomy following pelvic angiography one month after initial treatment. The diagnosis was invasive mole. The patient was given 3 courses of methotrexate post-operatively and achieved a complete, sustained remission. The patient was readmitted because of progressive dyspnea and cough on June 8, 1980. On June 20, 1980, a thoracotomy was performed to establish a definitive diagnosis of multiple discrete lesions in the right lung field and biopsy revealed metastatic choriocarcinoma. The patient was treated post-operatively with methotrexate, actinomycin D and vinblastine but died on August 16, 1980, at that time the hCG titer continued to rise from 4,800 to 18,000 mIU/ml. At autopsy, the patient had metastatic lesions of choriocarcinoma in the lung, liver, kidney, adrenal, intestine and skin. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "metastatic choriocarcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-162" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The sample was analyzed by paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the choriocarcinomas patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_163  a  gn:DS_163_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:2025" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-22" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_163" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "One of the three patients of choriocarcinoma, KUN." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "gestational choriocarcinomas" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-163" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dissolved in NaOH containing NaBH<sub>4</sub> and kept at 48  degree Celsius for 16 h and then added acetic acid. The sample was passed through a column of AG 50-X8 (H<sup>+</sup> form) resin and washed with water. The effluent was evaporated with methanol. The residue was passed through a column of Bond Elut C18 for removing peptides and washed with water and then the effluent was lyophilized. The sample was subjected to high voltage paper electrophoresis and the fractions were digested with <i>Arthrobacter ureafaciens</i> sialidase. The sample was dried thoroughly overnight <i>in vacuo</i> on P<sub>2</sub>O<sub>5</sub> and suspended in anhydrous hydrazine and incubated at 106  degree Celsius for 24 h. After evaporation with toluene repeatedly, the residue was then subjected to paper chromatography with use of butanol-1/ethanol/water (solvent I) for 18 h. The portion of paper included de-<i>N</i>-acetylated sugars larger than galactosaminitol was cut out, and the de-<i>N</i>-acetylated sugars were extraction with NH<sub>4</sub>OH. The sample was neutralized with HCl and evaporated to dryness. The sample was then <i>N</i>-acetylated with [<sup>3</sup>H] acetic anhydride in Na<sub>2</sub>CO<sub>3</sub>/NaHCO<sub>3</sub> buffer, at room temperature for 1 h and then added excess amount of acetic anhydride and the buffer and kept for another hour. The sample was applied to a column of AG 50(H<sup>+</sup>), and the column was washed with water. The sample was analyzed by paper chromatography with use of ethyl acetate/pyridine/acetic acid/water (solvent II)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the urine obtained from the choriocarcinomas patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_93  a   gn:DS_93_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_93" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "5-year-old" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#breed>
                "LWD" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "LWD-pig is an offspring of a male Duroc (D) and a female F1 hybrid pig (a female Landrace (L) and a male Large White (W))." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-93" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "pig" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The porcine tracheal tube was cut transversely into upper part and it was opened longitudinally. Then its luminal surface was cleaned with NaCl, removed by scraping, and cut into small pieces. The samples were pooled, lyophilized, and kept at -80 degree Celsius until use. The samples were delipidated by extraction solvents, ethanol, chloroform/methanol and chloroform/methanol/H<sub>2</sub>O." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was proteolyzed with pepsin plus glycoamidase A and further digested with pronase. After purification by Bio-Gel P-2 chromatography, the sample was labeled with fluorescent 2-aminopyridine and applied to Sephadex G-15 chromatography. The PA-glycan was separated by a TSK-gel DEAE-5PW column and further applied to a Shim-pack HRC ODS column, and the elution time of each peak was expressed as glucose unit (GU) value. The sample was analyzed by MALDI-TOF-MS. Some fractions contained two kinds of glycans were further fractionated by a TSK-gel Amide-80 column and the elution positions were calibrated in GU values. Sample PA-glycans were mapped in the GALAXY database (DOI: 10.4052/tigg.15.235). Unknown PA-glycans in the database were sequentially trimmed with exoglycosidases: α-galactosidase (coffee bean); β-galactosidase (jack bean); α-sialidase (<i>Arthrobacter ureafaciens</i>); and α2,3-sialidase (<i>Salmonella typhimurium</i> LT2). Then each sample was characterized by chromatographic analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-80 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans from porcine upper trachea." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9823" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "upper trachea" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_94  a   gn:DS_94_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_94" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "5-year-old" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#breed>
                "LWD" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "LWD-pig is an offspring of a male Duroc (D) and a female F1 hybrid pig (a female Landrace (L) and a male Large White (W))." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-94" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "pig" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The porcine tracheal tube was cut transversely into upper part and it was opened longitudinally. Then its luminal surface was cleaned with NaCl, removed by scraping, and cut into small pieces. The samples were pooled, lyophilized, and kept at -80 degree Celsius until use. The samples were delipidated by extraction solvents, ethanol, chloroform/methanol and chloroform/methanol/H<sub>2</sub>O." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was proteolyzed with pepsin plus glycoamidase A and further digested with pronase. After purification by Bio-Gel P-2 chromatography, the sample was labeled with fluorescent 2-aminopyridine and applied to Sephadex G-15 chromatography. The PA-glycan was separated by a TSK-gel DEAE-5PW column and further applied to a Shim-pack HRC ODS column, and the elution time of each peak was expressed as glucose unit (GU) value. The sample was analyzed by MALDI-TOF-MS. Some fractions contained two kinds of glycans were further fractionated by a TSK-gel Amide-80 column and the elution positions were calibrated in GU values. Sample PA-glycans were mapped in the GALAXY database (DOI: 10.4052/tigg.15.235). Unknown PA-glycans in the database were sequentially trimmed with exoglycosidases: α-galactosidase (coffee bean); β-galactosidase (jack bean); α-sialidase (<i>Arthrobacter ureafaciens</i>); and α2,3-sialidase (<i>Salmonella typhimurium</i> LT2). Then each sample was characterized by chromatographic analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-80 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans from porcine lower trachea." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9823" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "lower trachea" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_95  a   gn:DS_95_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_95" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "5-year-old" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#breed>
                "LWD" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "LWD-pig is an offspring of a male Duroc (D) and a female F1 hybrid pig (a female Landrace (L) and a male Large White (W))." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-95" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "pig" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The lung was cleaned and cut into small pieces and then homogenized in a cold buffer containing Tris-HCl, NaCl, sucrose and protease inhibitor cocktail set 1. The sample was then centrifuged and the supernatant was ultracentrifuged. The pellet was resuspended in NaCl and recentrifuged. The sample was dried." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was proteolyzed with pepsin plus glycoamidase A and further digested with pronase. After purification by Bio-Gel P-2 chromatography, the sample was labeled with fluorescent 2-aminopyridine and applied to Sephadex G-15 chromatography. The PA-glycan was separated by a TSK-gel DEAE-5PW column and further applied to a Shim-pack HRC ODS column, and the elution time of each peak was expressed as glucose unit (GU) value. The sample was analyzed by MALDI-TOF-MS. Some fractions contained two kinds of glycans were further fractionated by a TSK-gel Amide-80 column and the elution positions were calibrated in GU values. Sample PA-glycans were mapped in the GALAXY database (DOI: 10.4052/tigg.15.235). Unknown PA-glycans in the database were sequentially trimmed with exoglycosidases: α-galactosidase (coffee bean); β-galactosidase (jack bean); α-sialidase (<i>Arthrobacter ureafaciens</i>); and α2,3-sialidase (<i>Salmonella typhimurium</i> LT2). Then each sample was characterized by chromatographic analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans from porcine lung." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9823" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "lung" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_135  a  gn:DS_135_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-17" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_135" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#_The_sample_was_treated_with_neuraminidase_from_<i>C._perfringens</i>_and_then_heated.>
                "MatMetho_Edible bird’s nest (EBN) extract" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biological_product>
                "nest" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named sample 1 (S1)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#env_feature>
                "cave" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-135" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "swift" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Edible bird’s nest (EBN) was dried and grounded." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was hydrolyzed with sulfuric acid and then reacted with DMB reagent and heated. The sample was conducted by a high-performance liquid chromatography (HPLC) method using 1,2-diamino-4,5-methylenedioxy-benzene (DMB) (PMID: 8809024). The sample was incubated with digoxigenin (DIG)-labeled <i>Sambucus nigra agglutinin</i> (SNA) lectin or <i>Maackia amurensis</i> agglutinin (MAA) lectin using glycan determination kit. After washing with PBS, the membrane was incubated with HRP-conjugated anti-DIG antibody and then after additional washes in PBS and buffered glycerol were visualized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Edible bird’s nest (EBN) extract collected from a natural cave." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "46478" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_136  a  gn:DS_136_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-17" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_136" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#_The_sample_was_treated_with_neuraminidase_from_<i>C._perfringens</i>_and_then_heated.>
                "MatMetho_Edible bird’s nest (EBN) extract" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biological_product>
                "nest" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named sample 2 (S2)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#env_feature>
                "house" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-136" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "swift" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Edible bird’s nest (EBN) was dried and grounded." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was hydrolyzed with sulfuric acid and then reacted with DMB reagent and heated. The sample was conducted by a high-performance liquid chromatography (HPLC) method using 1,2-diamino-4,5-methylenedioxy-benzene (DMB) (PMID: 8809024). The sample was incubated with digoxigenin (DIG)-labeled <i>Sambucus nigra agglutinin</i> (SNA) lectin or <i>Maackia amurensis</i> agglutinin (MAA) lectin using glycan determination kit. After washing with PBS, the membrane was incubated with HRP-conjugated anti-DIG antibody and then after additional washes in PBS and buffered glycerol were visualized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Edible bird’s nest (EBN) extract collected from house-cultured." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "46478" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_244  a  gn:DS_244_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:6536" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-02-28" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_244" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Bence Jones (BJ) protein Wh lambda" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "plasma cell dyscrasia (monoclonal gammopathy)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-244" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was subjected to ammonium sulfate precipitation, dialyzed against water, and lyophilized. The sample was filtrated on Sephadex G-100." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was heated in anhydrous hydrazine at 100 degree Celsius for 8 h, and completely N-acetylated with acetic anhydride. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 h. The remainder was reduced with NaB<sup>2</sup>H<sub>4</sub> under the same conditions. The sample was subjected to Bio-Rad AG-50 (H<sup>+</sup>) column, and the column was washed with distilled water. The mixture of eluate and washings was evaporated under reduced pressure. The sample was evaporated repeatedly with methanol for free from boric acid. The sample dissolved in water was spotted on a sheet of Whatman No. 3MM paper and then subjected to paper chromatography using n-butanol/ethanol/water (solvent II) for 2 days. The sample radioactivated area was cut off and subjected to radiochromatoscanning. The major radioactive peak detected close to the origin was eluted with water. The deuterium-labeled sample remained at the origin was also eluted with water and added the radioactive oligosaccharides mixture to facilitate the detection. The sample was incubated with sialidase (data not shown). The sample was subjected to paper electrophoresis. The sample was subjected to Bio-Gel P-4 column chromatograph. The sample was subjected to sequential exoglycosidase digestion, was incubated with <i>diplococcal</i> β-galactosidase, incubation with diplococcal β-<i>N</i>-acetylhexosaminidase, jack bean β-<i>N</i>-acetylhexosaminidase, jack bean α-mannosidase, by further β-mannosidase, jack bean β-<i>N</i>-acetylhexosaminidase, and <i>Charania lampas<i> α-fucosidase (data not shown) or with β-mannosidase and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown). The sample was analyzed by Bio-Gel P-4 column chromatography at each step. The sample was dissolved in HCl, heated at 80 degree Celsius for 1 h and evaporated under reduced pressure. The sample was thoroughly dried in a desiccator over P<sub>2</sub>O<sub>5</sub> in vacuo. The sample was trimethylsilylated at room temperature for 1 h and analyzed by gas chromatograph-mass spectrometer. The sample was subjected to methylation analysis. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Bence Jones (BJ) protein Wh lambda obtained from the urine of patients with plasma cell dyscrasia (monoclonal gammopathy)." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_245  a  gn:DS_245_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID:>
                "DOID:3721" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-03-01" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX8|IGL1_HUMAN Immunoglobulin lambda-1 light chain OS=Homo sapiens OX=9606 PE=1 SV=1 QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGV PDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVT LFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASS YLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_245" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Bence Jones (BJ) protein Nei lambda" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX8" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "plasmacytoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-245" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The urine was added thymol as a preservative, pooled and filtered at 4  degree Celsius. The sample was added solid ammonium sulfate, precipitated for 24 h and centrifuged. The sample was dissolved in distilled water and dialyzed against running water. The sample was filtered again, lyophilized and stored at 4  degree Celsius." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was heated in anhydrous hydrazine at 100 degree Celsius for 8 h, and completely N-acetylated with acetic anhydride. Some of the sample was reduced with NaB<sup>3</sup>H<sub>4</sub> in NaOH at 30 degree Celsius for 4 h. The remainder was reduced with NaB<sup>2</sup>H<sub>4</sub> under the same conditions. The sample was subjected to Bio-Rad AG-50 (H<sup>+</sup>) column, and the column was washed with distilled water. The mixture of eluate and washings was evaporated under reduced pressure. The sample was evaporated repeatedly with methanol for free from boric acid. The sample dissolved in water was spotted on a sheet of Whatman No. 3MM paper and then subjected to paper chromatography using n-butanol/ethanol/water (solvent II) for 2 days. The sample radioactivated area was cut off and subjected to radiochromatoscanning. The major radioactive peak detected close to the origin was eluted with water. The deuterium-labeled sample remained at the origin was also eluted with water and added the radioactive oligosaccharides mixture to facilitate the detection. The sample was incubated with sialidase (data not shown). The sample was subjected to paper electrophoresis. The sample was subjected to Bio-Gel P-4 column chromatograph. The sample was subjected to sequential exoglycosidase digestion, was incubated with <i>diplococcal</i> β-galactosidase, incubation with diplococcal β-<i>N</i>-acetylhexosaminidase, jack bean β-<i>N</i>-acetylhexosaminidase, jack bean α-mannosidase, by further β-mannosidase, jack bean β-<i>N</i>-acetylhexosaminidase, and <i>Charania lampas<i> α-fucosidase (data not shown) or with β-mannosidase and jack bean β-<i>N</i>-acetylhexosaminidase (data not shown). The sample was analyzed by Bio-Gel P-4 column chromatography at each step. The sample was dissolved in HCl, heated at 80 degree Celsius for 1 h and evaporated under reduced pressure. The sample was thoroughly dried in a desiccator over P<sub>2</sub>O<sub>5</sub> in vacuo. The sample was trimethylsilylated at room temperature for 1 h and analyzed by gas chromatograph-mass spectrometer. The sample was subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "4  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Bence Jones (BJ) protein Nei lambda obtained from the urine of patients with plasmacytoma, a kind of plasma cell dyscrasia (monoclonal gammopathy). " .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_177  a  gn:DS_177_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-30" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_177" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biosample>
                "urine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-177" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was extracted by the standard kaolin-acetone method in combination with the alcohol precipitation. The sample was applied to DEAE-Cellulose column. The sample was purified by Sephadex G-100 column. The sample was dialyzed extensively against distilled water and lyophilized." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was incubated with sialidase from <i>Clostridium perfringens</i> in sodium acetate buffer, containing BSA and gamma-galactonolactone at 37 degree Celsius for 3 h with shaking. The sample was centrifuged and the gel was washed three times with the sodium acetate buffer containing BSA. The supernatant and washings were pooled, applied to a Column PD-10. The fractions were collected and lyophilised. N-linked sugar chains of the sample were released as oligosaccharides by hydrazinolysis and labelled by reduction with NaB[<sup>3</sup>H]<sub>4</sub> after <i>N</i>-acetylation. O-linked sugar chains were released by alkaline-NaBH<sub>4</sub> treatment and labelled by hydrazinolysis and re-N[<sup>3</sup>H]acetylation. Then the sample was analysed by high voltage paper electrophoresis, sequential exoglycosidase digestion, Bio-Gel P-4 column chromatography and immobilized lectin culumn chromatography." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Human chorionic gonadotropin was purified from the pooled urine of the healthy pregnant women." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "female" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_205  a  gn:DS_205_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DB_Memo>
                "" , "Edited Memo" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-10-30" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Discussion_Memo>
                "Discussionは後回しにしている" , "Edited Memo" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_90  a   gn:DS_90_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-06" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_90" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "blood" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-90" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "rabbit" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Fresh blood obtained from rabbits was haemolysed in acetic acid, followed by washes with saline and then dried. Lipids were extracted in ethanol, chloroform/methanol and acetone. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was labeled with 2-aminopyridine, purified on a DEAE column. The sample was applied to an ODS column. The sample was analysed by multi-dimensional HPLC mapping and MALDI-TOF-MS techniques in comparison with PA-glycans in the GALAXY database." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Glycans from lipids of rabbit blood." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9986" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_91  a   gn:DS_91_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-10" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_91" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "blood" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-91" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "chicken" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Fresh blood obtained from chickens was haemolysed in acetic acid, followed by washes with saline and then dried. Lipids were extracted in ethanol, chloroform/methanol and acetone. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was labeled with 2-aminopyridine, purified on a DEAE column. The sample was applied to an ODS column. The sample was analysed by multi-dimensional HPLC mapping and MALDI-TOF-MS techniques in comparison with PA-glycans in the GALAXY database." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-Glycans from lipids of chicken blood." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9031" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_17  a   gn:DS_17_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-14" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P01215|GLHA_HUMAN Glycoprotein hormones alpha chain OS=Homo sapiens OX=9606 GN=CGA PE=1 SV=1 MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRA YPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS >sp|P0DN87|CGB7_HUMAN Choriogonadotropin subunit beta 7 OS=Homo sapiens OX=9606 GN=CGB7 PE=2 SV=1 MEMFQGLLLLLLLSMGGTWASREMLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQASSSSKAPPPSLPSPSRLPGPSDTPILPQ >sp|P0DN86|CGB3_HUMAN Choriogonadotropin subunit beta 3 OS=Homo sapiens OX=9606 GN=CGB3 PE=1 SV=1 MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPT MTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDC GGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_17" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "human chorionic gonadotropin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P01215&P0DN87,P0DN86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "Mochida Pharmaceutical Co., Tokyo" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-17" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "A commercial hCG was freed from human chorionic thyroid-stimulating hormone by passage through a column of carboxymethyl cellulose. The sample in the unadsorbed fraction was further purified by the method of Bahl (PMID: 5768856). The sample was heated in anhydrous hydrazine at 100 degree Celsius for 20 h. The sample was then evaporated to dryness under reduced pressure over concentrated H<sub>2</sub>SO<sub>4</sub>. After freed from hydrazine by repeated evaporation with toluene, the sample was dried in a desiccator over concentrated H<sub>2</sub>SO<sub>4</sub> overnight. The sample was dissolved in saturated NaHCO<sub>3</sub> solution." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "Some of the sample was reduced with NaB<sup>3</sup>H in NaOH at 30 degree Celsius for 4 h. After that NaBH<sub>4</sub> in NaOH was added and incubation for 2 h. The other sample was reduced with NaBD<sub>4</sub> in NaOH under the same condition. The sample was passed through a column of Bio-Rad AG-50 (H+) and the column was washed with distilled water. The eluate and washings were combined and evaporated to dryness. The sample was then dissolved in a small amount of water and spotted on a sheet of paper. The paper was developed with solvent II (n-butanol/ethanol/water) for 2 days. The paper was cut off and subjected to radiochromatoscanning. The major radioactive peak detected close to the origin was eluted with water.  The samples remained at the origin with the deuterium-labeled ones, were also eluted with water. The radioactive oligosaccharides mixture was added to the sample. The sample was hydrolyzed in HCl at 100 degree Celsius for 2 h, and was freed from acid by repeated evaporation with water. The sample was <i>N</i>-acetylated and analyzed by paper electrophoresis using borate buffer. The others of samples were subjected to paper electrophoresis.  The samples were incubated with one of the following mixtures at 37 degree Celsius for 18 h: i) β-galactosidase digestion in sodium-citrate buffer, ii) β-<i>N</i>-acetylhexosaminidase digestion in sodium-citrate buffer, iii) α-mannosidase digestion in sodium-acetate buffer, iv) β-mannosidase digestion in sodium-citrate buffer, v) α-<sub>L</sub>-fucosidase digestion in sodium-citrate buffer.  And also one drop of toluene was added to all reaction mixtures. The samples were applied to a Bio-Gel P-4 column chromatography.  <i>N</i>-acetyl- and <i>N</i>-glycolylneuraminic acids were determined by methylation analysis as below.  The sample reduced with NaBD<sub>4</sub> was dissolved in dimethylsulfoxide and methylated with sodium methylsulfinyl carbanion and methyliodide. The sample was recovered by extracting the reaction mixture twice with chloroform and the combined solution was washed with H<sub>2</sub>O three times. The chloroform solution was applied to a column of silica gel. The column was washed with chloroform and then the sample was eluted from the column with methanol. This procedure was performed at 25 - 30°C. The sample was evaporated to dryness and mixed thoroughly with acetic acid containing H<sub>2</sub>SO<sub>4</sub> by stirring at room temperature for 2 h, and then heated at 76 degree Celsius for 2 h. The sample was passed through a column of Bio-Rad AG-3 and the column was washed with methanol. The eluate and washing were evaporated to dryness. The sample was dissolved in H<sub>2</sub>O containing of NaBH<sub>4</sub> and left at room temperature for 3 h. After adding 1 drop of glacial acetic acid, methanol was added and the sample was evaporated to dryness. It was repeated twice. The sample was dried over P<sub>2</sub>O<sub>5</sub> in vacuo for 1 h, dissolved in acetic anhydride and heated at 100 degree Celsius for 4 h. After evaporation with toluene, the sample was dissolved in chloroform. After wash with water twice, the chloroform layer was added anhydrous Na<sub>2</sub>SO<sub>4</sub> and evaporated to dryness. Analysis was performed with a gas chromatographmass spectrometer, using a glass column of 2% OV-17 coated on Gas-Chrom Q (80-100 mesh)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Commercial human chorionic gonadotropin." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_195  a  gn:DS_195_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-17" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P26201|CD36_BOVIN Platelet glycoprotein 4 OS=Bos taurus OX=9913 GN=CD36 PE=1 SV=5 MGCNRNCGLIAGAVIGAVLAVFGGILMPVGDMLIEKTIKKEVVLEEGTIAFKNWVKTGTD VYRQFWIFDVQNPDEVTVNSSKIKVKQRGPYTYRVRYLAKENITQDPETHTVSFLQPNGA IFEPSLSVGTEDDTFTILNLAVAAAPQLYPNTFMQGILNSFIKKSKSSMFQNRTLKELLW GYTDPFLNLVPYPITTTIGVFYPYNNTADGIYKVFNGKDDISKVAIIDTYKGRKNLSYWS SYCDLINGTDAASFPPFVEKTRVLQFFSSDICRSIYAVFGAEINLKGIPVYRFILPSFAF ASPFQNPDNHCFCTEKIISKNCTLYGVLDIGKCKEGKPVYISLPHFLHGSPELAEPIESL SPNEEEHSTYLDVEPITGFTLRFAKRLQVNMLVKPAKKIEALKNLKHNYIVPILWLNETG TIGDEKAEMFRNQVTGKINLLGLVEIVLLSVGVVMFIAFMISYCACRSKRVN" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "CD36" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_195" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Bos taurus" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "CH36" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9913" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P26201" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-195" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "bovine" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Bovine Milk Fat Globule Membrane (MFGM) was extracted with Triton X-114 in Tris-HCI buffer containing NaCl (TBS) and stirred at 4  degree Celsius for 30 min, and then centrifuged. The supernatant was subjected to phase partitioning by warming to 30  degree Celsius and centrifugation. The detergent phase was diluted with TBS, cooled to 4  degree Celsius, and repartitioned. The detergent phase was dialyzed against Tris-HCI buffer containing  Triton X-100 (TT). The sample was then chromatographed sequentially on carboxymethyl-Sepharose columns. The sample was eluted from each column with TT containing NaCl." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was dried thoroughly over P<sub>2</sub>O<sub>5</sub> in vacuo and subjected to hydrazinolysis for 15 h. Two-thirds of the liberated sample was reduced with NaB<sup>3</sup>H<sub>4</sub>. The remainder was reduced with NaB<sup>2</sup>H<sub>4</sub> and one-tenth of the tritiumlabeled oligosaccharides was added. A time course was monitored which the sample was hydrazinolysed to liberate oligosaccharides in each incubation time. Before the reduction with NaB<sup>3</sup>H<sub>4</sub> the sample was added xylose as internal standard. The radioactive oligosaccharides and [<sup>3</sup>H]xylitol were separated by paper chromatography. The sample was hydrazinolysed 100  degree Celsius 20h and subjected to paper chromatography. Half of them was reduced with NaB<sup>3</sup>H<sub>4</sub> and then hydrolyzed with HCI at 100  degree Celsius for 4 h. The remaining sample was hydrolyzed with HCl at 100  degree Celsius for 4 h and then reduced with NaB<sup>3</sup>H<sub>4</sub>. They were re-<i>N</i>-acetylated. The sample was added standard monosaccharide alcohols and injected into the HPLC system. The acidic fraction was digested exhaustively with <i>Arthrobacter ureafaciens</i> sialidase. The sample was subjected to WFA-agarose column chromatography. The passed through fraction (WFA<sup>-</sup>) was applied to a Con A-Sepharose column and eluted fraction with <i>N</i>-acetylgalactosamine (WFA<sup>+</sup>) was applied to a DSA-Sepharose column, and the bound fraction was eluted with <i>N</i>-acetylglucosamine oligomers, and then the passed through fraction (WFA<sup>+</sup>,DSA<sup>-</sup>) was further separated by RCA-1-agarose column chromatography. All fractions were applied to an AAL-Sepharose column and the bound fraction was eluted with α-<sub>L</sub>-fucose. The sample was subjected to Bio-Gel P-4 column chromatography. The sample was digested with diplococcal β-galactosidase followed by diplococcal β-<i>N</i>-acetylhexosaminidase. Some fraction was further digested with jack bean β-<i>N</i>-acetylhexosaminidase. Another fraction was digested with <i>Aspergillus saitoi</i> α-mannosidase I. Other fractions were treated with diplococcal endo-β-<i>N</i>-acetylglucosaminidase D (endo D) and/or <i>Streptomyces griseus</i> endo-β-<i>N</i>-acetylglucosaminidase H (endo H) (data not shown) before and after digestion with diplococcal β-galactosidase followed by diplococcal β-<i>N</i>-acetylhexosaminidase. Those structures were confirmed by sequential digestion with jack bean α-mannosidase, snail β-mannosidase, jack bean β-<i>N</i>-acetylhexosaminidase, and bovine epididymis α-<sub>L</sub>-fucosidase, and methylation analysis (data not shown). The fraction (WFA<sup>+</sup>, DSA<sup>-</sup>, RCA<sup>-</sup>) was eluted from the Con A-Sepharose column with α-methyl-<sub>D</sub>-glucopyranoside after some treatments. The acidic fraction was subjected to a Con A-Sepharose column. The retarded fraction of the column was then applied to a SNA-agarose column and eluted with lactose. The other experiment was that the sample was then digested exhaustively with Arthrobacter ureafaciens sialidase, and applied to a WFA-agarose column. And the sample was also subjected to methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "CD36 purified from bovine milk fat globule membrane." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "milk fat globule membrane" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_188  a  gn:DS_188_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:684" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-07" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_188" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "62" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The patient, HT, was diagnosed as hepatocellular carcinoma with liver cirrhosis by ultrasonography and angiography and later confirmed by histological examination at autopsy. Macroscopic feature of carcinoma; massive. The value of AFP (ng/ml) was 32,600 and CEA (ng/ml) was 3.3." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hepatocellular carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "Edmondson grade III" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-188" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200. The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed by comparing the fraction patterns of the radioactive oligosaccharides released by hydrazinolysis by paper electrophoresis and serial chromatography on columns of AAL-Sepharose, ConA-Sepharose, DSA-Sepharose, E-PHA-agarose, and Allo A-II agarose, followed by Bio-Gel P-4 column chromatography. The sample was further confirmed by sequential exoglycosidase digestion." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of patients with hepatocellular carcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_189  a  gn:DS_189_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:684" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-07" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_189" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "68" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The patient, NA, was diagnosed as hepatocellular carcinoma with liver cirrhosis by ultrasonography and angiography and later confirmed by histological examination at autopsy. Macroscopic feature of carcinoma; solitary. The value of AFP (ng/ml) was 9,800 and CEA (ng/ml) was 6.0." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hepatocellular carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "Edmondson grade III" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-189" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200. The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed by comparing the fraction patterns of the radioactive oligosaccharides released by hydrazinolysis by paper electrophoresis and serial chromatography on columns of AAL-Sepharose, ConA-Sepharose, DSA-Sepharose, E-PHA-agarose, and Allo A-II agarose, followed by Bio-Gel P-4 column chromatography. The sample was further confirmed by sequential exoglycosidase digestion." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of patients with hepatocellular carcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_190  a  gn:DS_190_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:684" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-07" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_190" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "65" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The patient, OY, was diagnosed as hepatocellular carcinoma with liver cirrhosis by ultrasonography and angiography and later confirmed by histological examination at autopsy. Macroscopic feature of carcinoma; massive. The value of AFP (ng/ml) was 1,800 and CEA (ng/ml) was 7.3." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hepatocellular carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "Edmondson grade II" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-190" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200. The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was subjected to paper electrophoresis. The acidic fractions were digested with exhaustive <i>Archrobacter</i> sialidase and partial desialylation (data not shown). The neutral and pooled converted neutral fractions from acidic were digested with a mixture of diplococcal β-galactosidase, almond α-fucosidase I, and jack bean β-<i>N</i>-acetylhexosaminidase. Then the sample was analyzed by Bio-Gel P-4 column chromatography. The mixture of the samples was separated by a ConA-Sepharose column chromatography into the passed-through fraction, ConA(-) and the bound fraction, ConA(+), which eluted with α- methyl mannnopyranoside. ConA(+) was separated by affinity chromatography on an AAL-Sepharose column into the passed-through fraction, fractions I, and the bound fraction, fractions II which eluted with buffer containing <sub>L</sub>-fucose. ConA(-) was separated by an AAL-Sepharose column into the passed-through fraction, AAL(-), retarded, AAL(R) and the bound fraction, AAL(+) which eluted with buffer containing <sub>L</sub>-fucose. AAL(-) was further separated by DSA-Sepharose column chromatography into retarded, DSA(R) and the bound fraction, fraction III which eluted with buffer containing <i>N</i>-acetylglucosamine oligomers mixture. DSA(R) was subjected to E-PHA-agarose column and named fraction VI. AAL(R) was subjected to DSA-Sepharose column and named fraction IV. AAL(+) was separated by DSA-Sepharose column chromatography into passed through fraction, DSA(-), retarded, DSA(R), and bound fraction, fraction V which eluted with <i>N</i>-acetylglucosamine oligomers solution. DSA(-) was further separated by E-PHA-agarose column chromatography into passed through, fractions VII and retarded fractions VIII. DSA(R) was subjected to E-PHA-agarose column and named fraction IX. The samples were subjected to Bio-Gel P-4 column chromatography. Aliquots of  the radioactive fractions were subjected to affinity chromatography with use of an Allo A-II-agarose column and the bound was eluted with the buffer containing lactose." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of patients with hepatocellular carcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_191  a  gn:DS_191_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:684" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-07" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_191" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "53" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The patient, HH, was diagnosed as hepatocellular carcinoma with liver cirrhosis by ultrasonography and angiography and later confirmed by histological examination at autopsy. Macroscopic feature of carcinoma; solitary. The value of AFP (ng/ml) was 200,000 and CEA (ng/ml) was 3.4." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "hepatocellular carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "Edmondson grade II" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-191" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200. The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed by comparing the fraction patterns of the radioactive oligosaccharides released by hydrazinolysis by paper electrophoresis and serial chromatography on columns of AAL-Sepharose, ConA-Sepharose, DSA-Sepharose, E-PHA-agarose, and Allo A-II agarose, followed by Bio-Gel P-4 column chromatography. The sample was further confirmed by sequential exoglycosidase digestion." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of patients with hepatocellular carcinoma." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_192  a  gn:DS_192_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_192" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-192" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200. The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed by comparing the fraction patterns of the radioactive oligosaccharides released by hydrazinolysis by paper electrophoresis and serial chromatography on columns of AAL-Sepharose, ConA-Sepharose, DSA-Sepharose, E-PHA-agarose, and Allo A-II agarose, followed by Bio-Gel P-4 column chromatography. The sample was further confirmed by sequential exoglycosidase digestion." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of healthy sample, ET." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_193  a  gn:DS_193_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_193" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-193" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200. The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed by comparing the fraction patterns of the radioactive oligosaccharides released by hydrazinolysis by paper electrophoresis and serial chromatography on columns of AAL-Sepharose, ConA-Sepharose, DSA-Sepharose, E-PHA-agarose, and Allo A-II agarose, followed by Bio-Gel P-4 column chromatography. The sample was further confirmed by sequential exoglycosidase digestion." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of healthy sample, KA." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_194  a  gn:DS_194_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-12-11" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens OX=9606 GN=TF PE=1 SV=3 MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "TF" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_194" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "transferrin" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P02787" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "Purchased from Sigma Chemical Co., St. Louis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-194" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The transferrin obtained from serum was applied to a column of Sephadex G-200. The positive samples were pooled and the sample was applied to a BSA-conjugated Sepharose 4B column. The passed through samples were pooled and applied to a column of anti-transferrin Sepharose 4B. After the column was extensively washed with PBS, the sample was eluted with glycine-HCI, pH 2.5, containing NaCl and collected. The sample was concentrated with immersible CX-30, and the buffer was changed to PBS with PD-10 column. The sample was passed through a column of Affi-Gel Blue and a column of Affi-Gel Protein A. The sample was finally concentrated, desalted and stored at -20  degree Celsius until used. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was analyzed by comparing the fraction patterns of the radioactive oligosaccharides released by hydrazinolysis by paper electrophoresis and serial chromatography on columns of AAL-Sepharose, ConA-Sepharose, DSA-Sepharose, E-PHA-agarose, and Allo A-II agarose, followed by Bio-Gel P-4 column chromatography. The sample was further confirmed by sequential exoglycosidase digestion." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-20  degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The serum transferrin of healthy and commercial sample." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_131  a  gn:DS_131_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1520" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-03" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=3 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPDAP TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNKLSVDHSDPVILNVLYGPDDPTI SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "CEACAM5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_131" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "carcinoembryonic antigen" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P06731" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_type>
                "A" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named TY and CEA-TY." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "colon carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "metastasis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-131" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was purified by Sepharose 6B and Sepharose 4B gel permeation chromatography followed by concanavalin A-Sepharose 4B affinity chromatography. The sample was dried." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The dried sample was suspended in anhydrous hydrazine and heated. The sample was dissolved in NaOH and reduced with NaB<sup>3</sup>H<sub>4</sub> after addition of lactose. [<sup>3</sup>H]Lactitol and tritium-labeled sample was separated by paper chromatography. The sample was reduced with NaB<sup>2</sup>H<sub>4</sub> to obtain deuterium-labeled oligosaccharide fractions for methylation analysis. The sample was incubated with galactose oxidase and horse radish peroxidase. The sample was incubated with NaB<sup>3</sup>H<sub>4</sub> and then reduced with NaBH<sub>4</sub>. The samples were incubated with (1) sialidase digestion, (2) the mixture of jack bean β-galactosidase and β-<i>N</i>-acetylhexosaminidase, β-galactosidase and β-<i>N</i>-acetylhexosaminidase digestion, (3) jack bean α-mannosidase digestion, (4) snail β-mannosidase digestion, (5) bovine epididymis α-fucosidase digestion, or (6) <i>Flavobacterium</i> endo-β-galactosidase digestion and D-galactono-gamma-lactone. Other conditions of exoglycosidase digestion were; (7) diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (8) sequential incubation with jack bean β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (9) sequential incubation with <i>Bacillus</i> α-fucosidase  and with a mixture of diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (10) almond α-fucosidase I, diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (11) sequential digestion with jack bean β-galactosidase and with jack bean β-<i>N</i>-acetylhexosaminidase, (12) sequential digestion with <i>Bacillus</i> α-fucosidase and with a mixture of diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase. After incubation, the samples were heated, it was passed through Dowex 50 (H<sup>+</sup> form) and AG-3(OH<sup>-</sup> form) columns and analyzed by either paper electrophoresis or Bio-Gel P-4 column chromatography. The sample was performed a methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides of carcinoembryonic antigens from liver metastases of primary colon cancer patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "liver" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_256  a  gn:DS_256_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1520" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-03-20" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=3 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPDAP TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNKLSVDHSDPVILNVLYGPDDPTI SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "CEACAM5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_256" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "carcinoembryonic antigen" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P06731" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_type>
                "A" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was complext type and named fraction N1, a part of nuetral oligosaccharides, obtained from TY (CEA-TY)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "colon carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "metastasis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-256" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was purified by Sepharose 6B and Sepharose 4B gel permeation chromatography followed by concanavalin A-Sepharose 4B affinity chromatography. The sample was dried." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The dried sample was suspended in anhydrous hydrazine and heated. The sample was dissolved in NaOH and reduced with NaB<sup>3</sup>H<sub>4</sub> after addition of lactose. [<sup>3</sup>H]Lactitol and tritium-labeled sample was separated by paper chromatography. The sample was reduced with NaB<sup>2</sup>H<sub>4</sub> to obtain deuterium-labeled oligosaccharide fractions for methylation analysis. The sample was incubated with galactose oxidase and horse radish peroxidase. The sample was incubated with NaB<sup>3</sup>H<sub>4</sub> and then reduced with NaBH<sub>4</sub>. The samples were incubated with (1) sialidase digestion, (2) the mixture of jack bean β-galactosidase and β-<i>N</i>-acetylhexosaminidase, β-galactosidase and β-<i>N</i>-acetylhexosaminidase digestion, (3) jack bean α-mannosidase digestion, (4) snail β-mannosidase digestion, (5) bovine epididymis α-fucosidase digestion, or (6) <i>Flavobacterium</i> endo-β-galactosidase digestion and D-galactono-gamma-lactone. Other conditions of exoglycosidase digestion were; (7) diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (8) sequential incubation with jack bean β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (9) sequential incubation with <i>Bacillus</i> α-fucosidase  and with a mixture of diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (10) almond α-fucosidase I, diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (11) sequential digestion with jack bean β-galactosidase and with jack bean β-<i>N</i>-acetylhexosaminidase, (12) sequential digestion with <i>Bacillus</i> α-fucosidase and with a mixture of diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase. After incubation, the samples were heated, it was passed through Dowex 50 (H<sup>+</sup> form) and AG-3(OH<sup>-</sup> form) columns and analyzed by either paper electrophoresis or Bio-Gel P-4 column chromatography. The sample was performed a methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides of carcinoembryonic antigens from liver metastases of primary colon cancer patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "liver" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_257  a  gn:DS_257_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1520" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2019-03-20" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=3 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPDAP TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNKLSVDHSDPVILNVLYGPDDPTI SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "CEACAM5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_257" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "carcinoembryonic antigen" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P06731" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_type>
                "A" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was sialic acid containing oligosaccharides and named fraction AN, a part of acidic oligosaccharides, obtained from TY (CEA-TY)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "colon carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "metastasis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-257" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was purified by Sepharose 6B and Sepharose 4B gel permeation chromatography followed by concanavalin A-Sepharose 4B affinity chromatography. The sample was dried." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The dried sample was suspended in anhydrous hydrazine and heated. The sample was dissolved in NaOH and reduced with NaB<sup>3</sup>H<sub>4</sub> after addition of lactose. [<sup>3</sup>H]Lactitol and tritium-labeled sample was separated by paper chromatography. The sample was reduced with NaB<sup>2</sup>H<sub>4</sub> to obtain deuterium-labeled oligosaccharide fractions for methylation analysis. The sample was incubated with galactose oxidase and horse radish peroxidase. The sample was incubated with NaB<sup>3</sup>H<sub>4</sub> and then reduced with NaBH<sub>4</sub>. The samples were incubated with (1) sialidase digestion, (2) the mixture of jack bean β-galactosidase and β-<i>N</i>-acetylhexosaminidase, β-galactosidase and β-<i>N</i>-acetylhexosaminidase digestion, (3) jack bean α-mannosidase digestion, (4) snail β-mannosidase digestion, (5) bovine epididymis α-fucosidase digestion, or (6) <i>Flavobacterium</i> endo-β-galactosidase digestion and D-galactono-gamma-lactone. Other conditions of exoglycosidase digestion were; (7) diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (8) sequential incubation with jack bean β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (9) sequential incubation with <i>Bacillus</i> α-fucosidase  and with a mixture of diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (10) almond α-fucosidase I, diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (11) sequential digestion with jack bean β-galactosidase and with jack bean β-<i>N</i>-acetylhexosaminidase, (12) sequential digestion with <i>Bacillus</i> α-fucosidase and with a mixture of diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase. After incubation, the samples were heated, it was passed through Dowex 50 (H<sup>+</sup> form) and AG-3(OH<sup>-</sup> form) columns and analyzed by either paper electrophoresis or Bio-Gel P-4 column chromatography. The sample was performed a methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides of carcinoembryonic antigens from liver metastases of primary colon cancer patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "liver" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_132  a  gn:DS_132_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1520" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-08" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=3 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPDAP TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNKLSVDHSDPVILNVLYGPDDPTI SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "CEACAM5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "carcinoembryonic antigen" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P06731" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_type>
                "A" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named MY and CEA-MY." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "colon carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "metastasis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-132" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was purified by Sepharose 6B and Sepharose 4B gel permeation chromatography followed by concanavalin A-Sepharose 4B affinity chromatography. The sample was dried." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The dried sample was suspended in anhydrous hydrazine and heated. The sample was dissolved in NaOH and reduced with NaB<sup>3</sup>H<sub>4</sub> after addition of lactose. [<sup>3</sup>H]Lactitol and tritium-labeled sample was separated by paper chromatography. The sample was reduced with NaB<sup>2</sup>H<sub>4</sub> to obtain deuterium-labeled oligosaccharide fractions for methylation analysis. The sample was incubated with galactose oxidase and horse radish peroxidase. The sample was incubated with NaB<sup>3</sup>H<sub>4</sub> and then reduced with NaBH<sub>4</sub>. The samples were incubated with (1) sialidase digestion, (2) the mixture of jack bean β-galactosidase and β-<i>N</i>-acetylhexosaminidase, β-galactosidase and β-<i>N</i>-acetylhexosaminidase digestion, (3) jack bean α-mannosidase digestion, (4) snail β-mannosidase digestion, (5) bovine epididymis α-fucosidase digestion, or (6) <i>Flavobacterium</i> endo-β-galactosidase digestion and D-galactono-gamma-lactone. Other conditions of exoglycosidase digestion were; (7) diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (8) sequential incubation with jack bean β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (9) sequential incubation with <i>Bacillus</i> α-fucosidase  and with a mixture of diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (10) almond α-fucosidase I, diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (11) sequential digestion with jack bean β-galactosidase and with jack bean β-<i>N</i>-acetylhexosaminidase, (12) sequential digestion with <i>Bacillus</i> α-fucosidase and with a mixture of diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase. After incubation, the samples were heated, it was passed through Dowex 50 (H<sup>+</sup> form) and AG-3(OH<sup>-</sup> form) columns and analyzed by either paper electrophoresis or Bio-Gel P-4 column chromatography. The sample was performed a methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides of carcinoembryonic antigens from liver metastases of primary colon cancer patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "liver" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_133  a  gn:DS_133_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:1520" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-08-08" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=3 MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPDAP TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNKLSVDHSDPVILNVLYGPDDPTI SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Gene_uniprot>
                "CEACAM5" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_133" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Organism_uniprot>
                "Homo sapiens" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "carcinoembryonic antigen" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Taxonomic_identifier_uniprot>
                "9606" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P06731" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_Se_type>
                "Se" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#blood_type>
                "A" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named TT and CEA-TT." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "colon carcinoma" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease_stage>
                "metastasis" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-133" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The sample was purified by Sepharose 6B and Sepharose 4B gel permeation chromatography followed by concanavalin A-Sepharose 4B affinity chromatography. The sample was dried." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The dried sample was suspended in anhydrous hydrazine and heated. The sample was dissolved in NaOH and reduced with NaB<sup>3</sup>H<sub>4</sub> after addition of lactose. [<sup>3</sup>H]Lactitol and tritium-labeled sample was separated by paper chromatography. The sample was reduced with NaB<sup>2</sup>H<sub>4</sub> to obtain deuterium-labeled oligosaccharide fractions for methylation analysis. The sample was incubated with galactose oxidase and horse radish peroxidase. The sample was incubated with NaB<sup>3</sup>H<sub>4</sub> and then reduced with NaBH<sub>4</sub>. The samples were incubated with (1) sialidase digestion, (2) the mixture of jack bean β-galactosidase and β-<i>N</i>-acetylhexosaminidase, β-galactosidase and β-<i>N</i>-acetylhexosaminidase digestion, (3) jack bean α-mannosidase digestion, (4) snail β-mannosidase digestion, (5) bovine epididymis α-fucosidase digestion, or (6) <i>Flavobacterium</i> endo-β-galactosidase digestion and D-galactono-gamma-lactone. Other conditions of exoglycosidase digestion were; (7) diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (8) sequential incubation with jack bean β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (9) sequential incubation with <i>Bacillus</i> α-fucosidase  and with a mixture of diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (10) almond α-fucosidase I, diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase, (11) sequential digestion with jack bean β-galactosidase and with jack bean β-<i>N</i>-acetylhexosaminidase, (12) sequential digestion with <i>Bacillus</i> α-fucosidase and with a mixture of diplococcal β-galactosidase and jack bean β-<i>N</i>-acetylhexosaminidase. After incubation, the samples were heated, it was passed through Dowex 50 (H<sup>+</sup> form) and AG-3(OH<sup>-</sup> form) columns and analyzed by either paper electrophoresis or Bio-Gel P-4 column chromatography. The sample was performed a methylation analysis." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "Oligosaccharides of carcinoembryonic antigens from liver metastases of primary colon cancer patient." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "liver" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_85  a   gn:DS_85_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-09" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_85" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "2 months to 8 years old n=3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "the Kasetsart University Veterinary Teaching Hospital (KUVTH), Faculty of Veterinary Medicine, Kasetsart University, Thailand." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The animals died without respiratory tract infections. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-85" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "dog" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The samples were the lower respiratory tracts. The samples were homogenized with miliQ water and freeze-dried. Then the samples were delipidated using ethanol, Chloroform/Methanol, and Chloroform/Methanol/miliQ water. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The samples were proteolyzed with pepsin and further digested with glycoaminidase A.  The reducing ends of the released <i>N</i>-glycans were labeled with fluorescent reagent 2-aminopyridine, then were fractionated on an DEAE column. The samples were separated by an ODS column and were subjected to MALDI-TOF-MS. The samples were further separated by an amide column.  The <i>N</i>-glycan  structures were  identified based on GU and mass values in comparison to PA-glycans in the GALAXY database(DOI: 10.4052/tigg.15.235). The unknown structures in GALAXY were characterized by exoglycosidase treatments (α-sialidase, α2,3-sialidase, α-fucosidase, α-galactosidase, β-galactosidase, and β-<i>N</i>-acetylglucosaminidase) and mass spectrometric analysis, as previously described (PMID: 7785764, PMID: 15958418)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans derived from domestic dog lung tissue." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9615" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "lung" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_86  a   gn:DS_86_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-06" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "2 months to 8 years old n=3" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#biomaterial_provider>
                "the Kasetsart University Veterinary Teaching Hospital (KUVTH), Faculty of Veterinary Medicine, Kasetsart University, Thailand." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The animals died without respiratory tract infections. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-86" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "cat" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The samples were the lower respiratory tracts. The samples were homogenized with miliQ water and freeze-dried. Then the samples were delipidated using ethanol, Chloroform/Methanol, and Chloroform/Methanol/miliQ water. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The samples were proteolyzed with pepsin and further digested with glycoaminidase A.  The reducing ends of the released <i>N</i>-glycans were labeled with fluorescent reagent 2-aminopyridine, then were fractionated on an DEAE column. The samples were separated by an ODS column and were subjected to MALDI-TOF-MS. The samples were further separated by an amide column.  The <i>N</i>-glycan  structures were  identified based on GU and mass values in comparison to PA-glycans in the GALAXY database(DOI: 10.4052/tigg.15.235). The unknown structures in GALAXY were characterized by exoglycosidase treatments (α-sialidase, α2,3-sialidase, α-fucosidase, α-galactosidase, β-galactosidase, and β-<i>N</i>-acetylglucosaminidase) and mass spectrometric analysis, as previously described (PMID: 7785764, PMID: 15958418)." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans derived from domestic cat lung tissue." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9685" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "lung" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_40  a   gn:DS_40_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#DOID>
                "DOID:2917" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#FASTA>
                ">sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2 QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHY ADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGK >sp|P0DOX7|IGK_HUMAN Immunoglobulin kappa light chain OS=Homo sapiens OX=9606 PE=1 SV=1 DIQMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPKLLMYKASSLESGVPS RFIGSGSGTEFTLTISSLQPDDFATYYCQQYNSDSKMFGQGTKVEVKGTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_40" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1 (kappa)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#disease>
                "cryoglobulinemia" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-40" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The needle crystals in the patient's serum were incubatied, isolated by centrifugation and then dissolved into physiological saline and recrystallized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested by glycoamidase and its reducing ends was aminated with 2-aminopyridine by use of sodium cyanoborohydride. The sample was purified by HPLC on a TSK gel DEAE-5PW column. And then the sample was separated on a Shim-pack HRC-octadecyl silica (ODS) column and a TSK-gel Amide-80 column. <i>N</i>-glycosylation profiles were analyzed by HPLC using three-dimensional sugar mapping technique." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The purified cryoglobulin, IgG1(kappa)  in the serum from the cryoglobulinemia patient." .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_41  a   gn:DS_41_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-05-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_41" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Protein_Name>
                "Immunoglobulin G1 (kappa)" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Uniprot_ID>
                "P0DOX5&P0DOX7" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#age>
                "0 - 85 years" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#bio_fluids>
                "serum" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#health_state>
                "healthy" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-41" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "human" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "The serum was passed through a column containing protein G-coupled Sepharose 4B and bound IgG was eluted." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was digested by glycoamidase A and its reducing ends was aminated with 2-aminopyridine by use of sodium cyanoborohydride. The sample was purified by a Sephadex G-15 column. And then the sample was separated on a Shim-pack HRC-octadecyl silica (ODS) column and a TSK-gel Amide-80 column. <i>N</i>-glycosylation profiles were analyzed by HPLC using three-dimensional sugar mapping technique." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_store_temp>
                "-80 degree Celsius" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "The purified cryoglobulin, IgG1(kappa)  in the serum from healthy control." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sex>
                "male n=227, female n=176" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_82  a   gn:DS_82_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-06-29" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_82" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#_The_sample_was_extracted_from_the_cells_with_ethanol,_chloroform/methanol,_chloroform/methanol/H<sub>2</sub>O,_and_acetone.>
                "MatMetho_Preparation of N-glycans from CAM and AM cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named CAM." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#dev_stage>
                "10-day-old embryonated eggs" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#egg>
                "embryonated eggs" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-82" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "Gallus gallus" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Chorioallantoic membrane cells of 10-day-old chicken embryonated eggs were washed to remove blood cells and lyophilized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was proteolyzed with pepsin and further digested with glycoamidase A. The sample was hydrolyzed with pronase and purified by a Bio-Gel P-2 column then dried. The sample was labeled with 2-aminopyridine, purified on a Sephadex G-15 column and then subjected to  (DEAE)-5PW column. The sample was analyzed by reverse-phase HPLC, which individual peak fractions were then isolated using a TSK-gel amide-80 column. <i>N</i>-glycan structures was identified using three kinds of HPLC columns in comparison with PA-glycans in the GALAXY database. PA-glycans, which were unknown in GALAXY, were trimmed by exo-glycosidase (α-sialidase, α2,3-sialidase, α-fucosidase, β-galactosidase and β-<i>N</i>-acetylglucosaminidase) treatment and were analyzed by MALDI-TOF-MS." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans from the lipid isolated from chorioallantoic membrane cells of 10-day-old chicken embryonated eggs." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9031" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "chorioallantoic membrane cells" .
@prefix edam:  <http://edamontology.org/> .
@prefix gn:    <http://purl.jp/bio/12/glyco/glyconavi#> .
@prefix id_pubmed: <http://identifiers.org/pubmed/> .
@prefix skos:  <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .
@prefix gs:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample#> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio:   <http://semanticscience.org/resource/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ga:    <http://purl.jp/bio/12/glyco/glyconavi/DiseaseAbun#> .
@prefix gsss:  <http://purl.jp/bio/12/glyco/glyconavi/DiseaseSample/SampleState#> .
@prefix obo:   <http://purl.obolibrary.org/obo/> .
@prefix gd:    <http://purl.jp/bio/12/glyco/glyconavi/disease#> .

gsss:DS_83  a   gn:DS_83_DiseaseSample_State ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#Date>
                "2018-07-02" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#GlycoSampleID>
                "GS_83" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#_The_sample_was_extracted_from_the_cells_with_ethanol,_chloroform/methanol,_chloroform/methanol/H<sub>2</sub>O,_and_acetone.>
                "MatMetho_Preparation of N-glycans from CAM and AM cells" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#description>
                "The sample was named AM." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#dev_stage>
                "10-day-old embryonated eggs" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#egg>
                "embryonated eggs" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#local_ID>
                "AH-83" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#organism>
                "Gallus gallus" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_collect_device>
                "Chorioallantoic membrane cells of 10-day-old chicken embryonated eggs were washed to remove blood cells and lyophilized. " ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#samp_mat_process>
                "The sample was proteolyzed with pepsin and further digested with glycoamidase A. The sample was hydrolyzed with pronase and purified by a Bio-Gel P-2 column then dried. The sample was labeled with 2-aminopyridine, purified on a Sephadex G-15 column and then subjected to  (DEAE)-5PW column. The sample was analyzed by reverse-phase HPLC, which individual peak fractions were then isolated using a TSK-gel amide-80 column. <i>N</i>-glycan structures was identified using three kinds of HPLC columns in comparison with PA-glycans in the GALAXY database. PA-glycans, which were unknown in GALAXY, were trimmed by exo-glycosidase (α-sialidase, α2,3-sialidase, α-fucosidase, β-galactosidase and β-<i>N</i>-acetylglucosaminidase) treatment and were analyzed by MALDI-TOF-MS." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#sample_title>
                "<i>N</i>-glycans from the lipid isolated from amniotic cells of 10-day-old chicken embryonated eggs." ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#taxonomy_id>
                "9031" ;
        <http://purl.jp/bio/12/glyco/glyconavi/GlycoSample#tissue_type>
                "amniotic membrane cells" .
